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Summary
The ubiquitin/proteasome system is the main cytosolic and nuclear proteolytic system of
eukaryotic cells, regulating a multitude of important cellular processes by controlling
protein levels. The proteasome is a highly processive enzyme that usually degrades
substrates to small peptides. However, some proteins evolved mechanisms allowing
them to escape complete degradation. These substrates engage the proteasome to
activate intrinsic dormant functions by processing their inactive precursors.
This study focuses on the mechanisms controlling partial degradation of proteins
by the ubiquitin/proteasome system using as an experimental model the activation of the
yeast transcription factors Spt23 and Mga2. Previous work showed that Spt23 and Mga2
undergo regulated processing of their ER membrane-bound inactive precursors (p120)
to shorter transcriptionally active forms (p90). The proteasome is believed to engage
loosely folded regions at either the N- or C-termini of its substrates for initiation of
degradation. However, during the processing reaction the N-terminal domains of
Spt23/Mga2 are not degraded, while the C-termini are localized to the ER lumen and not
accessible for the proteasome, suggesting internal initiation sites. In the first part of this
work, this hypothesis was experimentally tested. Processing of Mga2 variants with their
C-termini stabilized by fusion to a tightly folded domain resulted in accumulation of stable
C-terminal products, which are not normally detected due to their rapid degradation.
Similar results were obtained with native Spt23/Mga2 processed by functionally impaired
proteasomes, confirming that their partial degradation is initiated at internal sites.
Furthermore, tight dimerization of p120 molecules was shown to be crucial to halt
proteasome progression, thereby preventing complete degradation of p120 and allowing
p90 formation. Altogether, the data presented suggest that proteasomal processing of
Spt23/Mga2 is initiated by an internal cleavage, followed by bidirectional proteolysis of
the polypeptides until it is halted by a barrier, the dimerization domain. Importantly, this
work shows that not only partial but also complete degradation of proteins can be initiated
at polypeptide loops, suggesting a more general mechanism of proteasomal activity.
The second part of this work focused on the regulation of Spt23/Mga2 processing by
intramolecular interaction between the dimerization and ankyrin repeat domains. This
interaction could be shown to inhibit processing of the p120 molecule from the p120/p90
heterodimer and allow a distinct step of regulation of Mga2 activity by tightly controlled
mobilization of its processed transcriptionally active p90 form.
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1. Introduction
1.1. The ubiquitin/proteasome proteolytic pathway
The ubiquitin/proteasome system (UPS) is the main eukaryotic cytosolic and nuclear
proteolytic pathway serving for selective degradation of cellular proteins. By
influencing protein abundance, the proteasome contributes to the dynamic state of
cells, which allows a tight control of many biochemical pathways and cellular
responses upon changes of the environment.
The UPS was found to regulate a multitude of important cellular processes,
including cell cycle progression, transcription, immune response and quality control
of de novo-produced proteins. Since many substrates of the proteasome localize to
the same cellular compartments, the system needs to select possible targets,
discriminate them from other stable proteins and degrade them specifically at the
proper moment. Unlike conventional site-specific proteases, which recognize
substrates by specific motifs, the proteasome has no apparent preference for a
substrate sequence, as it has to act on a broad spectrum of proteins. To avoid
promiscuous degradation by the proteasome, a specialized system evolved that
selects proteins and marks them with the small protein ubiquitin. In addition, the
catalytic sites of this complex are not directly accessible for native proteins. In the
proteasome, the active sites are buried inside a protein barrel-like complex and access
to the proteasome is prevented by narrow openings, allowing only unfolded
polypeptide chains to enter the proteolytic chamber. The combination of a highly
selective and regulated recognition of substrates by the ubiquitylation machinery with
broad activity of the proteasome, make the UPS exceptionally potent degradation
system.
1.1.1. Enzymatic cascade for ubiquitin conjugation
Ubiquitin is a small, highly evolutionarily conserved protein found abundantly in all
eukaryotic cells. The conjugation of ubiquitin to a substrate (ubiquitylation) is a three-
step enzymatic reaction (Figure 1-1) that results in a covalent linkage between the C-
terminus of ubiquitin and a lysine residue of the target protein. When the substrate of
this conjugation reaction is a lysine residue of another ubiquitin moiety, a
polyubiquitin chain is formed. The first step, which is catalyzed by the ubiquitin-
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activating enzyme (UBA; E1), involves the ATP-dependent formation of a high-
energy thioester bond between the C-terminal glycine residue of ubiquitin and a
cysteine residue from the E1 active centre (McGrath et al., 1991). This activated
ubiquitin is transferred in a similar enzymatic reaction to a cysteine residue of the
ubiquitin-conjugating enzyme (UBC; E2). In a third step, ubiquitin is finally attached to
the target protein usually via an isopeptide bond between the C-terminal glycine of
ubiquitin and the ε-amino group of the substrate lysine residue. This reaction is
mediated by a class of enzymes called ubiquitin ligases (E3). Sometimes, for efficient
polyubiquitylation of a substrate, additional E4 enzymes are required (Koegl et al.,
1999; Richly et al., 2005).
The involvement of three distinct steps in ubiquitylation provides the means to
control substrate specificity. The first reaction of ubiquitin activation is mediated by a
single E1 enzyme encoded in all eukaryotes by a single gene (Uba1) (Pickart, 2001).
However, both E2 and E3 enzymes represent protein families. In the yeast
Saccharomyces cerevisiae there are 11 ubiquitin-conjugating enzymes and a much
larger number of E3 ligases. Usually, an E2 enzyme can interact with several E3
ligases and each of the E3 enzymes can selectively interact with several substrates
via specific recognition motifs. This ensures the targeting of many different proteins
to the proteasome in a selective and regulated way.
1.1.2. E3 ligases determine substrate specificity
E3 ubiquitin ligases comprise a large group of enzymes, which mediate the
attachment of ubiquitin molecules to substrates. This process must be highly specific
Figure 1-1. The enzymatic machinery for ubiquitylation. Ubiquitin is transferred to a substrate
through a cascade of E1, E2 and E3 enzymes, and in some cases additionally an E4 enzyme.
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to avoid undesired degradation of other proteins. In addition, E3 ligases are often of
modular organization in order to recognize a broad range of substrates. For efficient
ubiquitylation, the substrate must possess an E3-binding site and an exposed lysine
residue, which can accept the ubiquitin moiety from the E2/E3 enzyme complex.
E3 ubiquitin ligases can be divided according to the conserved catalytic
domains, into two major groups: the so-called HECT enzymes and RING finger-
containing enzymes, which differ greatly in their mechanism of reaction.
The HECT (homologous to E6AP C-terminus) domain family proteins harbour
an evolutionarily conserved sequence of about 350-amino acids, which is responsible
for the interaction with a ubiquitin-loaded E2 enzyme (Huibregtse et al., 1995;
Scheffner et al., 1995). The HECT domain also contains an invariant cysteine residue
to which the ubiquitin molecule is transferred from the E2 enzyme (Figure 1-2a). The
N-terminal domains vary among different members of these E3 ligases and are
responsible for specific interactions with ubiquitylation substrates. The first identified
protein of the HECT family was E6AP (E6-associated protein), which after oncogenic
papillomavirus infection in the presence of the viral E6 protein ubiquitylates and
targets the tumour suppressor p53 for rapid degradation (Scheffner et al., 1993). Of
the five members of HECT E3s in Saccharomyces cerevisiae, the best studied is
Rsp5. This enzyme is essential for cell viability and implicated in the regulation of
many cellular processes including fatty acids metabolism, transcription, endocytosis
and protein sorting. Rsp5 contains an N-terminal lipid-interacting C2 domain
responsible for its localization to endosomal membranes and three centrally located
WW domains that are known to bind specific (L/P)PXY amino acid sequences (PY
motifs) (Chang et al., 2000; Dunn et al., 2004).
The second class of E3 enzymes contains a short RING (“really interesting new
gene”) finger motif, rich in cysteine and histidine residues that coordinate two zinc
ions (Borden, 2000). Even though there is no sequence or structural similarity
between the HECT and RING domains, both domains bind to the E2 enzyme at the
same surface (Zheng et al., 2000). However, unlike the HECT domain, the RING
finger does not form covalent linkage with ubiquitin, but rather increases the
probability of the ubiquitin transfer reaction by bringing the E2 bound ubiquitin in
close proximity to the lysine residue of the substrate (Figure 1-2b). The RING finger-
containing E3 enzymes are composed of one or several different subunits. Single
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subunit enzymes are e.g.: cytosolic Ubr1, nuclear Rad18 or the ER membrane-bound
Hrd1 protein. These proteins contain the RING finger and the substrate recognition
site in the same molecule. The multisubunit E3 ligases are composed of scaffold
proteins, regulatory proteins and variable subunits, which recognize substrates.
Examples of the multisubunit RING finger E3 ligases in yeast are the SCF (Skp1-
Cul1-F-box) complex (Figure 1-2c), which is mainly involved in the degradation of
phosphorylated proteins (Petroski and Deshaies, 2005), and the APC/C (anaphase
promoting complex/cyclosome) complex (Figure 1-2d), which plays an essential role
in the degradation of cyclins (Peters, 2006). SCF complexes belong to a group of E3
ubiquitin ligases that are assembled on the cullin (Cul1/Cdc53) scaffold, which
recruits the RING finger protein Rbx1 and the Skp1 protein, which in turn interacts
with variable F-box containing substrate-recruiting adaptors. Notably, APC/C exhibits
a similar organization as it contains a cullin-like subunit called Apc2, a RING-finger
subunit Apc11 and variable substrate-binding subunits: Cdc20, Cdh1 or Ama1
(Peters, 2006).
1.1.3. Regulation of ubiquitin conjugation to substrates
Targeting of proteins for ubiquitylation needs to be tightly controlled to avoid any
erroneous degradation of cellular proteins. Therefore, proteins possess specific
degradation signals (degrons), which usually serve as E3 binding sites (Hochstrasser
Figure 1-2. Mechanisms of ubiquitylation by E3 ubiquitin ligases. (a) HECT type enzymes form a
thioester bond with ubiquitin via a cysteine residue in their active centre and subsequently transfer
ubiquitin to a lysine residue of a substrate. (b-d) RING finger containing ligases: monomeric (b) and
multi-subunit: SCF (c) and APC (d). RING finger containing enzymes facilitate transfer of ubiquitin
from the E2 enzyme to a substrate.
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et al., 1999). In addition, many regulatory mechanisms have evolved that assure
proper timing and modulate the selectivity of ubiquitylation.
In the well established N-end rule pathway, for example, the degron signal
recognized by the ubiquitin ligase Ubr1 is the N-terminal residue of certain proteins
(Bachmair and Varshavsky, 1989; Johnson et al., 1995). The identity of the N-
terminal residue defines the affinity for the Ubr1 ubiquitin ligase, which in turn
translates into different half-lives of the substrates. Other examples of degrons are
specific sequences, e.g. the destruction box and the KEN box of some cell cycle
regulators recognized by the APC/C complex (Burton and Solomon, 2000; Hilioti et
al., 2001; Pfleger and Kirschner, 2000) or the PXY motif found in many substrates of
the Rsp5 E3 ligase (Chang et al., 2000).
One central role of the UPS is protein quality control by the removal of proteins
that are aberrantly folded and therefore unable to perform their functions. In this
case, the target selection is thought to be mediated by recognition of certain
substructures, such as solvent-exposed hydrophobic patches, unpaired cysteines
and immature glycans, rather then by specific sequences. This process involves a
specialized subset of chaperones cooperating with the E3 ligases. In mammalian
cells, the cytosolic E3 ligase CHIP works together with Hsp70-Hsp90 chaperones to
target defective proteins for ubiquitylation (Esser et al., 2004). Another, well studied
cellular quality control pathway is ERAD (ER-associated degradation), which involves
E3 ligases that specifically target misfolded proteins with either lumenal and
transmembrane lesions (Hrd1 E3 ligase associated complex) or cytoplasmic lesions
(Doa10 E3 ligase complex) (Ismail and Ng, 2006). Specific recognition of Hrd1
substrates with misfolded luminal domains is mediated by the E3 ligase partner
protein Hrd3, the ER-lumenal chaperone Kar2 and the lectin-like protein Yos9,
querying the status of the substrates glycosylation (Denic et al., 2006; Gauss et al.,
2006). In the case of proteins with disturbed transmembrane domains only Hrd1 and
Hrd3 seem to be required (Carvalho et al., 2006). Misfolding of a protein must not
necessarily be the result of mistakes in folding of newly produced proteins, but can
also be done “on purpose” in order to regulate the abundance of certain proteins, as
it was reported for the yeast proteins Ole1 and Hmg2 (Braun et al., 2002; Shearer
and Hampton, 2005). Different mechanism, but the same principle can be applied to
the regulation of degradation of a1 and α2 transcription factors controlling opposite
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mating types in haploid yeast S. cerevisiae cells. The α2 factor is stable only in
diploid cells due to the binding of the a1 partner, which masks its hydrophobic degron
site Deg1, otherwise exposed to the solvent and recognized by Doa10 E3 ligase
(Johnson et al., 1998; Swanson et al., 2001).
A common mechanism by which the interaction of ubiquitin ligases with their
substrates is regulated involves post-translational modifications of either of them. The
most common type of substrate modification used to control degradation is
phosphorylation. The prerequisite for the ubiquitylation of the yeast G2 cyclins Clb2
and Clb3, the cyclin-dependent kinase inhibitor Sic1 or the mammalian IκB and
NFκB transcription factors is their phosphorylation allowing an interaction with the
appropriate SCF type E3 ligase (Willems et al., 2004). Another post-translational
modification regulating ubiquitylation of proteins may be the conjugation of the
ubiquitin-like protein SUMO (small ubiquitin-related modifier; Smt3 in yeast), termed
SUMOylation. As it was show for IκBα, SUMOylation on one of the ubiquitin acceptor
lysines inhibits its ubiquitylation and degradation, suggesting that SUMO can block
ubiquitylation by a direct competition for the modification site (Desterro et al., 1998).
Similarly to the modification of substrates, also E3 ligases can be modified to
change their activity or ability to bind a substrate. In yeast, upon DNA damage,
protein kinase A (PKA) phosphorylates the APC/C subunit Cdc20, blocking thereby
the degradation of cyclin Clb2 and securin and inducing cell-cycle arrest (Searle et
al., 2004). Also modification of the SCF complexes subunit Cul1 by the ubiquitin like
protein Nedd8 (in yeast Rub1) was shown to promote the ubiquitylation of certain
substrates (Podust et al., 2000).
Since ubiquitylation is a reversible modification, the degradation of substrates
can be additionally regulated by a special class of proteins termed deubiquitylating
(DUB) enzymes, which cleave specifically the isopeptide bond of ubiquitin
modification (Amerik and Hochstrasser, 2004). Such activity can lead to removal of
ubiquitin from the substrate. This type of regulation was shown in yeast for the DUB
enzymes Ubp2 or Otu1, which antagonize the E3 ligase Rsp5 and the E4 enzyme
Ufd2, respectively (Kee et al., 2005; Rumpf and Jentsch, 2006).
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1.1.4. The mode of ubiquitylation determines the fate of a conjugated
substrate
The most extensively studied function of ubiquitylation is the targeting of proteins for
degradation by the proteasome. However, in other cases ubiquitylation serves non-
proteolytic functions such as regulation of protein traffic or enzymatic activity. This is
reflected by the fact that different substrates can be modified by different types of
ubiquitylation. Ubiquitin can be attached either as a single molecule
(monoubiquitylation) or as an ubiquitin polymer (polyubiquitylation) to the substrate.
The polymeric ubiquitin chains can be further divided into different types, depending
on which of the seven lysine residues of ubiquitin is used to form the isopeptide bond
with the next ubiquitin molecule. Monoubiquitylation and differently linked
polyubiquitin chains are recognized in cells as signals that target the conjugated
proteins to different fates. Recognition of these signals is mediated by a large group
of ubiquitin-binding proteins, containing at least one of several classes of domains
that were shown to specifically interact with monoubiquitin and/or polyubiquitin
chains. Among these domains are UIM (ubiquitin interacting motif), UBA (ubiquitin
associated) and CUE (coupling of ubiquitin conjugation to endoplasmic reticulum
degradation) (Hicke et al., 2005).
Modification by monoubiquitin is not usually directly implicated in targeting of
proteins to the proteasome for degradation. Instead, this signal is broadly used to
mark proteins designated for endocytosis and intracellular trafficking. In S .
cerevisiae, internalization of various plasma membrane permeases and transporters
requires monoubiquitylation of their cytoplasmic domains by the Rsp5 ubiquitin
ligase. Moreover, another step of endocytosis, sorting of proteins to the
multivesicular bodies involves monoubiquitylation of cargo proteins (Welchman et al.,
2005). This type of modification is also used in DNA damage signalling. In this
process, replication stalled at DNA damage sites can be resumed upon PCNA
monoubiquitylation catalyzed by the E2 Rad6 (Ubc2) and E3 Rad18 enzymes, which
allows PCNA to associate with translesion polymerases that are able to read through
the damaged site (Hoege et al., 2002). Rad6 is also implicated in the
monoubiquitylation of histone H2B on the K123 residue and this modification is
required for transcriptional activation (Sun and Allis, 2002).
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The function of polyubiquitylation is primarily determined by the kind of ubiquitin
linkage in the chain attached to the substrate. The most abundant in cells and the
only essential for yeast viability are K48-linked chains, which target substrates to the
proteasome for degradation (Finley et al., 1994; Pickart and Fushman, 2004). The
role in proteolysis was reported also for K29-linked chains catalyzed by Ufd2, which
is, however, believed to switch to K48-linkage during extension (Koegl et al., 1999;
Saeki et al., 2004) and for K11-linked chains (Baboshina and Haas, 1996).
Interestingly, substrates conjugated with K6-linked chains in the DNA repair foci,
although targeted to the proteasome, are not degraded (Morris and Solomon, 2004;
Nishikawa et al., 2004).
The second most abundant mode of polyubiquitylation assembly in cells is the
conjugation of chains linked via the K63 residue of ubiquitin. This type of modification
is implicated in several non-degradative regulatory functions. In DNA repair, for
example, PCNA can be modified by the K63-linked chain by the activity of Rad6 and
Rad18, and the heterodimeric E2 enzyme Ubc13-Mms2 and the E3 enzyme Rad5
(Hoege et al., 2002). This K63-linked polyubiquitin is a signal for the error-free
pathway of DNA repair, which presumably involves a template switch to the
undamaged sister chromatid. Another example is the inflammatory response
pathway, where K63-linked chains function as signals for activation of the IκBα (the
inhibitor of transcription factors NFκB) kinase (IKK). Phosphorylation of IκBα  triggers
its degradation, allowing subsequent translocation of NFκB to the nucleus and
transcriptional response (Kanayama et al., 2004).
1.1.5. Composition and structure of the 26S proteasome complex
The 26S proteasome is the well known member of a family of so-called “chambered”
or “self-compartmentalized” proteases found in all organisms ranging from bacteria to
humans (Pickart and Cohen, 2004). Chambered proteases are large multi-subunit
enzymes, which physically sequester their proteolytic sites inside their barrel-shaped
structures. This structural organization determines a specific mechanism of
degradation, in which the recognition of degradation signals is independent of the
cleavage sites of substrates. Such mode of action gives an advantage to degrade
any type of substrates over “conventional proteases” recognizing specific sequences
near the cleavage sites. The 26S proteasome is a large 2.5 MDa ATP-dependent
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proteolytic complex composed of a central catalytic core particle (20S proteasome)
and two regulatory particles (19S caps) that sit at the top of two openings of the core
particle (Figure 1-3) (Baumeister et al., 1998). The 20S particle is a cylindrically
shaped complex composed of a stack of two identical inner hetero-heptameric rings
(made of β1 to β7 subunits; Pre3, Pup1, Pup3, Pre1, Pre2, Pre7, Pre4 in yeast) and
two identical outer hetero-heptameric rings (made of α1 to α7 subunits; Scl1, Pre8,
Pre9, Pre6, Pup2, Pre5, Pre10 in yeast) (Groll et al., 1997). Three of the β subunits
of each of the two rings harbour proteolytic sites of different cleavage preferences
(chymotrypsin-, trypsin- and caspase-like), although the cleavage site usage by the
proteasome is largely promiscuous (Kloetzel, 2004). Proteasomal substrates can
only access these catalytic sites via narrow pores in the α rings at either end of the
20S cylinder. This ensures that only unfolded polypeptide chains can enter the
proteasome (Groll et al., 1997). In addition, the access of substrates to the 20S
particle is gated by N-terminal extensions of the α-subunits (Groll et al., 2000) The
proteasomal gates open upon association with the 19S cap, allowing the passage of
substrates to proteolytic sites (Kohler et al., 2001). In the architecture of the 20S
proteasome certain interior compartments can be distinguished – two large axial
antechambers formed by the α and β rings and a central catalytic chamber formed by
Figure 1-3. The 26S proteasome. (a) Schematic representation of the 26S proteasome complex.
(b) Composite model of the three-dimensional structure of the 26S proteasome from Drosophila based
on electron microscopy and modelled using the crystal structure of the 20S proteasome from
Thermoplasma (Modified after Baumeister et al., 1998).
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the two β rings. The role of the antechambers is still not clear, but they might store
proteins in an unfolded or partially refolded state prior to degradation or store cleaved
polypeptides for further digestion to smaller peptides (Sharon et al., 2006).
Each 19S regulatory particle contains at least 17 different subunits and is
assembled from two subcomplexes: a base, which is composed of a hetero-
hexameric ring of AAA type ATPases (Rpt1-6) and two non-ATPase subunits (Rpn1-
2), and a lid that sits on the top of the base (subunits Rpn3, 5-9 and 11-12) (Figure
1-3a). Both subcomplexes are stably associated via an additional subunit Rpn10
(Glickman et al., 1998). The main functions of the 19S cap are recruiting substrates
tagged with the polyubiquitin chain, and unfolding and translocating them to the
catalytic particle. Polyubiquitin chains on target proteins are recognized directly by
components of the 19S cap and by ubiquitin-binding factors delivering substrates to
the 19S cap. Since the gates of the 20S proteasome are narrow, substrates need to
be unfolded in order to enter the catalytic chamber. This is mediated by the ATPases
located in the base (Braun et al., 1999). Interestingly, the 19S cap possesses also an
intrinsic deubiquitylation activity residing in the Rpn11 subunit of the lid (Yao and
Cohen, 2002). This enzyme is believed to take part in the recycling of ubiquitin
conjugated to the substrates destined for degradation. Moreover, there is a growing
list of proteins associating with the 19S cap, like the E3 ubiquitin ligases Ubr1and
Ufd4, the E4 enzyme Hul5, and the deubiquitylating enzyme Ubp6, which may
provide more regulatory functions for processing of substrates by the 26S
proteasome (e.g. by regulating polyubiquitin chain length on a substrate) (Crosas et
al., 2006; Hanna et al., 2006; Leggett et al., 2002; Xie et al., 2000).
1.1.6. Recognition and degradation of substrates by the 26S proteasome
To ensure selective degradation, several classes of proteins are involved in specific
recognition of ubiquitylated substrates and their delivery to ubiquitin receptors on the
proteasome. Studies on model substrates have shown that the minimal length of a
polyubiquitin chain usually required for efficient targeting to the 26S proteasome
encompasses four ubiquitin molecules (Thrower et al., 2000). The Rpn10 subunit of
the 19S cap possessing the UIM motif was shown to bind polyubiquitin chains, and
was proposed to function as a proteasomal receptor for ubiquitylated substrates
(Deveraux et al., 1994). Moreover, a recent report demonstrated that two
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homologous proteins Rad23 and Dsk2, both containing UBA domains and loosely
associating with the proteasome, deliver polyubiquitylated substrates to the 26S
proteasome (so called “escort pathway”) (Richly 2005). However, the triple knockout
of these genes in yeast is not lethal, indicating that other components are also
responsible for ubiquitin chain recognition (Elsasser and Finley, 2005; Richly et al.,
2005). A candidate for this function is one of the ATPases of the 19S cap, Rpt5, that
was also shown to bind ubiquitin chains (Lam et al., 2002). This possibility is
particularly interesting since such an interaction would also bring the substrate
directly to the unfolding machinery and in proximity to the proteasomal gates. In
addition, these various ubiquitin receptor sites at the proteasome might also have
preferential affinities to ubiquitin chains of different length and could bind substrates
depending on whether they are modified with short or long chains.
The initial recruitment of a substrate is followed by the engagement of its
loosely folded region (usually either of the polypeptide termini) by the ATPases ring
(Figure 1-4a) (Prakash et al., 2004). The ATPases are thought not only to provide a
force for sequential mechanical unfolding of the substrate and for the translocation of
the unfolded polypeptide to the catalytic particle, but they might also regulate opening
of the proteasomal gates (Kohler et al., 2001). Notably, not all proteins targeted to
the proteasome are degraded equally well. The degradation speed seems to be
determined by the unfolding efficiency by the ATPase motor, which is believed to
depend on the local structure stability of the protein region engaged by ATPases for
unfolding (Lee et al., 2001). Once the unfolding, translocation and degradation have
started, the substrate is fixed in the proteasome (Figure 1-4b), and no longer requires
the polyubiquitin tag. In fact, ubiquitin possesses an extraordinarily stable fold and by
being difficult to unfold it slows down the degradation (Yao and Cohen, 2002).
Therefore, and to save energy that otherwise would be used to produce ubiquitin de
novo, the proteasome has evolved a way to recycle ubiquitin. The removal of the
polyubiquitin chains is catalyzed by the 19S cap DUB enzyme Rpn11 and is coupled
to the substrate translocation step to ensure that too early chain removal will not
result in a release of the protein before engagement by ATPases (Figure 1-4c). Since
the proteasome is a highly processive protease, it usually degrades substrates
completely to small oligopeptides of about 5-20 residues in length. These
degradation products leave the proteasome by diffusion, perhaps also in a gated
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manner (Bajorek and Glickman, 2004; Kohler et al., 2001). The peptides generated
by the proteasome can be further degraded to free amino acids by cellular
peptidases, however in higher eukaryotes they are also transported via ER to the cell
surface and presented to the immune system by MHC class I molecules (Kloetzel,
2004).
Although most of the proteasomal substrates need the polyubiquitin mark, some
may be degraded in an ubiquitin independent manner. One such natural substrate of
the proteasome is ornithine decarboxylase (ODC) acting in the biosynthetic pathway
of polyamines. By a feedback mechanism, excess of polyamines leads to the
production of antizyme, an interactor of ODC, which enhances the affinity of ODC to
the proteasome and promotes its efficient degradation (Li and Coffino, 1992;
Murakami et al., 1992). In addition, in vitro experiments demonstrated that certain
unfolded protein segments are degraded by the 20S proteasome in an ubiquitin
independent manner, which suggests that some disordered proteins might possess
intrinsic features targeting them directly to the proteasome (Liu et al., 2003). This is
further supported by an observation that certain hydrophobic peptides activate the
peptidase activity of the proteasome, most likely by influencing opening of the gates
(Kisselev et al., 2002).
Figure 1-4. Mechanism of the ubiquitin/proteasome dependent degradation. (a) Polyubiquitylated
(red circles) substrate (black) is recognized by the 19S regulatory particle (19S RP) components. (b)
The ATPases of the base find a loosely folded “engagement site” (blue) of the substrate, start
unfolding and translocation of the unfolded polypeptide to the antechamber (AC) and then to the
catalytic chamber (CC). The substrate is degraded to small peptides by active sites (yellow dots)
located in CC. (c) The polyubiquitin chain is removed during the degradation by the Rpn11 DUB
enzyme of the 19S lid and further disassembled to free ubiquitin in the cytosol by other DUB enzymes
(not shown).
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1.2. Limited proteolysis of proteins
Proteolysis is employed by cells not only for the complete degradation of proteins but
represents also an important step for the maturation of some proteins. Similarly to the
modification of proteins by the attachment of various chemical groups, also
proteolytic processing of polypeptide chains was shown to modulate protein
conformation, as well as binding properties and activity. However, in contrast to
chemical modifications, which are usually reversible, the proteolytic cleavage is not.
The list of physiological processes found to be regulated by limited proteolysis
is large and still growing. Proteolytic processing was shown to function as early as at
the level of protein translation, where it is required to remove initiator methionine
or/and signal peptides from many secretory proteins. Furthermore, processing was
found to be a mechanism commonly used by enzymatic systems for activating
otherwise inactive precursor forms (zymogens). In many signalling pathways, limited
proteolysis enables activation of signalling molecules, e.g. by cleaving membrane-
bound proteins in order to release active fragments, which can be transported to the
nucleus for nuclear functions. Moreover, some proteins are produced as long fusions
(polyproteins) and their maturation requires specific cleavage into several active
fragments.
Most of the proteases mediating partial proteolysis of proteins are characterized
by a high specificity of the cleavage reaction and thus can only be employed for the
processing of a limited number of substrates. However, also the proteasome, which
has a broad range of substrates and is mainly implicated in the complete degradation
of proteins, can mediate limited proteolysis of some of its substrates.
1.2.1. Proteasome-independent processing of proteins
The importance of proteolytic processing was first demonstrated by studies on the
activation of two enzymes of the digestive system, trypsin and chymotrypsin, which
are produced in the pancreas as inactive forms, trypsinogen and chymotrypsinogen,
respectively (Neurath, 1989). Trypsinogen is activated upon secretion to the small
intestine, where it is activated by proteolytic cleavage by the enzyme enterokinase.
The resulting trypsin can further activate trypsinogen by autocleavage and in addition
process chymotrypsinogen to active chymotrypsin. The strategy to activate enzymes
by processing of inactive precursors is employed also in cascades of consecutive
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activation of zymogens during blood coagulation or in apoptosis (activation of
caspases) (Chang and Yang, 2000; Neurath, 1989).
Proteins of the ER, the Golgi apparatus and from the secretory pathway
possess a signal sequence, which targets them to the ER. Processing of these
proteins by the ER lumen enzyme signal peptidase occurs co-translationally and
leads to the removal of the signal peptide. An example of such processing is the
formation of the active form of the hormone insulin, which moreover requires a multi-
step proteolytic processing (Steiner, 1998). Insulin is synthesized as a precursor
polypeptide preproinsulin that contains an N-terminal signal sequence targeting the
polypeptide chain to the ER. In the first cleavage step occurring during the
translocation of the polypeptide to the ER lumen, proinsulin is formed by the
elimination of the signal sequence by the signal peptidase. A second processing step
occurs in secretory vesicles and involves a series of cleavage events mediated by
specific proteases, which remove an internal peptide from proinsulin. As a result,
active insulin consisting of two polypeptide chains connected by disulfide bonds is
secreted.
The yeast polyubiquitin gene UBI4 encodes for a polyprotein composed of five
tandemly repeated copies of ubiquitin, which is further processed to single ubiquitin
molecules by ubiquitin-specific peptidases. Production of ubiquitin by this mechanism
seems to be very efficient and can provide the cell with extra ubiquitin under stress
conditions, which is essential to sustain cell viability (Finley et al., 1987). Other
examples of polyprotein processing are Env, Gag and Gag-Pol polyproteins of the
human immunodeficiency virus (HIV) (Dunn et al., 2002). The retroviral genome is
translated by the host-cell machinery into polyproteins, which are cleaved at specific
sites by the viral peptidases to produce mature capsid proteins, non-structural
proteins and enzymes.
Proteolysis is a hydrolytic reaction, which requires the presence of water
molecules. Thus, the sites of proteolytic processing are believed to be located in the
flexible inter-domain segments of proteins or surface loops that are exposed to the
aqueous environment. Interestingly, a growing number of enzymes is reported to
mediate also the cleavage of transmembrane segments of proteins (Brown et al.,
2000). This regulated intramembrane proteolysis (RIP) is conserved from bacteria to
animals and involves distinct groups of specialized membrane-bound proteases,
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which are able to cleave residues inserted into the non-aqueous environment of
biological membranes. One of the proteins activated by such a mechanism is sterol
regulatory element binding protein (SREBP), a transcription factor that activates
genes essential for the biosynthesis of sterols and fatty acids in animal cells (Brown
et al., 2000). SREBP is synthesized as a transmembrane precursor protein, which is
kept in the ER when cholesterol levels are high. Upon depletion of cholesterol,
SREBP is transported to the Golgi apparatus where it undergoes activation upon two
sequential proteolytic cleavages by the site-1 and site-2 proteases, leading to the
liberation of the N-terminal active transcription factor domain. Another well known
example of RIP is processing of the plasma membrane signal receptor Notch, which
controls many developmental processes in animals (Fortini, 2002). Proteolysis of
Notch is catalyzed by the integral membrane multi-subunit protease γ-secretase,
which cleaves the transmembrane segment of Notch and allows its cytoplasmic
domain to translocate into the nucleus, where it functions as a transcriptional
activator. The same enzymatic complex mediates also the cleavage of amyloid
precursor protein (APP), which yields the amyloid β peptide (Aβ), forming
extracellular plaques in Alzheimer’s disease (Fortini, 2002).
1.2.2. Partial degradation of proteins by the proteasome
The main cellular task of the proteasome is the irreversible elimination of proteins in
order to regulate certain cellular processes or to remove potentially toxic misfolded
proteins. Therefore, the proteasome is highly processive and usually completely
degrades proteins to small peptides. Several features of the proteasome contribute to
this mechanism of action: the ATPase motor mediates the unfolding of substrates,
the six active sites in the proteolytic chamber efficiently cleave polypeptides and the
proteasomal gates prevent premature exit of the peptides until degradation is
completed. Although the proteasome is well equipped to destroy proteins, some of
proteins evolved mechanisms preventing complete degradation. Instead, these
substrates seem to use the proteasome system to activate certain intrinsic, but
dormant biological activities by specifically eliminating inhibitory domains while
leaving other domains intact. This phenomenon, termed regulated
ubiquitin/proteasome-dependent processing (RUP) was first described for the
mammalian transcription factor NFκB1. This protein resides in the cytosol as a
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dormant precursor (p105), which upon certain cellular stimuli becomes ubiquitylated
and targeted to the proteasome. Instead of the complete degradation, the
proteasome eliminates only the C-terminal domain of p105, yielding a shorter active
form (p50), which is subsequently translocated to the nucleus for transcriptional
response (Fan and Maniatis, 1991; Orian et al., 2000; Palombella et al., 1994). Later
studies identified more proteasomal substrates that are not degraded to completion,
but are rather activated by RUP: the mammalian transcription factor NFκB2 (p100
precursor processed to p52 subunit) (Amir et al., 2004), the yeast NFκB-related
proteins Spt23 and Mga2 (Hoppe et al., 2000; Rape and Jentsch, 2002), the
transcriptional regulator of the Sonic hedgehog pathway in Drosophila Cubitus
Interruptus (Ci) and its vertebrate homologs Gli2 and Gli3 (Jiang and Struhl, 1998;
Pan et al., 2006), and the mammalian transcription factor Sp1 (Su et al., 1999). In all
these cases, the substrates are apparently ubiquitylated upon certain cellular signals
and subsequently processed by proteasomes. This special mode of activation
suggests that they may possess specific features recognized by the proteasome as a
stop signal. However, such signal seems not to be a specific sequence, as a
comparison of sequences of the proteins mentioned above does not reveal one
common feature.
Based on the experimental data available for NFκB p105 and Spt23/Mga2, two
alternative models of processing mechanisms have been suggested that differ mainly
in the way how the proteasome initiates processing. According to the “end first”
model, the polypeptide chain is degraded from one end (in case of NFκB p105 the C-
terminus has been proposed), but proteolysis proceeds only halfway because the
proteasome encounters a “stop-transfer signal” that prevents further degradation
(Figure 1-5a) (Orian et al., 1999; Palombella et al., 1994). In the alternative “loop
model”, the substrate folds into a hairpin loop, which is threaded into the proteolytic
chamber, thereby enabling the proteasome to attack the substrate from an internal
site (Figure 1-5b-d) (Hoppe et al., 2000; Hoppe et al., 2001). In this model, complete
degradation is prevented by a tightly folded domain or through a tight binding to a
“life saving” partner (Lee et al., 2001; Rape et al., 2001; Rape and Jentsch, 2002;
Tian et al., 2005).
Particularly controversial is the mechanism of NFκB p105 processing initiation,
as in addition to the post-translational processing of the full-length precursor also a
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co-translational model has been proposed, in which the incompletely synthesized
nascent polypeptide chain serves as a processing substrate (Figure 1-5b). Since the
C-terminal ends of such precursors are buried in the ribosome and are therefore not
accessible for the proteasome, an internal initiation site has been suggested (Lin et
al., 1998; Lin et al., 2000). However, this model has been questioned recently by the
finding that the 20S proteasomes can process purified full-length NFκB p105
derivatives in vitro (Moorthy et al., 2006). The same authors suggested also that
ubiquitylation of p105 might not be required for the processing initiation and proposed
that certain regions in the NFκB precursor sequence could possess the ability to
open the otherwise closed gates of 20S proteasome (Figure 1-5c).
The “loop model” (Figure 1-5d) has been first proposed for the processing of the
Saccharomyces cerevisiae NFκB-related proteins Spt23 and its homolog Mga2
(Hoppe et al., 2000; Rape and Jentsch, 2002). The Spt23 precursor (p120) is
mono/oligoubiquitylated by the ubiquitin ligase Rsp5 and targeted to the proteasome
Figure 1-5. Models for proteasomal processing of NFκB p105 and Spt23 p120. (a) “Stop-transfer
model” proposed for the processing of the full-length precursor of NFκB p105. After ubiquitylation (red
circles), the 26S proteasome recognizes p105 and starts its degradation from the C-terminus (initiation
sites are indicated in blue), but stops when it encounters the GRR sequence (stop sign). (b) Model for
co-translational processing by endoproteolytic cleavage of p105 nascent polypeptide chains, which
dimerize on polyribosomes (green). The tight dimerization domain prevents complete degradation of
N-terminal parts of NFκB by the proteasome and leads to the formation of processed p50 form (c).
Model for post-translational, ubiquitin-independent processing of p105 by the 20S proteasome initiated
by internal cleavage. (d) The “loop model” for Spt23 p120 processing. The C-termini of p120
precursors is inserted into ER membrane via the transmembrane span and not accessible to the
proteasome. Processing involves cleavage of the polypeptide loop by the proteasome and
degradation of the C-terminal ER anchor, whereas p90 is protected from degradation by tight
dimerization with p120.
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for processing (the OLE pathway, see chapter 1.4) (Hoppe et al., 2000; Rape et al.,
2001). Similar to the NFκB situation, this process involves complete degradation of
the C-terminal domain, whereas the N-terminal part that constitutes the active
transcription factor (p90) is spared from degradation. The key argument for the “loop
model” stems from the fact that the C-terminus of Spt23 is buried in the ER
membrane, whereas the N-terminal domain constitutes the active transcription factor
and thus remains intact. It was therefore proposed that a central region of Spt23
forms a hairpin loop, allowing the proteasome to initiate processing from an internal
site (Hoppe et al., 2000). Based on the crystal structure of the yeast 20S proteasome
it was argued that the openings of the proteasome are wide enough to accommodate
two juxtaposed polypeptide chains (Rape and Jentsch, 2002). Support for this model
came from recent in vitro studies showing that artificial circular polypeptides and
cross-linked polypeptide chains are substrates of the proteasome (Lee et al., 2002;
Liu et al., 2003).
The evidence for the “stop-transfer signal” model came from observations that
proteins with certain regions of low complexity amino acid composition are poor
substrates for the proteasome. The sequence of the viral protein EBNA1 contains
glycine-alanine repeats, which are known to inhibit its proteasomal degradation,
allowing the Epstein-Barr virus to escape from the cellular immune defence (Sharipo
et al., 1998). Similar sequences rich in glycine residues (GRR; glycine-rich region)
were found in NFκB precursors close to their processing sites. Moreover, a deletion
of this region from the p105 precursor was shown to abolish formation of the
processed p50 form of the transcription factor (Lin and Ghosh, 1996; Orian et al.,
1999).
Notably, efficient processing requires that Spt23 homo-dimerizes via the IPT
domain (immunoglobulin-like/plexins/transcription factors) (Rape et al., 2001). The
IPT domain exists also in NFκB and its mutation abolishes processing of p105 (Lin et
al., 2000). This suggests that it plays the same role in the processing of mammalian
and yeast proteins. Since dimerization via the IPT domains is characterized by a very
stable fold and was shown to mediate a very strong interaction (Urban and Baeuerle,
1990), it was proposed to hinder the proteasome progression by being resistant to
unfolding by ATPases (Rape and Jentsch, 2002). A recent report suggested a new
model in which the tightly folded domains (e.g. IPT domain) work together with the
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low complexity regions (e.g. GRR) to stop the proteasome (Tian et al., 2005).
However, although yeast transcription factors have IPT domains, they seem not to
possess low complexity regions at proper positions. Notably, studies on NFκB
expressed in S. cerevisiae showed that p105 is efficiently processed by the yeast
proteasome perhaps in an ubiquitin dependent manner, but the p50 formation does
not depend on the presence of the GRR (Sears et al., 1998). This difference
suggests distinct mechanisms of the proteasomal progression stop in yeast and
mammals, or that the mechanism of partial degradation is more complex than
previously believed.
1.3. The OLE pathway
The fluidity of biological membranes in yeast Saccharomyces cerevisiae is largely
controlled by the activity of an ER membrane-bound Δ9-fatty acid desaturase
enzyme, Ole1, which converts saturated to unsaturated fatty acids (UFAs) by
introducing double bonds into their carbon chains. The importance of this process is
reflected by the fact that the activity of this enzyme is essential for yeast cell viability
(Zhang et al., 1999). The abundance of Ole1 in yeast is mainly controlled by the so-
called OLE pathway (Figure 1-6), which is extensively regulated by the proteasome,
and thus turned out to be a useful tool to study the UPS.
The first step of the OLE pathway involves the RUP-dependent activation of two
homologous transcription factors Spt23 and Mga2 that are partially overlapping in
activation the OLE1 gene (Hoppe et al., 2000). Although deletion of either of the
transcription factors alone has no significant phenotype in yeast, the double deletion
is lethal, but can be rescued by providing an external source of UFAs (Zhang et al.,
1999). Spt23/Mga2 are produced as 120 kDa precursor forms (p120), which are
inserted into the ER membrane via single C-terminal TM spans. Upon unsaturated
fatty acids depletion, Spt23 homodimerizes and is subsequently
mono/oligoubiquitylated by the HECT type E3 ligase Rsp5 (Hoppe et al., 2000). This
triggers the production of the processed form p90, which remains associated with the
partner p120 molecule (“processing template”) in a dormant complex at the ER.
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In a second step, p90 that retained its monoubiquitin mark is liberated from the
ER for nuclear export by the chaperone Cdc48Ufd1/Npl4 (Rape et al., 2001). This
complex specifically binds ubiquitylated proteins and is thereby capable of
segregating them from unmodified partners. Notably, p90 mobilization from p120 of
Mga2 also depends on the segregase Cdc48Ufd1/Npl4, however it has been reported
that it involves selective Rsp5-mediated polyubiquitylation of the processing template
molecule and targeting to the proteasome for complete degradation (this model
however, has been refused by the same authors recently) (Shcherbik and Haines,
2007; Shcherbik et al., 2003). Rsp5 and the Cdc48Ufd1/Npl4 complex play therefore
important roles in both branches of the OLE pathway – activation of Spt23 and Mga2,
but the detailed mechanisms of action are different. After mobilization from the ER
membrane, p90 forms of Spt23 and Mga2 are translocated into the nucleus to
activate expression of the OLE1 gene, thereby increasing the abundance of UFAs.
Another level of regulation in the OLE pathway affects the active transcription
factor. The nuclear Spt23 form is very unstable since the initial monoubiquitin on p90
Figure 1-6. The OLE pathway. Spt23 (in green) and Mga2 (in blue) transcription factors activation by
UPS. Monoubiquitylation (in red) of Spt23 by Rsp5 ubiquitin ligase is required for processing by the
proteasome (gray barrel). In case of Mga2, Rsp5 is dispensable for initiation of the proteasomal
processing (the E3 ligase is not known), but is responsible for liberation of p90 from processing
template p120. The Cdc48Ufd1/Npl4 complex (in yellow) plays several roles in the pathway: mobilization
of Spt23 or Mga2 p90 from the ER; recruitment of E4 enzyme (Ufd2) to Spt23 p90, its
polyubiquitylation and degradation; as well as ER associated degradation of Ole1 (not shown). In a
feedback regulation of the pathway, production of Ole1 protein leads to increased UFAs levels that
inhibit processing of Spt23.
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can be further extended by the Cdc48 binding E4 enzyme Ufd2, enabling targeting of
the transcription factor to the proteasome by the ubiquitin escort factor Rad23 (Richly
et al., 2005). Interestingly, in yeast strains harbouring an ufd2 deletion, Spt23 p90 is
partially stabilized and apparently overactive, as these cells are hypersensitive to
UFA supplement to the growth medium. This seems to be in line with the finding that
certain transcription factors are activated after mono/oligoubiquitylation and
transactivation is often coupled with degradation of a transcription factor (Muratani
and Tansey, 2003). Degradation of p90 can also be negatively regulated, as Ufd2
action can be antagonized by other Cdc48 cofactors: Ufd3 competing directly with
Ufd2 for the binding site on Cdc48 and Otu1 possessing a DUB activity (Rumpf and
Jentsch, 2006).
The Ole1 enzyme itself is a short-lived protein degraded by the ERAD
machinery, with its half-life negatively regulated by UFAs in a negative feedback loop
(Braun et al., 2002). Interestingly, high levels of UFAs, or alteration in membrane
fluidity, are also sensed by cells as signals to inhibit processing of Spt23 (Hoppe et
al., 2000). Moreover, experiments with addition of UFAs to the growth medium
showed that expression from the OLE1 promoter is efficiently shut down under such
conditions (Chellappa et al., 2001), despite the presence of Mga2, processing of
which was reported not to be significantly influenced by high levels of UFAs (Hoppe
et al., 2000). These data suggest that another mechanism could serve for inhibition
of the transcriptional activity of Mga2 (e.g. regulation of p90 mobilization). A distinct
regulatory mechanism was reported for activation of Mga2, which under hypoxic
conditions leads to a robust expression from the OLE1 promoter (Jiang et al., 2001).
Again, this induction can be strongly inhibited by increased UFA levels as a negative
feedback response (Chellappa et al., 2001). Changes of the membranes fluidity
might be directly sensed by the ER membrane-inserted precursor forms of
Spt23/Mga2, resulting in the regulation of their processing or mobilization of their
processed p90 forms.
Notably, the ubiquitin/proteasome system is involved in the control of several
consecutive steps of the OLE pathway, leading to both activation (Spt23 p120
processing, p90 mobilization, p90-mediated transcription) and inhibition (p90 and
Ole1 degradation) of the pathway. This multi-step regulation assures a tight and
quick response to changes of membranes fluidity in yeast cells.
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1.4. Aim of this work
The proteasome is the most abundant eukaryotic proteolytic complex, which controls
the half-lives of probably most intracellular proteins. Together with the selectivity of
the proteasome, ubiquitylation assures a high substrate specificity. Notably, some of
target proteins developed mechanisms that allow them to escape complete
degradation and to undergo proteasomal processing. Activation of the yeast
transcription factors Spt23 and Mga2 involves selective degradation of the C-terminal
parts of their inactive precursors, leading to the release of active N-terminal domains.
However, the mechanism of this non-conventional activity of the proteasome
remained unclear.
The aim of this study was to understand how partial degradation of Spt23 and
Mga2 by the proteasome is accomplished. To answer this question, variants of these
transcription factors were created, which helped to identify the features of Spt23 and
Mga2 that allow them to prevent complete degradation. Moreover, mutants of the
ubiquitin/proteasome system were used, in order to determine the structural
requirements for processing of the transcription factors.
Mechanism of Spt23/Mga2 partial degradation
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2. Results
2.1. Mechanism of Spt23/Mga2 partial degradation
2.1.1. Processing initiates from an internal site
It has been proposed that the proteasome initiates degradation of its substrates from
either their N- or C-termini, which are usually loosely folded (Lee et al., 2001;
Prakash et al., 2004). However, the C-terminal ends of Spt23/Mga2 precursors are
localized to the ER lumen and thereby not accessible to the proteasome, while the N-
terminal parts encompassing the transcription activation domains are protected
against proteasomal degradation. To explain how processing of this membrane
bound proteins is initiated, it was proposed that central regions of Spt23/Mga2 form
hairpin loops allowing the processing initiation from an internal site (Hoppe et al.,
2000; Rape et al., 2001; Rape and Jentsch, 2002).
The easiest way to prove the proposed model for proteasomal processing
initiation would be the isolation of processing intermediates corresponding to the N-
and C- terminal parts of the protein resulting from the initial cleavage. However, C-
terminal processing intermediates of Spt23/Mga2 were normally not observed, most
likely due to their very rapid elimination (Hoppe et al., 2000). To circumvent this
problem, Mga2 variants that have their C-terminal domains stabilized by fusion to the
Mus musculus dihydrofolate reductase (DHFR) sequence were generated. The
advantage of this experimental approach comes from the fact that DHFR is a tightly
folded monomeric protein, which is strongly stabilized by binding of its ligand
analogue methotrexate (MTX). This domain was shown to be resistant to unfolding
and degradation by prokaryotic ATP-dependent proteases and the proteasome
(Eilers and Schatz, 1986; Johnston et al., 1995; Lee et al., 2001). To allow the
detection of the fusions, myc and HA epitopes were added at their N- and C-termini,
respectively. In the initial experiment, the transmembrane lacking form of Mga2
(mycMga2ΔTM-DHFRHA) was investigated (Figure 2-1a). This truncated protein is
soluble and has in principle its C-terminus accessible for proteasomal degradation
initiation. The ligand driven stabilization of DHFR in the fusion construct should
thereby allow discriminating between two possible ways of processing initiation,
either from an internal site or from the C-terminus.
Mechanism of Spt23/Mga2 partial degradation
25
Analogous to the findings with Spt23 (Hoppe et al., 2000), truncated Mga2
forms are processed less efficiently than the normal protein, however their
processing yields similar p90 fragments (Figure 2-1b). As detected by Western blot
analysis, expression of mycMga2ΔTM-DHFRHA in S. cerevisiae led to the generation of
p90 levels similar to those of the control mycMga2ΔTM. Addition of MTX to the growth
medium did not change the processing efficiency (Figure 2-1b; anti-myc blot).
Moreover, in the same experiment, additional anti-HA reactive fragments of about 35
kDa (C35; singular term “fragment” will be used for this nonhomogeneous pool of
proteins) were observed, representing the truncated C-terminal part of the fusion
construct that were not detectable for the WT protein (mycMga2HA). Interestingly, the
abundance of C35 was further increased upon MTX addition to the growth medium,
indicating that the accumulation of the C-terminal fragment depends on the stability
of DHFR.
Figure 2-1. Processing of soluble Mga2 variants initiates from an internal site. (a) Schematic
representation of Mga2ΔTM-DHFR fusion protein. Approximate fragment sizes of p90 and C35 are
indicated by brackets. The position of the IPT and ankyrin repeat (ANK) domains and the
transmembrane span (TM) are indicated. (b) Identification of N- and C-terminal processing fragments.
Cell lysates were analyzed by immunoblotting with either anti-myc or anti-HA antibodies. Addition of
methotrexate (MTX; “+”) stabilized the C-terminal domains of mycMga2ΔTM-DHFRHA, yielding upon
processing the C-terminal fragment C35. The positions of p120, p90, C35 and tagged free DHFR
(DHFRHA) are indicated. Cytosolic Pgk1 protein was used as loading control.
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In a similar experiment, a DHFR fusion to the full-length membrane-bound
Mga2 (mycMga2-DHFRHA; Figure 2-2a) was investigated. This fusion protein was
inserted into the ER membrane similarly to WT Mga2 as judged by a membrane
fractionation experiment and was also efficiently processed (Figure 2-2b, c). Again,
processing of this construct, in addition to the N-terminal p90 fragment, gave rise to a
specific C-terminal fragment of about 32 kDa (C32) that was stabilized upon addition
Figure 2-2. Processing of Mga2 p120 initiates from an internal site. (a) Schematic representation
of Mga2-DHFR fusion protein. Approximate fragment sizes of p90 and C32 are indicated by brackets.
(b) Processing of mycMga2-DHFRHA but not mycMga2HA gives rise to the C-terminal intermediate
fragment (C32; anti-HA immunoblot). Addition of MTX stabilizes C32 and does not interfere with p90
production (anti-myc immunoblot). The positions of p120, p90, C32, and DHFRHA are indicated. The
ER integral membrane protein Dpm1 was used as loading control. (c,d) ER-lumenal localization of the
C32 fragment. (c) Membrane fractionation experiment. Total extracts (“T”) of WT cells expressing
mycMga2HA or mycMga2-DHFRHA grown in the presence or absence of MTX were fractionated into pellet
(“P”) and soluble (“S”) fractions. The Western blot was probed with anti-myc or anti-HA antibodies to
detect full-length proteins (p120) and p90 and C32 fragments. The C32 fragment is found in the pellet
fraction, indicating its localization to the ER. ER-membrane-bound Dpm1 was used for fractionation
control. (d) Protease protection assay. Whole cell lysates from cells used in (c) were incubated with
Proteinase K in the absence or presence of Triton X-100. Full-length mycMga2-DHFRHA is Proteinase K
sensitive, indicating that it faces the cytosol. In contrast, C32 is largely protected against Proteinase K,
analogous to the ER-lumenal protein Kar2, indicating that it localizes to the ER lumen. Asterisks
denote cross-reactive bands.
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of MTX and not detected for the WT protein (Figure 2-2b; anti-HA blot). Moreover,
the abundance of p90 was again not influenced by MTX, indicating that the C-
terminus accessibility is not important for the processing of either of the Mga2
versions. Furthermore, localization of the C32 fragment was investigated by
membrane fractionation and proteinase K protection assays and C32 was found to
reside in the ER lumen (Figure 2-2c, d). It therefore represents the C-terminal
remnant of the ER membrane inserted p120 precursor and thus shows that the C-
terminus is not required for the initiation of processing. Both investigated C-terminal
fragments, C35 and C32, were slightly larger than DHFRHA itself and thus likely
contained about 40-60 extra residues on the N-terminal side of the DHFR domain. As
catalytic sites are separated spatially from the opening of the proteasome, the DHFR
fragments released from the stalled proteasome contain additionally parts of the
undegraded Mga2 polypeptide chain.
Altogether, the employed experimental approach allowed the detection of C-
terminal intermediates of Mga2 derivatives processing in addition to the p90
fragment. These data suggest that processing of Mga2 initiates from an internal site,
most likely in a polypeptide loop located in the C-terminal part of p120. Moreover, it
could be shown that proteasome progression towards the C-terminus of the protein
can be stopped by stable structures encountered during degradation, a mechanism,
which could be similar to that employed for p90 production.
2.1.2. Processing intermediates are trapped in proteasome mutants
Further support for the finding that processing of Mga2-DHFR variants is initiated
from an internal site came from experiments performed under conditions that allow to
trap processing intermediates of native Spt23 and Mga2 precursors. Previously, it
was reported that yeast cells carrying point mutations in the proteasome, such as
pre1-1 or cim3-1 (point mutations in the genes for a β-subunit of the 20S barrel and
an ATPase subunit of the 19S cap, respectively; (Ghislain et al., 1993; Heinemeyer
et al., 1991; Seufert and Jentsch, 1992), accumulate proteolytic intermediates of
some short-lived ERAD substrates due to inefficient proteasomal activities (Mayer et
al., 1998). Specifically, these cells have difficulty in extracting and degrading ER
membrane-inserted parts of the proteins.
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This suggested that after initiation of processing of Spt23/Mga2 in proteasomal
mutants, degradation of the C-terminal part of the precursor might be inefficient,
leading to an accumulation of C-terminal cleavage fragments. It was previously
described, the processing of Spt23 can be only partially blocked in these leaky
mutants, while inhibition of Mga2 processing was much stronger (Hoppe et al., 2000).
As shown in Figure 2-3a,b, experiments with proteasome mutants expressing doubly
tagged mycSpt23HA or mycMga2HA grown at the non-permissive temperature revealed
that they accumulate proteolytic fragments of about 50 kDa (termed C50 fragment;
detected by anti-HA immunoblot for the C-terminal epitope), which were completely
absent in the WT control. Since the same Spt23 C50 fragment accumulated in two
distinct proteasome mutants, the C50 formation seems to be specific for the
attenuated proteasomes activity. Further investigation of this fragment by a
membrane fractionation experiment revealed its exclusive localization to the
microsomal pellet fraction (Figure 2-3c). In line with previously published data (Hoppe
et al., 2000; Rape et al., 2001), this finding indicates that proteasomal processing of
Spt23 occurs directly at the ER membrane and does not require membrane
extraction prior to processing initiation.
Spt23 is the key regulator of membrane fluidity in yeast cells, and its processing
is negatively regulated by unsaturated fatty acid pools. It was reported previously that
palmitoleic acid (16:1) added to the yeast growth medium at high concentration is
Figure 2-3. Accumulation of proteolytic intermediates of Spt23 and Mga2 in proteasome
mutants. (a) Mga2 processing and (b) Spt23 processing in proteasome mutants gown at 37°C gives
rise to an additional C-terminal C50 fragment. Note that Spt23 p90, a short-lived protein (Hoppe et al.,
2000; Richly et al., 2005), is stabilized in the proteasome mutant (c) The C-terminal C50 fragment of
Spt23 localizes to the ER membrane. Total extracts (“T”) of WT or cim3-1 cells expressing mycSpt23HA
were fractionated into pellet (“P”) and soluble (“S”) fractions. ER membrane protein Dpm1 was used
as fractionation control.
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able to block processing of Spt23 (Hoppe et al., 2000). This physiological regulation
could therefore be used to demonstrate that C50 is indeed an intermediate of p120
processing by the proteasome, as UFAs abundances should influence C50 fragment
formation in proteasome mutant cells. As expected, addition of palmitoleic acid to the
growth medium of cells expressing mycSpt23HA, led to the stabilization of the p120
precursor, inhibiting thereby the production of the N-terminal p90, and in cim3-1 cells
also the formation of the C-terminal C50 fragment (Figure 2-4a). This indicates that
the production of both N- and C-terminal Spt23 fragments is controlled by the same
physiological trigger.
To further demonstrate that the C50 fragment is formed from the Spt23 p120
precursor, a processing time-course experiment was performed. Mutant cim3-1 cells
expressing mycSpt23HA were first grown in the presence of palmitoleic acid to inhibit
processing of Spt23 and then transferred to a medium that lacks UFAs. After
cycloheximide addition, samples were withdrawn at various time points and protein
levels were determined by Western blot analysis. As shown in Figure 2-4b, both p90
and C50 accumulated over time in vivo with similar kinetics, and the fragment
Figure 2-4. The C50 fragment is an intermediate of Spt23 proteasomal processing (a) Inhibition of
processing of Spt23 by addition of palmitoleic acid (16:1) at 37°C for 90 min leads to reduced production
of p90 and C50. (b) N- and C-terminal fragments (p90 and C50) of Spt23 are generated with similar
kinetics and on expense of the full-length p120. Proteasome mutant cells (cim3-1) were grown at room
temperature in palmitoleic acid-containing medium to block processing of mycSpt23HA and were
subsequently shifted to 37°C to induce proteasome defects. Cells were transferred to palmitoleic acid-
free medium and cycloheximide was added to the culture to block translation. Samples were withdrawn
after indicated times and subjected to Western analysis. The graph shows the quantification of the data.
Detected signals were normalized to the loading control and to the level of p120 at the 0 time point. (c)
The C50 fragment is not produced by degradation of Spt23 initiated from N-terminus. DHFR fusion to N-
terminus of Spt23 lacking residues 1-446 (mycDHFR-Spt23HA) does not interfere with C50 formation in
cim3-1 cells grown at 37° C in presence of MTX (“+”). Precursor (DHFRSpt23un), processed form
(DHFRSpt23pr) of the fusion protein and C50 fragments are indicated.
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accumulation was on expense of the p120 precursor. This finding confirmed that p90
and C50 are derived from the p120 precursor and that both fragments were produced
concurrently in the proteasomal processing reaction.
To confirm that the C50 fragment resulted entirely from internally initiated
processing reaction, an N-terminal DHFR fusion to Spt23 was created. In this
construct, the N-terminal transcription factor domain (residues 1 to 446) was replaced
by the DHFR protein (mycDHFR-Spt23HA). The fusion protein was efficiently processed
and, when tested in cim3-1 mutant cells, showed the same C50 fragment as
observed previously (Figure 2-4c). Formation of this product was not changed by the
addition of MTX, which stabilizes the N-terminus against initiation of proteasomal
degradation. Thus, the obtained result demonstrates that the C50 fragment does not
derive from N-terminally initiated degradation of Spt23 but only from internally
initiated processing.
Altogether, the above findings show that proteasome mutants are useful tools to
detect the otherwise short-lived C-terminal intermediates of Spt23 and Mga2
processing, which is initiated by endoproteolytic cleavage of the polypeptide chains.
2.1.3. Mapping of the processing initiation site
The results presented above suggested that the processing initiation site might be
located in the region between the p90 and C50 fragments. Deletion of this part of the
protein, supposedly forming a putative hairpin loop engaging the proteasome, should
therefore interfere with the processing of Spt23. As both p90 and C50 migrate as a
collection of bands, only a rough estimation of the sizes was possible. By creating
truncation forms of Spt23, p90 was found to be composed of about 680 N-terminal
residues, whereas C50 of the 300 C-terminal residues of Spt23 (Figure 2-5b). This
indicated that the initial cleavage site should be located in the region between amino
acids 680 and 782, containing the ankyrin repeats in the central part. Based on the
yeast proteasome crystal structure, Rape and Jentsch deduced that the distance
from the outside of the 20S proteasome to the active sites equals approximately 20
amino acids of an extended polypeptide chain and proposed that a stretched hairpin
loop should be at least 40 amino acids in size (Groll et al., 1997; Rape and Jentsch,
2002). Hence, the central ankyrin repeat-containing region fulfils the length criteria for
building up the proposed hairpin loop. However, deletion of the ankyrin repeat
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domain alone (Spt23Δ709-771) did not abolish processing (Figure 2-5c; in fact it
moderately induced processing), indicating that the ankyrin repeat itself is not the
crucial processing signal. Interestingly, also deletions of sequences that directly flank
the ankyrin repeats (Spt23Δ651-708, Spt23Δ775-814), or even of the entire 164
amino acids ankyrin repeat-containing region, only moderately interfered with Spt23
p90 formation (Figure 2-5a,c).
These findings suggest that the elements that promote processing from an
internal site may be redundant and do not seem to be equivalent to specific amino
acid sequences. In fact, the observation that the fragments produced by proteasomal
processing are not homogenous in size is consistent with this observation. These
Figure 2-5. Mapping of the processing initiation site. (a) Schematic representation of Spt23
deletion mutants used for processing initiation site mapping. (b) Size estimation of p90 and C50
fragments. Constructs composed of N-terminal 680 and C-terminal 302 residues were found to
migrate in SDS-PAGE similarly to p90 and C50, respectively. Epitopes used for detection are the
same as in mycSpt23HA (control lanes). (c,d) Processing of mycSpt23HA deletion mutants. Various
deletion mutants of Spt23 within the ankyrin repeat-containing region were assayed for processing in
WT cells (c ) and cim3-1 mutant cells (d). None of the introduced deletions was able to abolish
processing of Spt23 in WT cells. However, deletion of the entire ankyrin-containing region (Δ651-814)
leads to inhibition of the processing in cim3-1 mutant cells grown at 37 °C, as p120Δ651-814 and its
monoubiquitylated form (indicated by an arrow) are strongly stabilized and p90 and C50 fragments are
diminished. (e) Anti-myc immunoprecipitation under denaturing conditions of mycSpt23HA or
mycSpt23Δ651-814 proteins expressed from GAL1-10 promoter in pre1-1 cells grown at 37 °C. The
crude extract input is shown in left panel. The immunoprecipitated material (right panel) was analyzed
by immunoblots with anti-myc (left lines) and anti-ubiquitin (right lines) antibodies.
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results implicate also that the nature of the defects in cim3-1 and pre1-1 mutants is a
loss of processivity of the enzymatic reaction, as the proteasomes are able to initiate
and continue degradation of short fragments, but cannot complete the degradation
(e.g. due to diminished substrate unfolding activity of the 19S ATPases).
Interestingly, in cim3-1 cells grown at the non-permissive temperature,
expression of the mycSpt23Δ651-814HA construct did not result in formation of the C50
fragment and the p120 form was strongly stabilized (Figure 2-5d). Since the
abundance of p90 was also diminished, this was likely due to processing inhibition of
this Spt23 mutant. Moreover, a band migrating slower than p120Δ651-814
accumulated strongly and could represent a monoubiquitylated precursor form. To
confirm the identity of this modification, lysates from proteasome mutants cells grown
at the non-permissive temperature and overexpressing mycSpt23HA or mycSpt23Δ651-
814 were subjected to anti-myc immunoprecipitation under denaturing conditions and
the precipitated material was analyzed by Western blot against ubiquitin (Figure
2-5e). This experiment revealed that indeed short ubiquitin conjugates are formed on
the p120 precursor of normal and mutant Spt23, and the p120 monoubiquitylation
signal co-migrates with the previously detected slower migrating band (compare anti-
myc and anti-ubiquitin blots). This result suggests that although p120Δ651-814 is
ubiquitylated, it is not a good substrate for processing by functionally impaired
proteasomes. As processing of Spt23Δ651-814 could only be inhibited in the cim3-1
mutant but not in WT cells, this suggests that the removed region serves as a
primary processing initiation site, and that the engagement of an alternative site
requires full proteasomal activity. Efficient processing of Spt23Δ651-814 may require
generation of a loop by local unfolding of the sequence neighbouring the yet
Figure 2-6. Folding prediction for Spt23. FoldIndex graph shows tendency for folding of Spt23.
Folded (green) and unfolded (red) regions, p90 and C50 approximate sizes are indicated. The C-
terminus of Spt23 is largely unfolded, indicating that it may serve as the initiation site for processing.
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unidentified ubiquitylation site. This result suggests also that the cim3-1 mutation
most likely impairs the unfolding activity of the proteasome and therefore creation of
an alternative initiation site.
Analysis of the Spt23 amino acid sequence with the protein folding prediction
program FoldIndex (Prilusky et al., 2005) revealed a tendency for an unfolded
conformation of the whole C-terminal region of Spt23, starting with the sequence
following ankyrin repeats up to the TM span (Figure 2-6). This suggests that this
region might be able to form the initiation loop/loops. In addition, also the region
located between the IPT domain and ankyrin repeats contains an unfolded stretch,
which could serve as an initiation site. The folding prediction may explain as well why
the proteasome removes the C-terminal part of Spt23 p120 so rapidly, since it may
lack any structured regions that might be difficult to unfold and translocate into the
proteasomal cavity. Moreover, after the initial recruitment by the ubiquitin signal, the
proteasome may easier remodel this loosely folded part of Spt23 and therefore
create the alternative processing initiation loop.
2.1.4. The IPT domain stops proteasome degradation progression
As shown above, the production of stable Spt23/Mga2 C-terminal fragments by 26S
proteasomes can be observed either when complete degradation is prevented by
tightly folded barriers (e.g. DHFR), or if the proteasome is functionally impaired by
mutation. It was previously reported that some tightly folded proteins are more
resistant to unfolding by ATPases (Lee et al., 2001). It was therefore interesting to
investigate whether formation of the p90 fragments of Spt23/Mga2 involves a stable
structure resistant to proteasome action. A good candidate for such a barrier is the
IPT domain, since crystallographic studies showed that dimerized NFκB IPT domains
exhibit very stable immunoglobulin-like folds (Ghosh et al., 1995; Huang et al., 1997;
Muller et al., 1995). Moreover, deletion of the IPT domain from NFκB or Spt23/Mga2
abolishes their processing (Lin et al., 2000; Rape et al., 2001; Shcherbik et al., 2004).
This suggests that the IPT domain may be specifically required for the generation of
the processing products, or it is necessary to define these proteins as proteasome
substrates.
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To address this question, Spt23WT or Spt23ΔIPT variants (Figure 2-7a) were
expressed in the cim3-1 proteasome mutant cells. Interestingly, the C-terminal C50
fragment that is specific for cells expressing functionally impaired proteasomes was
produced regardless whether the IPT domain was present or not (Figure 2-7b). This
indicates that the IPT domain itself is not essential for Spt23 proteolysis. However,
expression of Spt23ΔIPT in this mutant led to the accumulation of novel N-terminal
fragments (N75). This suggests that certain more stably folded regions within the N-
Figure 2-7. The alternative to Spt23 processing is complete degradation. (a) Schematic
representation of Spt23 WT and an Spt23 variant that lacks the IPT domain (Spt23ΔIPT), and of the
corresponding N- and C-terminal fragments (brackets) observed in the cim3-1 proteasome mutant
(p90, N75, C50). (b) Detection of Spt23 WT and Spt23ΔIPT-derived fragments in WT and cim3-1
mutant cells. The level of total protein of Spt23Δ IPT is reduced to about 40% of WT Spt23
(quantification not shown). Note that the full-length Spt23 is stabilized in the cim3-1 mutant, indicating
that WT proteasomes completely degrade Spt23 if the IPT domain is absent. (c) ER membrane
localization of the C50 fragment. Lysates from WT and cim3-1 cells expressing Spt23ΔIPT, grown at
37 °C were subjected to membrane fractionation. Dpm1 was used as the fractionation control. (d)
Kinetics of N75 and C50 formation from Spt23ΔIPT precursor in cim3-1 cells. The experiment was
performed as in Figure 2-4b. (e) Addition of palmitoleic acid (16:1) not only inhibits processing of WT
Spt23, but also inhibits complete degradation of the Spt23ΔIPT variant.
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terminal domain of Spt23 (besides the IPT domain) hinder complete degradation, but
only in cells that express functionally impaired proteasomes. In addition, fractionation
experiment showed that the C50 fragment was exclusively localized to the ER
membranes, while most of N75 was soluble (Figure 2-7c). Interestingly, the most
abundant fragment from N75 was partially localized to the pellet fraction, indicating
that there are additional regions besides the IPT domain that mediate or stabilize
Spt23 dimers. In addition, when the dimerization mutant turnover was investigated in
cim3-1, it showed concomitant formation of both the N75 and C50 fragments from the
precursor form (Figure 2-7d). These results suggest that the N75 form is an
equivalent to Spt23 p90, since its formation is initiated by the same way, although it
differs by the mechanism by which proteasomal progression is halted (proteasome
defect versus stable IPT domain, respectively).
All these data support the hypothesis that the alternative to Spt23 processing is
complete degradation. Indeed, in Spt23ΔIPT-expressing cells not only p90 was
absent, but the total amount of the Spt23 protein was concurrently reduced to less
than 40% (Figure 2-7b). Intriguingly, addition of palmitoleic acid to the growth
medium not only down-regulated Spt23 WT processing, but also led to a significant
stabilization of the unprocessed Spt23ΔIPT variant (Figure 2-7e). Together, these
data suggest that the cellular signal (low concentration of unsaturated fatty acids)
triggers proteasomal degradation of Spt23, which normally leads to processing due
to the presence of the IPT domain. However, the same conditions will cause
complete Spt23 degradation, if the IPT domain has been experimentally removed.
2.1.5. Complete degradation can be initiated internally
Given the finding that in vivo proteasomes can initiate processing of Spt23/Mga2
from a centrally located polypeptide loop, it was tempting to speculate that this
mechanism can be applied more generally also for the complete proteasomal
degradation of substrates. One of the proteins that undergoes rapid, regulated
degradation by UPS is an integral ER-membrane protein Hmg2, which is one of two
isozymes of yeast HMG-CoA reductases (HMGR), the rate-limiting enzymes in
cholesterol biosynthesis (Hampton and Rine, 1994). Degradation of Hmg2 involves
key players of the ERAD (ER-associated degradation) machinery and was shown to
be tightly regulated by certain physiological cues, with its half-life varying between 5-
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10 min and 6h (Bays et al., 2001; Hampton and Rine, 1994). Hmg2 is composed of a
large N-terminal transmembrane region and a C-terminal cytosolic catalytic domain,
both connected by a not conserved linker region. Interestingly, the individual
transmembrane spans that are connected by polypeptide loops facing the cytosol, as
well as the flexible linker region between the transmembrane and catalytic domains,
could serve as possible internal initiation sites for proteasomal degradation.
To test the hypothesis that degradation of Hmg2 can be initiated from an
internal site, the turnover of the short-lived variant of Hmg2 that carries a myc epitope
tag close to the N-terminus (6mycHmg2; Hampton et al., 1996) was investigated. In
order to detect also C-terminal proteolytic fragments, an HA-tag was added to its C-
terminus (6mycHmg2HA). As expected, also this doubly tagged Hmg2 variant was
rapidly degraded in WT and strongly stabilized in the cim3-1 proteasome mutant
strain (Figure 2-8a). Yet, concomitant with the slow decay of the full-length protein in
the proteasome mutant, several anti-myc and anti-HA-reactive fragments appeared
during the chase period. Notably, both N- and C-terminal fragments accumulated
with similar kinetics, suggesting that the degradation of Hmg2 via ERAD is most likely
initiated from an internal site (or several internal sites). Moreover, since many of
these N- and C-terminal fragments localized to the microsomal pellet fraction (Figure
2-8b), these findings also indicate that the observed proteasomal ERAD mechanism
takes place directly at the ER membrane prior to the substrate retrotranslocation.
It was reported that he half-life of Hmg2 is regulated by ubiquitylation catalyzed
by the integral ER membrane ubiquitin ligase Hrd1. Since this enzyme is not
essential for yeast viability, it was possible to directly investigate how ubiquitylation of
Hmg2 influences the appearance of degradation intermediates. The experiment with
cim3-1 Δhrd1 cells expressing 6mycHmg2HA grown at 37 °C revealed that the full-length
protein was stabilized and the formation of both the N- and C-terminal degradation
intermediates was strongly reduced, as compared to cim3-1 cells (Figure 2-8c).
These degradation products were not completely absent, suggesting that additional
pathways may contribute to the degradation of 6mycHmg2HA.
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Together these results demonstrated that the degradation of Hmg2 induced by
the E3 ligase responsible for its natural regulation in vivo is initiated from an internal
site. This suggests a more general mechanism by which flexible polypeptide loops
flanked by folded regions may often serve as internal initiation sites for degradation.
Figure 2-8. Degradation of Hmg2 by ERAD gives rise to both N- and C-terminal fragments in
proteasome mutants. (a) WT and cim3-1 cells expressing doubly tagged 6mycHmg2HA were grown at
37 °C to induce proteasomal activity defects in cim3-1. CHX was added to the cultures to inhibit
translation and samples were withdrawn after indicated time points. N- and C-terminal fragments were
detected using anti-myc and anti-HA-specific antibodies, respectively. Dpm1 levels were monitored for
loading control. The decay of the full-length Hmg2 protein and the production of the degradation
fragments were quantified (bottom panel). (b) N- and C-terminal degradation intermediates of
6mycHmg2HA localize to the ER membrane. Membrane fractionation was performed for WT and cim3-1
cells expressing 6mycHmg2HA grown at 37 °C. Degradation intermediates formed in cim3-1 are found in
the pellet. ER-membrane-bound Dpm1 was used for fractionation control. (c) Formation of Hmg2
degradation intermediates is reduced in cells lacking Hrd1.
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2.2. Regulation of Spt23/Mga2 activation by the ankyrin repeat
domain
The processing of Spt23/Mga2 is strikingly similar to that of the mammalian NFκB
precursors. In both cases, it requires ubiquitylation and the proteasome to eliminate
C-terminal parts of the proteins, whereas the N-terminal transcription factor domains
are spared from degradation. Further comparison of their domain compositions
reveals more similarities (Figure 2-9). Precursors of all of these transcription factors
posses centrally located IPT domains mediating dimerization and C-terminally
located ankyrin repeat domains, which are completely degraded during the
processing reaction. The conserved topology of these domains may reflect their
similar functional relationship and suggest similar modes of processing regulation for
yeast and mammalian transcription factors.
The ankyrin repeat is a 33-residue sequence motif and is one of most common
structural constituents of proteins. It folds into two antiparallel α-helices followed by a
β-hairpin or a long loop. In most cases, ankyrin repeats are found as tandem repeats
and they are responsible for mediating various specific protein-protein interactions
(Mosavi et al., 2004; Sedgwick and Smerdon, 1999).
Figure 2-9. Yeast Spt23/Mga2 and mammalian NFκB transcription factors share domain
homology. Transcription factor domains and dimerization domains (IPT) are located in the N-terminal
and central parts of the proteins that are protected from proteasomal degradation. Ankyrin repeats
(grey boxes) are located in the C-terminal parts of the proteins, which are completely removed upon
proteasomal processing (processing sites are indicated by arrows). Spt23/Mga2 possess additionally
a C-terminal transmembrane span (TM) anchoring the proteins in the ER membrane.
2.2.1. The ankyrin repeat domain interacts with the dimerization domain
of Mga2
It was reported that p50, the processed form of the NFκB p105 subunit, binds ankyrin
repeats of the p105 precursor and inhibits its processing (Cohen et al., 2001). In
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addition, crystal structure data provide evidence for an interaction of NFκB dimers
with ankyrin repeats of IκB molecules that are homologous to the C-terminal ankyrin
repeat domains of NFκB precursors (Huxford et al., 1998; Jacobs and Harrison,
1998). Interestingly, this interaction involves extensive contacts of ankyrin repeat
domain with the dimerization surface formed by IPT domains and in addition extends
to a downstream located NLS signal, masking it and preventing translocation of the
protein to the nucleus (at least in case of the p65 subunit). As both the IPT and
ankyrin repeat domains are present also in the p120 precursor of Spt23/Mga2 and
are both highly conserved between most of their fungal orthologs, this suggests a
common mechanism of interaction and perhaps regulation of processing.
To test whether the ankyrin repeat and dimerization domains of the yeast
transcription factors can interact, an Mga2 variant with the TEV protease site
introduced between the IPT domain and the ankyrin repeats (amino acids 671-678 of
Mga2 replaced with the ENLYFQG sequence) was generated. The construct was
additionally tagged with myc and HA epitopes at the N- and C-terminus, respectively
(mycMga2(TEV)HA; Figure 2-10a). This experimental approach allows separation of the
N- and C- terminal parts of Mga2 upon cleavage of the specific site by the TEV
protease, in a proteasome-independent way (that would normally lead to a complete
elimination of the C-terminus) and assaying if they are still associated. As shown in
Figure 2-10b, the introduced TEV site did not interfere with the processing reaction
as compared to the WT protein. Lysates from Δmga2 cells overexpressing
mycMga2(TEV)HA under the control of GAL1-10 promoter were incubated with 0.2%
dodecyl maltoside to extract Mga2 from membranes and subsequently subjected to
immunoprecipitation with anti-HA antibodies to pull down precursor forms of
mycMga2(TEV)HA. Beads containing immunoprecipitated material were split into two
parts, which were then incubated with or without the TEV protease. The beads were
subsequently washed and bound proteins were analyzed by Western blots against N-
or C-terminal tags (Figure 2-10c). In this experiment, Mga2(TEV) p120 was pulled
down together with a minor pool of the associated p90 form. Immunoprecipitated
proteins were efficiently cleaved by the TEV protease and a significant pool of the N-
terminal cleavage fragment remained associated with the C-terminal part immobilized
on the beads. In a similar experiment with microsomes isolated from cells expressing
mycMga2(TEV)HA and treated with or without the TEV protease, analogous results
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were obtained (Figure 2-10d). After centrifugation and separation of the soluble
material, both N-terminal and C-terminal cleavage products were found to be associated
with the membrane fraction. These data demonstrate that the N- and C-terminal
domains of Mga2 can interact, possibly via the IPT and ankyrin repeat domains.
Figure 2-10. N- and C-terminal parts of Mga2 can interact. (a) Schematic representation of the
Mga2 construct with introduced TEV protease cleavage site (TEV). Approximate sizes of N- and C-
terminal cleavage products (N(TEV) and C(TEV), respectively) and p90 are indicated by brackets.
Note the roughly similar size of N(TEV) and p90 fragments. (b) Introduction of TEV site does not
interfere with the processing. Lysates of Δmga2 cells expressing mycMga2(TEV)HA under the control of
GAL1-10 promoter were analyzed by Western blotting. (c) Beads with anti-HA immunoprecipitated
mycMga2(TEV)HA were incubated in buffer without (“–”) or with TEV protease (“+”). The material bound
to beads (“Beads”) and the released soluble proteins (“Eluate”) were analyzed by immunoblots against
N- and C-terminal tags (myc and HA, respectively) (d) Membrane fraction containing Mga2(TEV)
protein was prepared by high spin centrifugation, incubated in the absence or presence of TEV
protease and subjected to Western analysis. (c,d) Input lane (c) contains lysate of cells used for the
experiments. Investigated protein fragments are indicated. Note that p90 co-migrates in SDS-PAGE
with the N(TEV) fragment.
To test whether the ankyrin repeat and dimerization domains are able to interact
directly, the yeast two-hybrid system was employed. Mga2 domain composition
(Figure 2-11) was predicted using the protein domains architecture program SMART
(Letunic et al., 2006). In all of the created constructs, the transcription activation
domain (TAD) was omitted in order to avoid previously reported autoactivation
(Zhang et al., 1997). Even though, Mga2 and some of its truncations exhibited strong
activation of reporter promoters, which for some of the constructs could be blocked
by addition of various concentrations of 3-aminotriazole (see Materials and Methods).
Also the TM span and the ER-lumenal domain were not included in any of the
constructs to avoid membrane insertion and permit nuclear localization. Truncations
of Mga2 that contained the IPT domain were used as baits for testing interactions
with constructs containing the ankyrin repeat domain. The results of this experiment
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confirmed that the ankyrin repeat and IPT domains interact (Figure 2-11). All baits
interacted with the ankyrin repeat-containing constructs, however, not with the
ankyrin repeats alone. This suggests that the two isolated ankyrin repeats may form
only part of the interaction surface and do not bind to the IPT domain strong enough
to activate the reporter system. Interestingly, it has been reported that terminal
ankyrin repeats are difficult to detect by protein domain architecture analysis
programs, as they often vary in many otherwise well-conserved hydrophobic residues
from the consensus sequence (Mosavi et al., 2004). It is therefore conceivable that
perhaps another not predicted ankyrin repeat stabilizes the structure and binding to
the IPT domain of Mga2. In any case, binding of the C-terminal region of Mga2 to the
IPT domain clearly depends on all ankyrin repeats as a point mutation in the second
repeat (ANK*; consensus site LHFA mutated to AAFP; according to Mosavi et al.,
2002) abolished the interaction (Figure 2-11). The results presented above strongly
suggest that the interactions mediated by the ankyrin repeats are conserved between
the yeast Mga2/Spt23 and the mammalian NFκB transcription factors.
Figure 2-11. Ankyrin repeat and dimerization domains of Mga2 interact. Schematic
representation of the yeast two-hybrid interactions between Mga2 ankyrin repeat (ANK) and
dimerization (IPT) domains containing constructs. Truncations used for the assay, fused to GAL4
activation (AD) or DNA binding (BD) domains, are described by the respective numbers of residues
from Mga2 (right panel). Additional mutations are indicated. The minimal fragments of Mga2 required
for the interaction are highlighted by red boxes. The observed interaction with IPT domain depends
strictly on the presence of ankyrin repeats, seems however to be additionally stabilized by
downstream regions, as the isolated ANK truncation does not sustain the interaction.
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2.2.2. Deletion of the ankyrin repeat domain destabilizes Mga2
To investigate the functional importance of the ankyrin repeats of Mga2, constructs
that lack this domain (Mga2ΔANK) were created and compared with full-length forms
of the protein. Western blot analysis of lysates from WT cells expressing normal
mycMga2 or mutant mycMga2ΔANK constructs under the control of endogenous or
GAL1-10 promoters revealed that although both forms are efficiently processed, the
total abundance of the protein lacking the ankyrin repeat domain was reduced to
about 65% (Figure 2-12a). This indicates that the deletion of the ankyrin repeats
destabilizes the protein. In fact, quantification of p120 and p90 abundances showed
that the precursor form is stronger influenced by the deletion, so that the processing
efficiency (ratio of p90 to p120 abundances) increases. This suggests that this
mutation may affect the turnover of the precursor protein by increasing the
processing of Mga2.
To test this hypothesis, the half-life kinetics of Mga2WT and Mga2ΔANK were
investigated by the GAL1-10 promoter shut-off experiment. This experiment revealed
that WT Mga2 p120 and p90 forms are very stable with half-lives of a few hours
(Figure 2-12b; upper panel). In contrast, when the mycMga2ΔANK variant was
Figure 2-12. Deletion of the ankyrin repeat domain influences the stability of Mga2 p120 and
p90. (a) Expression of WT and ΔANK forms of Mga2 from endogenous or the GAL promoters was
investigated by Western blot analysis. (b) GAL promoter shut-off experiment for WT cells expressing
Mga2 and Mga2ΔANK grown at RT. The ankyrin repeats mutation destabilized, the otherwise very
stable, p120 and p90 forms. (c) Overexpression of the ankyrin repeats does not lead to the
stabilization of the p120 form of the endogenously expressed mycMga2ΔANK. The constructs 704-1037
and 704-900 containing the ankyrin repeat domain are truncations of Mga2 that were previously
identified in YTH assay (Figure 2-11) to be sufficient to interact with the IPT domain. All truncation
constructs are tagged with the HA epitope at their N-termini and are expressed under the control of
the ADH1 promoter. “-“ denotes empty vector control; an asterisk indicates a crossreactive band. Pgk1
was used as a loading control.
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examined, both p120 and p90 became unstable with half-lives of about 45 min and
2.5 h, respectively (Figure 2-12b; lower panel). The reason for the observed
destabilization of p90 must be caused indirectly by the ankyrin repeats deletion, as
the p90 fragment seems not to contain the ankyrin repeats (note that p90 expressed
from the Mga2WT protein migrates at the same height on the SDS gel as p90 from
the Mga2ΔANK variant; Figure 2-12). Interestingly, overexpression of various Mga2
constructs containing ankyrin repeats did not cause a stabilization of the p120
precursor of the Mga2ΔANK mutant protein (Fig2-12c). This may suggest that the
interaction between the ankyrin repeat and the IPT domain is functional only if it
occurs in the same p120 molecule (intramolecular interaction).
2.2.3. Deletion of the ankyrin repeat domain leads to enhanced activation
of Mga2
Decreased stability of the Mga2ΔANK variant suggests that its activity may be
compromised as well. The Mga2ΔANK mutant protein was therefore tested for its
ability to rescue the synthetically lethal mutant Δspt23 Δmga2. This mutant strain is
inviable due to the absence of the Ole1 protein and therefore insufficient levels of
UFAs. However, the viability of Δspt23 Δmga2 can be restored by heterologous
expression of OLE1 or by addition of oleic acid (the product of the Ole1 enzymatic
activity) to the growth medium (Zhang et al., 1999). Δspt23 Δmga2 mutant cells were
transformed with low copy vectors expressing mycMga2 or mycMga2ΔANK from their
endogenous promoters and tested in serial dilutions for their ability to grow on plates
with or without oleic acid supplement (Figure 2-13a). Both Mga2WT and Mga2ΔANK
were able to restore the viability of Δspt23 Δmga2 cells equally well, suggesting that
the transcriptional activity of the Mga2ΔANK mutant protein is sufficient to maintain
yeast cell viability.
The transcriptional activity of Mga2 and Mga2ΔANK was further assessed in a
transcription reporter assay, in which the β-galactosidase-encoding gene placed
under the control of the OLE1 promoter is used as a reporter gene. To exclude
activation of the reporter by the endogenous Spt23 and Mga2 proteins, the assay
was performed in Δspt23 Δmga2 cells, whose viability was restored by heterologous
expression of OLE1 from the ADH1 promoter. Subsequently, this reporter strain was
transformed with mycMga2 or mycMga2ΔANK expressed from the endogenous
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promoter. Finally, equal amounts of cells were plated and incubated at 30 °C. After
36 hours of growth, an X-Gal overlay assay was performed and the results were
examined 90 min later. Surprisingly, the mycMga2ΔANK mutant, although less
abundant in cells, turned out to be stronger activator of transcription than the
Mga2WT protein (Figure 2-13b). This result suggests that the ankyrin repeat domain
might be a negative regulator of Mga2 activity. As the ankyrin repeats are not present
in the p90 protein, this function may be achieved either by inhibition of p120
processing or translocation of p90 to the nucleus.
Figure 2-13. The ankyrin repeat domain is not required for the Mga2 essential function and
negatively regulates its activity. (a) Mga2ΔANK is able to rescue Δmga2 Δspt23 cells indicating that
this mutation does not interfere with Mga2 essential functions in yeast cells. WT and Δmga2 Δspt23
cells expressing normal or ΔANK form of Mga2, or transformed with empty vector as a control (“-“),
were plated in 10-fold dilutions on synthetic media with or without oleic acid (18:1) supplement. Plates
were incubated at 30 °C for 3 days. (b) Mga2ΔANK is a more potent transcription factor as compared
to Mga2WT. Δmga2 Δspt23 cells rescued by the overexpression of Ole1 protein from the ADH1
promoter and carrying the reporter gene under the control of OLE1 promoter were transformed with
Mga2, Mga2ΔANK or empty vector as a control. Equal amounts of cells (3 independent clones from
each transformation) were plated on selective medium and after 36h of incubation at 30°C the X-Gal
overlay assay was performed. After 90 minutes of incubation with the substrate at 30°C plates were
scanned.
2.2.4. The ankyrin repeat domain controls localization of Mga2
Increased transcriptional activity of the Mga2ΔANK mutant protein in comparison with
the Mga2WT protein suggests that the ankyrin repeats may influence the nuclear
localization of the transcription factor Mga2 p90. To test whether deletion of ankyrin
repeats changes the intracellular localization of Mga2, immunofluorescence
microscopy was employed. Cells expressing mycMga2 or mycMga2ΔANK from the
GAL1-10 promoter were harvested in the exponential phase of growth, fixed with
formaldehyde, and analyzed by indirect anti-myc deconvolution immunofluorescence
microscopy (Figure 2-14a). Since the myc epitope of the investigated variants was
fused to the N-terminus of Mga2, it allowed detection of both p120 and p90 forms.
Regulation of Spt23/Mga2 activation by the ankyrin repeat domain
45
This experiment revealed a striking difference in the localization of the investigated
proteins. While Mga2WT showed predominantly ER and perinuclear staining,
Mga2ΔANK was mainly nuclear. These results suggest that although the WT form of
Mga2 is efficiently processed, only a minor pool of p90 is translocated into the
nucleus. In contrast, the processed form of the Mga2ΔANK mutant protein is
transported efficiently to the nucleus. This is in line with an earlier experiment (Figure
2-13b) showing that the transcriptional activity of the Mga2ΔANK mutant is increased
in comparison to the WT protein. These findings suggest that the ankyrin repeat
domain may be crucial for regulating Mga2 intracellular localization and function.
It was previously demonstrated that Mga2 p90 is kept in a dormant form at the
ER membrane, presumably by association with the p120 partner molecule
(Shcherbik et al., 2003). To test whether the ankyrin repeat domain-mediated
interaction may directly contribute to the stability of the Mga2 p120/p90 complex, a
membrane fractionation experiment was performed with extracts from cells
expressing either the Mga2WT or the Mga2ΔANK mutant protein. Both Mga2 and
Mga2ΔANK p90 forms were found in the soluble fraction and in the membrane bound
p120/p90 heterodimeric complex (Figure 2-14b). The p120/p90 association could not
be resolved by treatment with high salt, indicating a strong interaction. However,
incubation of the membrane fraction with a high pH buffer led to a significant release
of p90, confirming a peripheral membrane association. On the other hand, the p120
form proved to be an integral membrane protein, as it could only be extracted by
Figure 2-14. Ankyrin repeats inhibit nuclear localization of Mga2. (a) Intracellular localization of
mycMga2 and mycMga2ΔANK was investigated by indirect anti-myc deconvolution immunofluorescence
microscopy. WT form of Mga2 localizes to the ER and nuclear envelope, while the ΔANK mutant
accumulates strongly in the nucleus. (b) Deletion of the ankyrin repeat domain does not change
p120/p90 interaction strength. Membrane fraction from WT cells expressing Mga2 or Mga2ΔANK was
treated with high salt buffer, high pH buffer or 0.1% SDS. “T” indicates whole cell extracts, “S” –
soluble and “P” – membrane fractions. Asterisks denote crossreactive bands.
Regulation of Spt23/Mga2 activation by the ankyrin repeat domain
46
detergent treatment. Deletion of the ankyrin repeats did not significantly change the
localization and interaction strength, suggesting that this domain is not crucial for
stabilizing the association of p90 with the precursor molecule.
2.2.5.  Degradation of Mga2 p120 and release of p90 is inhibited by the
ankyrin repeat domain
Mga2 p120 seems to be degraded by an ERAD-related reaction involving the
ubiquitin ligase Rsp5 and the Cdc48Ufd1/Npl4 complex (Shcherbik et al., 2003). This
process was proposed to liberate Mga2 p90 from the ER membrane. The deletion of
the ankyrin repeats strongly destabilized Mga2 (Figure 2-12b), suggesting that this
domain may regulate the ERAD of p120.
To test the involvement of Rsp5 and the Cdc48Ufd1/Npl4 complex in the
destabilization of Mga2ΔANK, expression shut-off assays in rsp5-1 and ufd1-2 (Ufd1
is an essential component of the Cdc48Ufd1/Npl4 complex; Meyer et al., 2000) yeast
mutants grown at the non-permissive temperature were performed. These
experiments revealed that both Rsp5 and Ufd1 contribute to the enhanced
degradation of p120ΔANK, as this deletion construct was stabilized in both rsp5-1
and ufd1-2 mutants when compared to WT cells (Figure 2-15a). Also the slow
turnover of the p120WT protein was influenced in both mutant cells. Moreover,
similar to the data reported for some ERAD substrates examined in cdc48, ufd1 and
npl4 mutants (Bays et al., 2001; Jarosch et al., 2002), the ubiquitylated forms of p120
Mga2 and p120 Mga2ΔANK accumulated in ufd1-2 cells. This suggests that both
proteins are recognized and modified by the ubiquitin ligase Rsp5, and that the
ankyrin repeats-mediated interaction might therefore inhibit a downstream step
during the engagement of ubiquitylated substrates by the proteasome. This is further
supported by a preliminary co-immunoprecipitation experiment showing that there is
no enhanced binding of Rsp5 to Mga2ΔANK if compared to Mga2WT (data not
shown).
Both rsp5-1 and ufd1-2 mutant cells strongly stabilized not only p120 but also
the p90 form of Mga2ΔANK (Figure 2-15a). It is therefore possible that, similar to
certain transcription factors that are controlled by degradation after transcription
initiation (Muratani and Tansey, 2003), p90 is degraded once it has reached the
nucleus and turned on the expression of OLE1. As shown by expression shut-off
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(Figure 2-15a) and immunofluorescence (Figure 2-14a) experiments with the
Mga2WT protein, the mobilization of p90 is slow, presumably because it is kept at the
ER membrane in an inactive complex with the p120 form and thus remains stable.
However, in case of the ankyrin repeats mutant protein, p90 is rapidly released from
the ER and translocated to the nucleus where it can be degraded. In addition,
degradation of p90 in the nucleus could also depend on Rsp5 and the Cdc48Ufd1/Npl4
complex, similarly to the situation for Spt23 (Richly et al., 2005).
In the next experiment, the half-life of the Mga2ΔIPT mutant protein, whose
dimerization and therefore the formation of p90 form is abolished (Figure 2-15b), was
investigated. The expression shut-off experiments showed that Mga2ΔIPT is a short-
Figure 2-15. Ankyrin repeat domain of Mga2 inhibits Rsp5 and Cdc48Ufd1/Npl4 mediated
degradation of p120. (a) Increased degradation/processing of p120ΔANK can be significantly blocked
in rsp5-1 and ufd1-2 mutants. GAL promoter shut-off experiments were performed for Mga2 and
Mga2ΔANK expressed in WT, rsp5-1 and ufd1-2 mutants. The cells were grown in galactose
containing medium at 30 °C to reach logarithmic phase of growth. Prior to glucose and CHX addition,
the cells were incubated for 3h at non-permissive temperature (37 °C). Graph (right panel) shows
quantification of p120WT or p120ΔANK decay under the investigated conditions. (b) Mga2ΔIPT mutant
does not form the processed p90 fragment. (c) Mga2ΔIPT p120 form is unstable in WT, but strongly
stabilized in ufd1-2 mutant cells. GAL promoter shut-off experiment for Mga2ΔIPT expressed in WT or
ufd1-2 cells at 37 °C. Quantified data is presented on the graph (right panel).
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lived protein in WT cells, but is stabilized in ufd1-2 mutant cells (Figure 2-15c). The
finding that deletion of the IPT domain causes destabilization of the Mga2 precursor,
similarly to the deletion of the ankyrin repeats, supports the hypothesis that the
intramolecular interaction between these two domains is responsible for the high
stability of the Mga2WT precursor (compare Figure 2-15a and c). The fact that
Mga2ΔIPT is stabilized in ufd1-2 cells suggests that its degradation might involve the
same machinery that is used to liberate the processed transcription factor from the
processing template molecule.
Since the Mga2ΔANK variant is characterized by increased mobilization of p90,
this deletion construct might be able to rescue yeast mutant phenotypes associated
with reduced levels of the Ole1 protein. It was reported that the phenotype of the
ufd1-2 yeast mutant strain can be suppressed by addition of oleic acid to the growth
medium (Hoppe et al., 2000), suggesting that the primary defect in these cells is
associated with the OLE pathway. The Mga2ΔANK variant was tested in temperature
sensitive ufd1-2 mutant cells for the ability to promote their growth at non-permissive
temperatures. Indeed, expression of the Mga2ΔANK but not the Mga2WT protein in
this strain partially rescued its lethality at 34 °C (Figure 2-16a). To investigate how
the deletion of the ankyrin repeats influences association of Mga2 p90 with ER
membranes in the ufd1-2 mutant, a membrane fractionation experiment was
performed. While in WT cells about 60 % of Mga2WT p90 and 70 % of Mga2ΔANK
p90 were found in the soluble fraction, in ufd1-2 cells mobilization of Mga2WT p90
was impaired (about 40% of soluble p90). In contrast, the mobilization efficiency of
Mga2ΔANK p90 in the ufd1-2 background (70%) was comparable to that of WT cells
(Figure 2-16b). These results suggest that, the mobilization of Mga2ΔANK p90 is at
least partially independent of the Cdc48Ufd1/Npl4 complex.
The deletion of the gene for the ubiquitin ligase Rsp5 in S. cerevisiae is lethal
as it blocks processing of Spt23 and mobilization of Mga2 p90 and therefore the
expression of OLE1 (Hoppe et al., 2000; Shcherbik et al., 2003). However, the
viability of the Δrsp5 strain can be restored by addition of oleic acid to the growth
medium (Hoppe et al., 2000). To test whether Mga2ΔANK can also rescue the
lethality of the Δrsp5 strain, cells were transformed with plasmids expressing either
the Mga2WT or Mga2ΔANK protein under the control of the endogenous promoter.
Interestingly, expression of the Mga2ΔANK but not of the Mga2WT protein could
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restore the viability of Δrsp5 cells (Figure 2-16c), suggesting that the mobilization of
p90 from p120ΔANK is mediated by an additional, Rsp5-independent mechanism.
Next, the Mga2WT and Mga2ΔANK proteins expressed in the Δrsp5 strain (in the
presence of oleic acid in the growth medium) were analyzed by immunoblotting,
which revealed that the p90/p120 ratio of Mga2ΔANK was increased as compared to
Mga2WT (Figure 2-16c; right panel). While the p90 form of the WT protein is less
abundant than p120 and might therefore be part of the ER-bound heterodimeric
complex, the p90 form of the Mga2ΔANK variant is more abundant than p120,
indicating that a significant fraction of the protein is most likely soluble. Since
degradation of Mga2 p120 requires Rsp5-mediated polyubiquitylation, it is tempting
to speculate that the increased p90 mobilization of Mga2ΔANK in Δrsp5 strain could
result from an action of the ubiquitin ligase responsible for targeting of Mga2 for
processing. In the case of the Mga2ΔANK mutant protein, the p120 molecule from
Figure 2-16. Mga2ΔANK expression can partially rescue ufd1-2 cells grown at 34°C (a) and rescue
Δrsp5 mutant cells grown at RT (c). (a) Equal amounts of ufd1-2 cells expressing Mga2WT or ΔANK
mutant constructs were plated in 10-fold dilution on YPD plates with or without oleic acid supplement and
incubated at different temperatures for 3 days; “-” indicates empty vector control. (b) Mobilization of p90 is
inhibited in ufd1-2 strain for Mga2WT but not for the Mga2ΔANK protein. Membrane fractionation
experiment for WT and ufd1-2 cells expressing mycMga2 and mycMga2ΔANK grown at 37 °C. “T” indicates
whole cell extracts, “S” – soluble and “P” – membrane fractions. Dpm1 was used as the fractionation
control. (c) Δrsp5 cells were transformed with mycMga2 or mycMga2ΔANK constructs in the presence of oleic
acid in the selection medium. Positive clones were further tested on plates with or without oleic acid for
their ability to grow at RT. Cells from the rescue experiment were grown in YPD medium supplemented
with oleic acid and analyzed by Western blotting (right panel).
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the p120/p90 complex might be targeted for the proteasomal processing, which
would lead to the formation of two soluble p90 fragments. Since the E3 ligase, which
induces the processing of Mga2, has not been identified so far, this hypothesis could
not be tested experimentally.
In conclusion, the results presented above suggest that the ankyrin repeat
domain of Mga2 inhibits ERAD of the processing template molecule and thus
mobilization of the active transcription factor p90 from the ER.
2.2.6. The ankyrin repeat domain inhibits processing of Mga2ΔTM
The finding that deletion of the ankyrin repeats of Mga2 influences mobilization of
p90 by both Rsp5-dependent and -independent processes raised the question
whether the latter mechanism may involve processing of the precursor from the
p120/p90 complex. This would be in line with the observation that processing ratio of
Mga2ΔANK was slightly increased in comparison to Mga2WT (Figure 2-12a).
Support for this hypothesis came from experiments with the Mga2ΔTM variant,
which is soluble and in principle does not need the mobilization step in order to be
translocated to the nucleus. This form is not efficiently processed, however, when the
ankyrin repeats were mutated in the mycMga2ΔTM variant (mycMga2ΔANKΔTM), the
processing defect was suppressed (Figure 2-17a) and this effect was independent of
the Rsp5 ubiquitin ligase (Figure 2-17b). Similar results were obtained for the
mycMga2ΔANKΔTM-DHFRHA variant regardless of whether the C-terminus of the
construct was stabilized by MTX or not. As shown earlier for the weak processing of
mycMga2ΔTM-DHFRHA (Figure 2-1b), also the processing of the mycMga2ΔANKΔTM-
DHFRHA variant resulted in the C35 intermediate that could be induced by
stabilization of the DHFR domain (Figure 2-17c), suggesting that it is initiated at an
internal site of the precursor. Moreover, the C35 fragment was more abundant in the
case of the protein harbouring the ankyrin repeats mutation and correlated well with
the enhanced processing, implicating an increased turnover of this protein. Similar
results were obtained for the mycSpt23ΔTM-DHFRHA and mycSpt23ΔANKΔTM-DHFRHA
fusion constructs (Figure 2-17d), suggesting that the function of the ankyrin repeats
is conserved between the Spt23 and Mga2 proteins.
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When the turnover of Mga2ΔTM and Mga2ΔANKΔTM proteins was investigated
it turned out that, in contrast to the stable Mga2WT protein, Mga2ΔTM was short-
lived, and its half-life was further diminished by deletion of the ankyrin repeats, as a
result of increased processing (Figure 2-18a). In addition, deletion of the ankyrin
repeat or the IPT domains in the soluble Mga2ΔTM-DHFR variant led to a drastic
destabilization of the protein (Figure 2-18b). As expected for the IPT-lacking form of
Mga2, its degradation does not yield the p90 fragment. These results show that
removal of either of the partner interaction domains, i.e. the ankyrin repeats or the
IPT domain, results in the same effect on the half-life of the Mga2ΔTM precursor
form. Moreover, the finding that Mga2ΔTM form is unstable in comparison to
Mga2WT suggests that displacement of p120 from the membrane not only inhibits
the processing but also targets Mga2 for complete degradation. The complete
degradation of the Mga2ΔTM-DHFR fusion protein was not changed in comparison to
Mga2ΔTM (compare Figure 2-18a and b), suggesting that it is either initiated from the
same internal site as processing (but processing is not achieved, e.g. due to impaired
dimerization), or it is initiated from another N-terminal site.
Since the deletion of the transmembrane span does not include the Rsp5-
binding site located in the C-terminal part of Mga2 (Shcherbik et al., 2004), it is
Figure 2-17. Ankyrin repeats inhibit processing of Mga2ΔTM and Spt23ΔTM. (a) Deletion of the
ankyrin repeat domain can rescue processing defects of Mga2ΔTM. WT cells grown at RT expressing
mycMga2WT, ΔTM or ΔANKΔTM forms were harvested and lysates were analyzed by Western blots.
(b) Processing of Mga2ΔANKΔTM does not depend on Rsp5. Δrsp5 cells (rescued by Ole1 under the
control of ADH1 promoter) expressing mycMga2ΔTM and mycMga2ΔANKΔTM forms were grown at RT.
(c) Processing of mycMga2ΔANKΔTM-DHFRHA is initiated from an internal site. WT cells expressing
mycMga2ΔTM-DHFRHA, mycMga2ΔANKΔTM-DHFRHA or DHFRHA were grown for 3 hours in the presence
or absence of MTX. Note that the C-terminal processing intermediate (C35) abundance correlates with
the processing efficiency. (d) Processing of the TM span lacking form of Spt23 is inhibited by ankyrin
repeat domain. Lysates from cells expressing mycSpt23ΔTM-DHFRHA or mycSpt23ΔANKΔTM-DHFRHA
were analyzed by anti-myc and anti-HA immunoblots. Increased processing of the ΔANK variant
correlates with higher abundance of the C35 intermediate. Dpm1 and Pgk1 were used as loading
controls.
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possible that this E3 ligase could be responsible for the observed instability of the
Mga2ΔTM variant. Therefore, Mga2ΔTM stability was investigated in Δrsp5 and ufd1-
2 mutant cells. This experiment showed that the p120ΔTM turnover is independent of
both Rsp5 and Ufd1 (Figure 2-18c,d). Moreover, the ufd1-2 rescue experiment
revealed that Mga2ΔANKΔTM but not Mga2ΔTM expression can fully restore viability
of the mutant strain at 37 °C (Figure 2-18e). This result suggests that not only
displacement from the ER but also the removal of the C-terminal parts of p120 by
processing is required for transcription factor activation. However, the inability to
rescue the OLE pathway defects by the Mga2ΔTM form (also in case of the Δspt23
Δmga2 double knockout cells) seems to be dose dependent (Hoppe et al., 2000 and
data not shown), implying that it may also be the result of the increased instability of
the Mga2ΔTM variant.
One possible scenario is that the E3 ligase, which normally mediates complete
degradation of p90 in the nucleus, is also responsible for the observed instability of
the Mga2ΔTM mutant. Such degradation may be initiated from a site (e.g. the N-
terminus), which would not lead to the formation of p90. Since proteasomes of the
cim3-1 mutant strain seem to be able to initiate degradation/processing, but are
impaired in proteolytic processivity, various Mga2ΔTM variants were tested in these
cells for accumulation of degradation intermediates. All constructs were strongly
stabilized in these mutant cells, and additionally several degradation byproducts,
which are only slightly smaller than the precursor forms accumulated in cells as
detected by the immunoblot against the C-terminal tag (Figure 2-18f). This result
demonstrates that degradation of some molecules initiates from the N-terminus or a
site close to the N-terminus. Interestingly, proteolysis of a fraction of the
Mga2ΔANKΔTM and Mga2ΔIPTΔTM proteins, but not of the Mga2ΔTM variant, seem
to be initiated at an internal site (most likely the processing initiation site), as both
variants accumulated C-terminal degradation intermediates of about 75 kDa in
cim3-1 cells (Figure 2-18f; C75 fragments). Moreover, the Mga2ΔIPTΔTM variant
accumulated also N-terminal proteolytic fragments in cim3-1 cells (Figure 2-18f; NΔIPT
fragment), supporting the interpretation that proteolysis of this protein is initiated
additionally at an internal site. These results suggest that the interaction between the
ankyrin repeats and the IPT domain inhibits initiation of Mga2ΔTM processing,
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possibly by stabilizing a conformation that prevents formation of the polypeptide loop
in the centre of the precursor.
Figure 2-18. Ankyrin repeats-mediated interaction inhibits the processing of Mga2. (a,b) Loss of
ANK-IPT interaction destabilizes soluble forms of Mga2. (a) Mga2ΔTM p120 form is a short-lived
protein and can be further destabilized by ankyrin repeats mutation (Mga2ΔANKΔTM). Cycloheximide
chase experiment for WT cells expressing mycMga2WT, ΔTM or ΔANKΔTM proteins under the control
of endogenous promoter, grown at RT. (b) Cycloheximide chase experiments in the presence of MTX
in the growth medium for WT cells expressing mycMga2ΔTM, ΔANKΔTM or ΔIPTΔTM mutants
possessing C-terminal fusion of DHFRHA. (c,d) Turnover of Mga2ΔTM p120 form does not depend on
Rsp5 and Ufd1. GAL promoter shut off experiments were performed at RT for WT and Δrsp5 (c) or at
37 °C for WT and ufd1-2 (d) cells expressing mycMga2ΔTM. (a-d) Graphs (right panels) show
quantification of p120 decay of different constructs of Mga2 in indicated strains and conditions. (e)
Expression of Mga2ΔANKΔTM protein rescues ufd1-2 mutant cells grown at 34 °C and 37 °C. The
experiment was performed as described for Figure 2-16a. (f) Ankyrin repeats-mediated interaction
masks the processing initiation loop. Degradation of Mga2ΔTM is initiated from the N-terminus. WT
and cim3-1 cells expressing mycMga2ΔTM, ΔANKΔTM or ΔIPTΔTM proteins with DHFRHA fused to the
C-terminus were grown at 37 °C for 3h. p120, p90, NΔIPT (N-terminal processed form of ΔIPT
variant), C35 fragment, intermediates of N-terminally initiated and internally initiated proteolysis (C75)
are indicated. Dpm1 is used as a loading control.
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3. Discussion
Since the proteasome was discovered in the early 1990’s, numerous reports have
proven its importance for the complete elimination of cellular proteins. However, a
growing number of recent studies show that besides this function, the proteasome
acts also in unconventional ways in regulated ubiquitin/proteasome-dependent
processing or even non-proteolytic processes. These diverse activities of the
proteasome raise the question how the fate of different proteasomal substrates is
determined.
This study focuses on the understanding of the mechanism and regulation of
unconventional activities of the proteasome in partial protein degradation using as an
experimental system the activation of the yeast transcription factors Spt23 and Mga2.
In addition, the understanding of this process provides implications to general
mechanisms of protein degradation by the proteasome.
3.1. Proteolytic systems for processing of proteins
Limited proteolysis is an important cellular mechanism commonly employed for the
generation of biologically active proteins by processing of their inactive precursors.
Next to the broad array of site-specific proteases, which by the nature of their
enzymatic reaction mediate partial proteolysis, the proteasome was found to be
involved in processing of many substrates as well. Why the proteolytic system that
was designed for complete destruction of proteins is also utilized for partial
proteolysis seems to be an intriguing and open question. Perhaps the possibility to
choose between complete or partial degradation might contribute to a more dynamic
regulation of protein activity, and might be advantageous over processing by the
conventional proteases.
Hydrolysis of peptide bonds requires an aqueous environment and therefore the
sites for initiation of cleavage by the proteases need to be located in exposed parts of
substrates, such as flexible inter-domain segments or surface exposed loops. This
requirement appears to be omitted by RIP substrates, such as SREBP, APP or
Notch, which are cleaved at transmembrane segments (Brown et al., 2000). It is
believed, however, that enzymes mediating RIP are able to create an aqueous
microenvironment around the catalytic site by a unique arrangement of their
transmembrane domains (Wolfe and Kopan, 2004). Site-specific proteases seem to
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recognize their substrates by short sequences near (or within) the cleavage sites, or
by a unique conformation of substrates (Neurath, 1989; Wolfe and Kopan, 2004). In
contrast, the proteasome seems to cleave virtually any sequence. Interestingly, some
sequences were reported to stop proteasomal degradation (e.g. the glycine-alanine
repeats of EBNA1 protein), but they rather seem to affect engagement of the
substrates with the proteasome (Sharipo et al., 1998). Specificity of the proteasome
is mainly brought about by the covalent attachment of the ubiquitin mark to the
substrates, a process mediated by numerous specialized enzymes. This seems to
provide a powerful step ensuring tight regulation of the fates of a broad range of
different proteins. Moreover, the substrates also require an exposed unfolded region
that can be translocated into the degradation tunnel to initiate sequential unfolding
and degradation of the polypeptide chain.
At a first glance, the high processivity of the proteasome seems not to be
suitable for processing of proteins, but as discussed below, it can also have clear
advantages. It demands from the precursor proteins that they possess tightly folded
barrier domains (e.g. the IPT domain of Spt23/Mga2), which allow restricted
proteolysis and thus the accumulation of processed fragments. Notably, the folding of
the barrier domains can be regulated (e.g. DHFR is stabilized by MTX) and may be
characterized by a different local stability of N- and C-termini. This offers a way to
control substrate fate by either processing or complete degradation, depending on
the folding state or the direction of the proteasome-mediated proteolysis (see below).
Since protein folding is a dynamic process, also the cleavage fragments produced by
the proteasome vary from those produced by site-specific proteases. Products of
proteasomal processing seem not to be constant in size, but rather appear as a
collection of fragments (Spt23 p90 and C50 forms, Mga2 C35 cleavage
intermediate), indicating several different cleavage sites. In contrast, conventional
proteases seem not to rely on the presence of tightly folded regions in their
substrates, but rather such domains, which stop proteolysis due to their limited
availability for the active sites.
In principle, single cleavage by site-specific peptidases produces two
polypeptides. Processing of precursors by these enzymes are commonly employed
to separate a sterically hindering (zymogens activation) or an anchoring domain
(SREBP activation) from active parts of the precursor. In contrast, the known
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examples of RUP suggest that the proteasome usually degrades only one part of the
precursor protein (an inhibitory domain) to small peptides, thereby yielding only one
polypeptide fragment. This mechanism allows a unique regulation of proteins, whose
inhibitory domains must be completely degraded, since they could bind and inhibit
the active domains. Such mechanism is required for the processing of NFκB
proteins, which possess inhibitory ankyrin repeat domains that, if isolated from the
precursors, can still bind and inhibit the transcription factor (Moorthy and Ghosh,
2003). Analogous interaction appears to take place with the Mga2 precursor
domains, suggesting that complete elimination of the C-terminal ankyrin repeats is
indeed required.
Interestingly, limited proteasomal proteolysis might also yield two fragments. As
demonstrated in this study, proteasomal processing can be initiated from an internal
site of the precursor molecule. Therefore, if the substrate possesses two tightly
folded domains located N- and C-terminally from the initiation loop, proteasomal
activity can separate two polypeptide chains, both of which might have biological
functions.
3.2. Mechanism of proteasomal processing of Spt23/Mga2
3.2.1. Initiation signal for processing of Spt23/Mga2
The proteasome recognizes and binds the ubiquitin modification of its substrates.
Proteins degraded by the proteasome are usually modified by polyubiquitin chains
and most monoubiquitylated proteins are not targeted to the proteasome. However, it
was demonstrated that mono/oligoubiquitylation of the Spt23 precursor by the
ubiquitin ligase Rsp5 is essential for processing initiation (Hoppe et al., 2000).
Interestingly, Rsp5 was shown to efficiently catalyse polyubiquitylation of its
substrates in vitro. However, in cells this polyubiquitylation activity seems to be
counteracted by the deubiquitylating enzyme Ubp2 (Kee et al., 2005; Kee et al.,
2006). Ubp2 and the UBA domain containing protein Rup1 form a complex with
Rsp5, and may lead to the generation of mono/oligoubiquitylation instead of the
polyubiquitin chain. This suggests that short ubiquitin chain on Spt23 may represent
a signal specific for limited degradation. Since the 19S cap possesses multiple
subunits that are involved in binding of ubiquitin, it is tempting to speculate that they
are not equivalent in recruiting substrates modified by ubiquitin chains of different
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lengths. Therefore, different binding sites on the proteasome might contribute to the
regulation of the fate of substrates. Interestingly, the processed Spt23 p90 protein
seems to retain the ubiquitin modification after the release from the proteasome,
suggesting a difference between recognition of a signal for processing and
degradation. Sites recognizing polyubiquitin chains may be located in close proximity
to the Rpn11 deubiquitylating enzyme, which removes the ubiquitin mark from
substrates, while sites for mono/oligoubiquitylated substrates may be spatially
separated from Rpn11. Notably, the binding of single ubiquitin molecule may also be
weaker than that of polyubiquitin chain and facilitate early release of
monoubiquitylated substrate from the proteasome. This could have implications for
the termination of the processing reaction and the release of p90. Moreover, it is
possible that for efficient engagement of Spt23 precursor by the proteasome not only
the monoubiquitin mark, but also an additional binding site is needed (e.g. the
processing initiation loop, which is supposed to bind to the ATPases ring).
Importantly, shorter ubiquitin chains on the proteasomal substrates may offer an
additional step in the regulation of their fates. The 19S cap of the proteasome was
proposed to act as a “molecular gearbox”, which by remodelling of ubiquitin chains of
substrates bound to the proteasome might shift their fates (Jentsch and Rumpf,
2007). Indeed, it was recently demonstrated that the deubiquitylating enzyme Ubp6
and the E4 enzyme Hul5 associated with the 19S cap could regulate the half-life of
certain substrates by controlling their ubiquitin chain length (Crosas et al., 2006;
Hanna et al., 2006). In addition, trimming of ubiquitin chains by Ubp6 may act as a
timer for unfolding and degradation, and facilitate release of proteins from the
proteasome. Interestingly, since Rsp5 is also responsible for the complete
degradation of Mga2 p120, which apparently requires the formation of longer
ubiquitin chains, it is possible that the molecular gearbox mechanism in this case
shifts the fate of the substrate towards complete degradation. Alternatively, an
additional, yet unknown factor might be involved in modulating the ubiquitylation
efficiency of the Rsp5 enzyme.
3.2.2. Processing of Spt23/Mga2 initiates at an internal site
Proteasomal degradation relies on the activity of the hexameric ring of AAA ATPases
that guard the entry to the catalytic particle. Narrow openings of the proteasome do
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not allow globular domains to be efficiently degraded, unless they become
sequentially unfolded and translocated into the proteasome. In the last years it
became more evident that proteins in addition to the ubiquitin signal need to possess
an unstructured region near the ubiquitylation site, which facilitates unfolding by the
ATPases (Lee et al., 2001; Prakash et al., 2004). After this step, processivity of the
proteasome assures that the whole substrate is degraded to small peptides.
However, some proteins evolved mechanisms to interfere with the continuous
degradation mediated by the proteasome, resulting in their processing and activation
of their dormant activities. The first protein reported to undergo proteasomal
processing was the mammalian transcription factor NFκB1, whose inactive precursor
p105 is trimmed by the proteasome to give a rise to an active N-terminal p50
fragment (Fan and Maniatis, 1991; Palombella et al., 1994). Since the C-terminal
domain of p105 is completely degraded by this reaction, it was proposed that the
proteasome initiates the degradation from the C-terminus of p105. A “stop-transfer
sequence” was suggested to interfere with proteasomal progression, leading to the
release of the processed p50 fragment (Orian et al., 1999). However, later reports
suggested that processing of NFκB might be more complicated, since p105 appears
to undergo processing already at the ribosome before the full-length protein is
synthesized, and it seems to require precursors dimerization (Lin et al., 1998; Lin et
al., 2000). In this proposed “co-translational” mechanism of processing, the C-
terminal part of p105 nascent polypeptide chain is buried in the ribosome, suggesting
that processing could be initiated from an internal site in the p105 sequence. Support
for this hypothesis came from an in vitro study on circular variants of natively
disordered proteins, which showed that the proteasome initiates degradation in
unstructured regions by an “endoproteolytic” cleavage (Liu et al., 2003). Since after
synthesis polypeptides do not immediately adopt native ternary structures, they could
serve as unfolded regions for the proteasomal cut, explaining the results observed for
p105. However, the idea that the proteasome can initiate processing from internal
sites also posttranslationally came from the work on the yeast transcription factor
Spt23. This protein undergoes proteasomal processing of a full-length precursor
p120, which results in the formation of a shorter N-terminal fragment p90 (Hoppe et
al., 2000). Since the C-terminus of Spt23 is localized to the ER lumen, it is not
accessible for the proteasome. This is reminiscent of the proposed co-translational
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processing of p105 and suggests that the proteasome initiates processing of p120
from a flexible polypeptide loop (the “loop model”) located in the middle of the Spt23
sequence (Rape and Jentsch, 2002). Moreover, Spt23 (and its homolog Mga2)
shares domain organization with NFκB, and requires dimerization and ubiquitylation
for processing, suggesting similar mechanisms. However, a direct evidence for the
initiation of proteasomal processing from internal sites was lacking due to the rapid
elimination of C-terminal sequences of the transcription factor precursors in the
processing reaction (Hoppe et al., 2000).
Two experimental approaches applied in this study provided the final
confirmation of the “loop model”. The first series of experiments demonstrated that a
fusion of a stably folded DHFR domain to the C-terminus of soluble (ΔTM) or
membrane bound Mga2 precursors do not interfere with their processing (Figure 2-1
and Figure 2-2). DHFR was previously shown to be resistant to unfolding and
degradation by the proteasome, especially if its structure was stabilized by binding of
the ligand MTX (Johnston et al., 1995; Lee et al., 2001). Moreover, in addition to the
N-terminal p90 fragment, processing of these fusion proteins yielded stable
fragments corresponding to the undegraded C-terminal domains. This strongly
supports the hypothesis of an internal initiation site for the proteolysis. After
degradation initiated from a polypeptide loop, the proteasome starts concurrent
bidirectional degradation of two N- and C-terminal parts of the polypeptide,
which is however not completed due to the hindrance by stable folds encountered
by the proteasome (Figure 3-1b-d). Moreover, as soluble and ER membrane-bound
Mga2 precursors are apparently processed in a similar manner, precursor processing
according to the loop model is not limited to membrane proteins. Since Spt23/Mga2
and NFκB precursors are homologous proteins, it seems likely that also processing
of NFκB transcription factors is initiated at a flexible loop in the centre of the p105
polypeptide.
In the second experimental approach, residual processing of native forms of
both transcription factors Spt23 and Mga2 by leaky proteasome mutants led to an
accumulation of C-terminal byproducts of p120 processing (Figure 2-3), again
supporting the “loop model” for partial degradation. Since these processing
intermediates are fragments of about 300 amino acids and are localized to ER
membranes (Figure 2-4), this implies that processing initiates in a region near the
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Figure 3-1. Hypothetical model for proteasome-mediated degradation and processing. The
proteasome (grey) harbours within its 20S particle (dark grey) a central catalytic cavity and two
antechambers. Substrate (black) recruitment is usually mediated by the ubiquitin modification of the
substrate (not shown). (a) Complete substrate degradation may commence by the insertion of an
internal polypeptide loop through the openings of the proteasome into the proteolytic chamber. The
inserted polypeptide chain may partially re-fold in the antechambers and thereby prevent it from
slipping back into the cytosol (not shown). Degradation initiates by a cut within the loop and continues
bidirectionally (red arrows) towards both the N- and C-terminal ends of the polypeptide (middle
column). If there are no steric constraints (first row), degradation continues in both directions (red bold
arrows) until the polypeptide is completely degraded to small peptides, which exit the proteasome by
diffusion (not shown). (b-d) Protein processing occurs if the polypeptide contains tightly folded
dimerization domains (e.g. the IPT domain of Spt23; b) or other tightly folded domains (e.g. MTX-
stabilized DHFR; c,d). These domains cannot enter the central cavity and therefore cause incomplete
degradation, i.e. degradation proceeds only towards the end that is not hindered by barriers (red bold
arrows). The processing product contains the tightly folded (or dimerization) domain, and additionally
segments distal from these domains and a short polypeptide stretch that reflects the distance from the
proteasome openings to the active sites. (d) Degradation of substrates that contain tightly folded
domains both N- and C-terminally of the inserted loop yield two processing products. Only the
authentic N- and C-termini are labelled.
ankyrin repeats of Spt23/Mga2 and that this step takes place directly at the ER
membrane. Moreover, the finding that degradation of the ERAD model substrate
Hmg2 is also initiated from internal site/sites (Figure 2-8) suggests that such mode of
action may be employed more often by the proteasome, also for the complete
elimination of proteins (Figure 3-1a).
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3.2.3. Formation of a flexible loop for processing initiation
It is believed that the proteasome starts degradation of substrates in unstructured
regions close to ubiquitylation sites (Prakash et al., 2004). The finding that the
initiation of Spt23/Mga2 processing occurs by a cleavage at the internal site of p120
suggests that such a region exists in the centre of the p120 precursor. However, it is
not clear how such regions are formed. It was speculated that these sites should be
able to adopt hairpin loop conformations, which would allow their grabbing by
ATPases of the 19S cap and translocation through the narrow proteasomal gates to
reach the active centres of the proteasome for initial cleavage. Indeed, analysis of
the crystal structure of the yeast 20S proteasome showed that its openings are wide
enough to accommodate two juxtaposed polypeptide chains (Rape and Jentsch,
2002). Furthermore, it was experimentally demonstrated with substrates cross-linked
by disulfide bonds that even up to three chains can enter the proteasome
simultaneously (Lee et al., 2002).
It has been proposed for the glycine rich region (GRR) located in the centre of
the p105 precursor that it could serve as the initiation site for processing, since it is
necessary for p50 formation (Lin and Ghosh, 1996; Rape and Jentsch, 2002). This
site seems to be highly flexible and loosely folded, and therefore it could form the
loop accessible for initial cleavage by the proteasome. However, a recent study
demonstrated that the p105 protein lacking GRR, still undergoes complete
degradation suggesting that possibly additional regions might contribute to the
formation of a loop as well (Tian et al., 2005).
In this study, identification of the C-terminal processing intermediate C50
resulting from aberrant processing of Spt23 in proteasome mutants cells (Figure
2-3b), combined with the size estimation of p90 and C50 fragments (Figure 2-5b)
allowed the finding of the region where the initial cleavage of Spt23 occurred. This
site is located within the ankyrin repeat-containing region, but since the ankyrin
repeats are well-folded structures, this rather suggests the flanking sequences as
candidate sites. Analysis of the potential folding of this region by the FoldIndex
program (Figure 2-6) supports this idea, as the ankyrin repeat-flanking segments
exhibit a tendency to adopt unfolded conformations. Interestingly, none of the tested
deletions in this region could abolish processing (Figure 2-5c), suggesting that other
sites may compensate for the absence of the primary site. However, processing
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initiated from this alternative site/sites seems to involve local unfolding of the p120 C-
terminal region, since an Spt23 mutant protein harbouring a deletion of the whole
investigated ankyrin repeat-containing region could not be processed by attenuated
proteasomes (Figure 2-5d). Moreover, it seems attractive to speculate that the loops
that first enter the proteasome might not always be identical to the regions that are
first degraded by the proteasome. Given the fact that the proteasome possesses two
large antechambers that border the central catalytic chamber, it seems possible that
substrates will partially re-fold within the antechambers (perhaps preventing thereby
the substrate to slip back to the cytosol), thus allowing flanking polypeptide segments
to slip into the catalytic chamber for the initial cut. This is in agreement with the
notion that undegraded tails from different DHFR fusions released from the
proteasome show variable sizes (see chapter 2.1.1; C35 and C32 fragments; also
(Lee et al., 2001), suggesting that their polypeptide chains partly re-folded inside the
proteasome.
Interestingly, the initial cleavage site of Spt23/Mga2 is located near the ankyrin
repeats, which are responsible for the inhibition of processing, suggesting that the
interaction mediated by this domain could lead to masking or re-structuring of the
processing initiation loop. This could be mediated either by docking of the processed
p90 form to the region of the initiation site and sterically masking it, or by
intramolecular interaction involving changes in the conformation of the C-terminal
region of p120 (see below).
3.2.4. Regulation of loop formation by the ankyrin repeat domain of Mga2
Analysis of the Spt23/Mga2 and NFκB precursor sequences shows similarity in the
IPT and ankyrin repeat domain organization, suggesting a conserved function for
both regions (Figure 2-9). Since the ankyrin repeats, which are usually protein-
protein interaction motifs, are located in the putative region of initial cleavage of
Mga2 by the proteasome, it is possible that they could influence formation of the
processing initiation loop. Indeed, in experiments with the soluble Mga2ΔTM variant
that cannot be efficiently processed, the precise deletion of the ankyrin repeats
restored the formation of the p90 form (Figure 2-17). Moreover, in cim3-1 mutant cells
the Mga2ΔANKΔTM variant accumulated proteolytic fragments, indicating that
processing is initiated at an internal site (Figure 2-18f; C75 fragments). This strongly
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suggests that the ankyrin repeat domain may be an inhibitory element for formation of
the processing initiation loop. Similarly, deletion of the ankyrin repeats from the NFκB
precursor p105 leads to increased processing, but apparently does not change the
efficiency of polyubiquitylation of the precursor (Cohen et al., 2001). In addition, the
mutation of the ankyrin repeat domain in the native Mga2 protein variant strongly
destabilized the p120 molecule (Figure 2-12b) and led to an accumulation of the
active transcription factor p90 in the nucleus (Figure 2-14a). Thus, the ankyrin
repeats inhibit degradation or/and processing of the Mga2 precursors.
Interestingly, the ankyrin repeats can interact with the IPT domain of Mga2 and
the mutation of either of the domains led to similar effect on the Mga2 precursor half-
life. This strongly argues for a model in which the interaction of these domains results
in the inhibition of both processing and complete degradation of the Mga2 precursor,
most likely by the same mechanism, namely by masking the site for initiation of
proteolysis.
Notably, the interaction between the ankyrin repeat and the dimerization
domains seems to be conserved evolutionarily. The intracellular localization of
transcription factors from the NFκB family is controlled by a group of IκB proteins,
which associate with NFκB dimers and thereby sequester them in the cytoplasm, and
also directly interfere with their ability to bind to DNA (Baldwin, 1996). The structural
hallmark of various IκB proteins is the ankyrin repeat domain, containing six or seven
closely adjacent repeats mediating their interactions with the transcription factors.
Importantly, this domain is very similar to the C-terminal region of the NFκB
precursors and both seem to be equivalent. In fact, it was reported that the p105
precursor could also mediate IκB-like functions depending on its ankyrin repeat
domain (Fu et al., 2004; Moorthy and Ghosh, 2003; Rice et al., 1992). Interestingly, a
close homolog of Spt23 from yeast Candida albicans (CaSpt23) does not contain the
ankyrin repeat domain. However, an inspection of the C. albicans as well as the S.
cerevisiae genome database revealed the presence of several ankyrin repeat-
containing proteins of unknown function, which could act similarly to IκB molecules to
regulate CaSpt23 or ScSpt23.
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What might be the mechanism of ankyrin repeat-mediated inhibition? A model
proposed for the processing of the p105 protein seems attractive, which suggests
that the ankyrin repeat domain of p105 could serve as a docking site for the
processed p50 fragment, preventing thereby proteolysis of the precursor molecule
(Cohen et al., 2001). A similar feedback mechanism could be also applied to Mga2,
where the product of the processing reaction p90 would mask the processing
initiation loop of the p120 precursor (Figure 3-2a). A variation of this model, involving
a ternary interaction between the two IPT domains of the p120/p90 complex and the
ankyrin repeats of the p120 molecule seems also plausible (Figure 3-2b). In this latter
mechanism, an intramolecular interaction between the N- and C-terminally located
domains of the same p120 molecule might cause the polypeptide chain to fold back
and result in a “closed conformation”. Such conformational change of the Mga2
precursor could influence the putative processing initiation loop, which resides near
the ankyrin repeats. This mode of the interaction is supported by crystal structure
studies on NFκB-IκB complexes, which show that the ankyrin repeats of IκB bind to
the cleft between the two dimerized IPT domains of NFκB proteins (Huxford et al.,
Figure 3-2. Hypothetical models for the ankyrin repeat domain-mediated inhibition of the Mga2
precursor processing. (a) Processed p90 fragment docks via the IPT domain to the precursor
molecule and masks the processing initiation site. (b) C-terminal domains of the Mga2 p120 dimer are
immobilized due to the insertion into the ER membrane, hindering the intramolecular rearrangements.
After processing one of the p120 molecules, the C-terminal anchor is removed, which allows folding
back of the polypeptide chain. Conformational change masks the processing initiation loop. Mga2
molecules are shown in gray and dark gray, the flexible processing initiation sites – in blue. Only the
original N- and C-termini are indicated. The putative initiation loop could be also located in a flexible
region between the IPT and ankyrin repeat (ANK) domains (not shown).
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1998; Jacobs and Harrison, 1998).
Interestingly, as shown in this study, the ankyrin repeat domain is also an
inhibitory element for the translocation of the processed active transcription factor
p90 to the nucleus. It seems that prevention of processing of the processing template
molecule may allow a separate, most likely tightly regulated step of p90 mobilization
from the dormant membrane-bound p120/p90 complex. This may involve ERAD of
the processing template molecule (Shcherbik et al., 2003). Under normal conditions,
mobilization of Mga2 p90 is slow, which is reflected by the high stability of p120 in
expression shut-off experiments (Figure 2-12b and Figure 2-15a). Interestingly,
deletion of the ankyrin repeats of Mga2 led to an Rsp5-dependent drastic
destabilization of p120 and release of p90, resulting in strong activation of OLE1
expression (Figure 2-15a and Figure 2-13b). This suggests that physiological
Figure 3-3. Hypothetical models for the ankyrin repeats-mediated inhibition of the Mga2 p90
mobilization from the p120/p90 complex. (a) The p120 molecule from the p120/p90 complex is
polyubiquitylated by the Rsp5 enzyme and the interaction between the ankyrin repeats and the IPT
domain is resolved (probably additional factor is involved). This leads to complete elimination of the
processing template molecule. (b) The closed conformation of the p120/p90 complex is resolved upon
polyubiquitylation by the Rsp5 enzyme. Internal degradation initiation site is used for complete
elimination or processing (not shown) of the processing template. (c) Complete degradation of the
processing template is initiated from the N-terminal site. Blue arrows show direction of degradation
initiated from internal or terminal sites.
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regulation of p90 mobilization might occur by dissociation of the ankyrin repeats-
mediated intramolecular interaction, which would then lead to a conformational
change and expose the loop for initiation of complete degradation or even
processing of the processing template molecule from the p120/p90 dimer (Figure 3-
3a,b). However, how this regulation is achieved is not clear yet. Possibly, additional
factors are involved, which upon binding to Mga2 allow to change its conformation or
to dissociate the interaction between the ankyrin repeats and the IPT domain (e.g.
ATPase function of Cdc48). Also another model is possible in which complete
degradation of p120 is initiated from the N-terminal site of the protein. Since the
intramolecular interaction between the ankyrin repeats and the IPT domain might
lead to a folding back of the precursor molecule, it could present certain N-terminal
regions of Mga2 for ubiquitylation by the C-terminally bound Rsp5 enzyme and allow
initiation of degradation from the N-terminus of p120 (Figure 3-3c). As demonstrated
in this study, IPT dimerization does not block proteasomal progression initiated form
the N-terminus (Figure 2-18f), therefore such proteolysis may lead to complete
degradation of p120.
3.2.5. Mechanism of limited proteasomal degradation
The proteasome usually degrades proteins to short peptides. Thus, the identification
of RUP substrates raised the question how these proteins escape from complete
destruction. The GRR residing in a central region of p105 has been proposed to be a
“stop-transfer signal”, as deletion of these residues abolished processing in
mammalian cells (Ciechanover et al., 2001; Orian et al., 1999). Later reports
suggested that rather the stability of the dimerization domain of NFκB may play a role
in resisting the proteasomal unfolding activity (Lin et al., 2000; Lin and Kobayashi,
2003). Strong support for this hypothesis came from studies showing that certain
stably folded domains cannot be degraded by the proteasome and moreover can
protect other downstream regions against the degradation (Johnston et al., 1995; Lee
et al., 2001). The IPT domain of NFκB precursors is characterized by a stable
immunoglobulin-like fold and upon dimerization the polypeptide chain is difficult to
unravel from the structure, because it is buried in the dimerization surface (Ghosh et
al., 1995; Muller et al., 1995). Therefore, this domain is a good candidate for a barrier
for complete proteasomal degradation. Furthermore, it was demonstrated that
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prokaryotic ATP-dependent proteases, which are distantly related to the proteasome,
can release substrates that are difficult to unfold (Kenniston et al., 2005). This
indicates that processivity of chambered proteases can be influenced by tightly
folded structures. A recent report combines both proposed models and suggests that
the IPT domain of NFκB works in combination with a downstream low-complexity
region (the GRR sequence) to block proteasome progression and to protect the N-
terminal parts of the proteins from degradation (Tian et al., 2005). In this model, the
dimerization domain of p105 interferes with the unfolding activity of the proteasome
and the GRR reduces affinity of the engaged substrate to the proteasome, thereby
facilitating the release of the processed form (p50). Although the yeast Spt23/Mga2
precursors possess centrally located IPT domains as well, they lack low-complexity
sequences at positions similar to those found in NFκB. Moreover, Spt23 and Mga2
precursors harbouring deletions in sequences located downstream of the IPT domain
at the position occupied by the GRR in p105, are still processed by the proteasome
(data not shown). However, deletion of the IPT domain of Spt23/Mga2 was shown to
completely abolish processing (Rape et al., 2001; Shcherbik et al., 2004), indicating
that dimerization may be the only requirement for efficient proteasome progression
stop in yeast.
Data presented in this study suggest that the alternative to precursor
processing in cells is the complete degradation of the molecule. The Spt23ΔIPT
mutant protein is completely degraded in WT cells, however, when the same variant
is a substrate for attenuated proteasomes, it is processed to the N-terminal fragment
(N75) analogously to p90 and the C-terminal C50 fragment (Figure 2-7b). This result
demonstrates that the IPT domain forms a barrier for the proteasome, since
processing seems to be normally initiated in the Spt23ΔIPT mutant, but it does not
yield a p90 fragment. This is because bidirectional proteolysis initiated from the
internal site of this mutant is not stopped, and thus leads to the complete degradation
of the protein. In addition, the tightly folded DHFR domain fused to the C-termini of
Spt23/Mga2 variants was able to stop proteasome progression independently of low-
complexity sequences (Figure 2-1, Figure 2-2 and Figure 2-17). This suggests that
(at least for yeast proteasomes) stable folds may be sufficient for degradation
termination. This is in line with a report demonstrating that p105 is also processed in
yeast cells independently on the GRR presence (Sears et al., 1998). Conversely,
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Spt23 was shown to be efficiently processed in mammalian cells after ubiquitylation
by the Rsp5 homologue Nedd4 (Shcherbik et al., 2002), suggesting that low-
complexity sequences may also not be absolutely required for processing of all
proteins by mammalian proteasomes. It seems possible that depending on the
substrate the strength of the proteasome is regulated by additional factors. In the
case of the yeast transcription factors the signal for processing could be weaker than
in the mammalian counterparts and could involve a lower unfolding force of the
proteasome.
It is important to note that the folding of the degradation barriers might be
regulated. This idea is suggested by the fact that DHFR itself possesses a tight fold
and can inefficiently stop the proteasomal progression, but when it is further
stabilized upon binding of its ligand MTX, it becomes more effective in inhibiting the
degradation (Figure 2-1b). A similar mode of regulation may exist for the dimerization
strength of Spt23/Mga2, which might be modulated by ER membrane fluidity.
Interestingly, also the direction of degradation seems to be crucial for the function of
the barrier domains, since the IPT domain of Mga2 is efficiently degraded if the
initiation site is within the N-terminal region of Mga2 (Figure 2-18f).
3.3. Regulation of the OLE pathway by the ubiquitin/proteasome
system
UFAs are essential components of membrane lipids that determine the optimal
fluidity of biological membranes and are thus essential for cell viability. Not only
depletion (Zhang et al., 1999), but also too high levels of UFAs can be deleterious for
cell growth (Stukey et al., 1989). Therefore, the level of OLE1 expression is tightly
controlled by the content of fatty acids in the cell (Choi et al., 1996). Expression of
the OLE1 gene is also regulated during the cell cycle with highest mRNA levels in the
late G1 or early S phase (McConnell et al., 1990; Spellman et al., 1998). This
increased expression might be needed to provide the daughter cell with sufficient
UFAs levels. As crucial for cell viability, the activity of the OLE pathway is precisely
adjusted by several mechanisms, among them proteasome-mediated processes, the
majority of which deals with the activation of Spt23 and Mga2 proteins. Interestingly,
although both of the transcription factors are highly homologous and both activate
OLE1 gene expression, they seem to be differentially regulated. It seems as if the
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activity of Spt23 is regulated mainly at the level of processing (negatively by UFAs
and positively by elevated temperatures), while the activity of Mga2 is rather
controlled at the level of p90 mobilization (negatively by the ankyrin repeat domain
and positively under hypoxic conditions) (see below).
Under normal growth conditions, the major transcription factor for constitutive
mild activation of the OLE1 promoter seems to be the Spt23 protein, rather than
Mga2. This is suggested by some experimental evidence. In immunofluorescence
microscopy experiments, Spt23 protein shows mainly nuclear localization (Hoppe et
al., 2000), whereas Mga2 gives ER and nuclear envelope staining, suggesting that
Mga2 p90 is inefficiently liberated from the dormant p120/p90 complex (Figure 2-
14a). This seems to correlate well with the notion that Spt23 is a high-turnover
protein due to the rapid processing of p120 form and the rapid degradation of p90
(probably in the nucleus after transcription activation) (Richly et al., 2005), while both
p120 and p90 forms of Mga2 are stable (Figure 2-12b). Moreover, Mga2 was shown
to be a more potent activator of the OLE1 transcription than Spt23 (Chellappa et al.,
2001), raising the possibility that Mga2 is utilized by cells upon stress conditions that
require enhanced levels of UFAs, whereas Spt23 ensures normal OLE1 gene
expression.
The situation may be drastically different under conditions of depletion of UFAs
or enhanced cellular requirements for UFAs. The processed p90 form of Mga2 might
be rapidly mobilized from the dormant complex at the ER and contribute to the
enhanced OLE1 expression. In line with this model, it was reported that the
transcriptional activity of Mga2 is strongly induced under hypoxic conditions (Jiang et
al., 2001). Since the enzymatic reaction catalyzed by Ole1 requires molecular oxygen
as an electron acceptor, upregulation of Ole1 protein in hypoxic conditions may help
to sustain sufficient levels of its enzymatic activity. This regulation may also be
important to turn on other target genes of Mga2 (Auld et al., 2006). It was
demonstrated that under this conditions the processing ratio (p90/p120) of Mga2
increased (Jiang et al., 2002), which was rather an effect of the enhanced
degradation but not processing of the Mga2 p120 molecule, as p120 levels
decreased and p90 levels were not changed. This strengthens the hypothesis that
Mga2 is activated upon certain conditions by p90 release from the dormant ER-
localized complex. It was proposed that this process involves complete degradation
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of the p120 molecule (Shcherbik et al., 2003). Moreover, as shown in this work, the
mobilization of p90 seems to be regulated by the interaction between the ankyrin
repeats and the IPT domain of Mga2 (see above).
Interestingly, also in cells grown at elevated temperatures the OLE1 gene might
be strongly activated by a mechanism involving the enhanced processing of the
Spt23 transcription factor (Hoppe et al., 2000). High temperature-stress alters protein
folding processes in cells, which may therefore require more fatty acids in order to
increase the capacity of ER, the cellular compartment where the protein folding and
quality control occurs.
Additional mechanisms that possibly induce the expression of OLE1 gene
under certain conditions might rely on a stabilization of the active transcription factor.
Two recent reports identified factors that regulate degradation of Spt23 p90 in the
nucleus (Richly et al., 2005; Rumpf and Jentsch, 2006). Notably, these factors have
opposite functions: the E4 enzyme Ufd2 promotes degradation of p90, while the
deubiquitylating enzyme Otu1 cooperates with the Ufd3 protein to stabilize p90.
Therefore, it is possible that under conditions of increased needs for the Spt23
transcription factor, the activity of Otu1 and Ufd3 proteins is higher than that of Ufd2,
leading to stabilization of the transcription factor and high expression from OLE1
promoter.
A third mode of the OLE pathway regulation might operate to prevent
expression of the OLE1 gene under conditions of increased membrane fluidity.
Indeed, the OLE pathway is strongly influenced by high levels of UFAs as it is
completely turned off under such conditions (Choi et al., 1996). It was reported that
processing of Spt23 but not of the Mga2 protein could be inhibited by high levels of
UFAs (Hoppe et al., 2000). It was proposed that the Spt23 precursor might directly
sense fluidity or thickness of the lipid bilayer. Upon changes in membrane fluidity, the
Spt23 molecule might undergo a conformational change, which could regulate either
the formation of the processing initiation loop (possibly involving the ankyrin repeats),
the folding of degradation barrier (the IPT dimerization strength might be regulated by
membrane fluidity), or the association with the Rsp5 ubiquitin ligase. It is interesting
to note that while prevention of either the loop formation or the interaction with the
ubiquitin ligase will exclude proteasomal degradation and processing, a prevention of
the barrier formation will promote the complete elimination of p120. The latter
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mechanism could be employed for the regulation of Mga2 protein abundance upon
conditions of increased membrane fluidity. Although Mga2 processing was only
moderately inhibited by high levels of UFAs, its abundance diminished significantly,
suggesting that p120 might undergo enhanced degradation (data not shown).
Moreover, results presented in this study demonstrate that selection of the initiation
site and the direction of proteolysis may be critical for the fate of substrates.
Therefore, an additional way to control the activity of the OLE pathway might rely on
the selection of either the internal or the N-terminal site for initiation of proteolysis,
and thus the decision to process or degrade Spt23/Mga2, respectively. Finally,
another mechanism most likely employed to reduce OLE1 expression may involve
enhanced polyubiquitylation of the p90 fragment by the E4 enzyme Ufd2 and its
subsequent degradation (Richly et al., 2005).
It seems likely that combination of all of these regulatory mechanisms could be
valuable for the fine-tuning of Spt23/Mga2 activity (Table 3-1), ensuring a fast and
accurate adaptation to cellular needs. Moreover, since there are certain similarities
between the Spt23/Mga2 and the NFκB proteins, similar mechanisms could also be
operating for the control of these mammalian transcription factors and, perhaps more
generally, to control the fates of numerous other proteins.
Table 3-1. Hypothetical regulatory modes for the OLE pathway. The interplay between processing
and complete degradation of the Spt23/Mga2 precursors (p120), and the active transcription factor
(p90) mobilization and degradation decides on the activity of the OLE pathway. In the “OFF” mode,
both the p120 and p90 proteins are eliminated, thus the OLE pathway is turned off. In the “STAND-
BY” mode, p120 is present but not processed; the OLE pathway is turned off. In the “ON” mode, p120
is stable and efficiently processed, producing high levels of p90 (in addition p90 is stabilized); the OLE
pathway is turned on.
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3.4. Complete degradation and processing of substrates by the
proteasome
The main way to control the fates of the proteasomal substrates seems to rely on
regulating their ubiquitylation. Interestingly, not all ubiquitylated substrates are
efficiently degraded by the proteasome. Results presented in this study demonstrate
that the availability of a flexible region for initiation of degradation is crucial for its
engagement by the proteasome (see above). Moreover, the selection of one of more
available flexible degradation initiation sites of the target proteins seems to be critical
for regulation of their fates as well. Findings that certain stable domains can hinder
degradation depending on the direction of the proteasomal proteolysis seem to
explain well how such regulation may decide on the fate of a substrate. Interestingly,
when degradation of Mga2ΔTM is initiated from the N-terminus, the IPT domain
seems not to hinder the proteasomal progression, as no stable C-terminal proteolytic
fragments of expected molecular weight are formed (Figure 2-18f). Work on circular
permutants of DHFR demonstrated that efficient unfolding and degradation by the
proteasome depends on the local stability of the structure engaged first by the
ATPase machinery, rather than the global stability of the domain (Lee et al., 2001).
Therefore, if the local stability of the N-terminal part of the IPT domain is lower than
that of the C-terminal part, the proteasome can unfold and degrade completely the
IPT domain during proteolysis initiated at the N-terminal site of p120. However, in the
opposite situation, when the C-terminally located initiation site is chosen, the
proteasome stops degradation after it reaches the C-terminal stable part of the IPT
domain, which is resistant to unfolding by the ATPase motor and thus releases the
partially degraded substrate, the p90 form. In addition, masking of the unstructured
initiation region may decide whether the ubiquitylated protein is stably engaged by
the degradation machinery or not.
The finding that during the degradation of the ERAD substrate Hmg2 both N-
and C-terminal fragments accumulate transiently during the process (as shown in
cim3-1 mutants; Figure 2-8), strongly argues that also complete proteasomal
degradation may be initiated internally. Selection and cleavage of cytosolic loops of
this substrate may allow a separate extraction of TM spans and thus might help to
degrade a large transmembrane region composed of eight TM spans. It seems
possible that the proteasomal ATPases may be involved in the extraction of Hmg2
Discussion
73
TM segments from the membrane, similarly to the previously described situation for
certain short-lived artificial ERAD substrates (Mayer et al., 1998). Interestingly, not
only the N-terminal transmembrane part-derived fragments were found in the pellet
fraction, but the C-terminal intermediates as well. This suggests that the fragments
might be kept at the ER membrane associated with the proteasome and other ERAD
components, most likely in repetitive inefficient degradation attempts.
It is likely that proteasomes in general might commence degradation from
internal sites, or even that the same substrates may be degraded from various
internal or terminal initiation sites, depending on position of the ubiquitin chain. If
selection of the degradation initiation site is regulated, this may have interesting
implications for the fate of the target protein. In line with this idea, the attachment site
of polyubiquitin chain may select the initiation site. Indeed, experiments with IκBα
showed that it is ubiquitylated at two N-terminally located lysines (Scherer et al.,
1995) and that its degradation initiates from the N-terminus, since an N-terminal
fusion of a glycine-alanine repeat region does not interfere with IκBα ubiquitylation,
but blocks its degradation (Sharipo et al., 1998). In addition, the N-end rule substrate
ubiquitin-X-β-galactosidase is ubiquitylated at N-terminal sites and degraded from the
N-terminus (Bachmair et al., 1986; Bachmair and Varshavsky, 1989). Moreover, it
was shown for the Sic1 protein that different sites for the attachment of the
polyubiquitin chain to the substrate are not equivalent in promoting degradation
(Petroski and Deshaies, 2003), most likely due to the different distance to the
unstructured initiation site for proteolysis.
Identification of stable proteolytic fragments of Hmg2 in proteasome mutant
cells raises the question whether they might also accumulate naturally in WT cells. It
seems likely that the activity of the proteasome can be regulated in cells by certain
physiological cues. In such hypothetical situation, proteolytic fragments could be
formed and they might have physiological function. For example, incompletely
degraded parts of proteins containing functional degron site might compete with the
full-length substrate for the ubiquitin ligase and therefore contribute to a negative
feedback loop in regulating degradation. Another possibility could be an inactivation
of certain substrates by partial degradation. For example, complete degradation of
polytopic proteins seems to require a long time of engagement of the proteasome
and a high consumption of energy due to the need to extract the TM spans. Upon
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conditions of diminished activity of the proteasome, it could be advantageous to
remove only a fragment crucial for the biological function of the protein. Such
processed non-functional product could be further completely degraded under normal
conditions.
Interestingly, even the short peptides produced by the proteasomal degradation
have other functions, than to serve as molecular bricks to build new proteins after
further decomposition to amino acids. It is clear that even low concentrations of a
single peptide can have biological functions. One well known case are the peptides
derived from proteasomal or lysosomal proteolysis, which are bound by the major
histocompatibility complexes (MHC) (Kloetzel, 2004). Although yeast cells do not
possess MHC molecules, other proteins possessing peptide-binding pockets may be
regulated by the proteasome mediated-proteolysis of certain substrates. Indeed,
small peptides are employed by yeast, for example in the signalling of mating. When
a yeast cell encounter the mating pheromones produced by the cell of the opposite
cell type, it induces the expression of mating genes and thus prepares the two cells
to form a diploid cell (Marsh et al., 1991). Moreover, some peptides produced by
cleavage of longer precursors have functions that are independent of their
precursors. It was demonstrated that peptides produced by cleavage of signal
sequences from certain substrates by the signal peptide peptidase can be released
to the cytosol and bind to calmodulin, a protein involved in the regulation of many
cellular processes (Martoglio and Dobberstein, 1998). Also the signal peptide of the
glycoprotein of the lymphocytic choriomeningitis virus (LCMV) is first utilized to target
the protein to the ER, but after cleavage it has an additional functions in the virus life
cycle (Froeschke et al., 2003).
Therefore, degradation of proteins or rather processing of polypeptides to
smaller peptides, could serve to produce fragments that might act as “intracellular
hormones” or signalling molecules. These functions may be generally overlooked in
studies on degradation of proteins by the proteasome, due to a technical difficulty in
detection of short peptides, but could have a high impact on the regulation of many
cellular processes.
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4. Materials and methods
4.1. Materials
4.1.1. Chemicals and reagents
Unless otherwise mentioned, chemicals and reagents were purchased from
Amersham-Pharmacia, Applied Biosystems, Biomol, Biorad, Difco, Fluka, Invitrogen,
Kodak, Merck, New England Biolabs, Promega, Roth, Roche, Riedel de Haen, Serva
or Sigma. For all methods described, de-ionized sterile water, sterile solutions and
sterile flasks were used.
4.1.2. Antibodies
Antibodies were used in this study for detection of proteins by immunoblotting, for
studying protein-protein interactions by immunoprecipitation and intracellular
localization of proteins by immunofluorescence microscopy.
Table 4-1. Antibodies used in this study
Primary antibodies: Source
Monoclonal anti-c-myc (9E10) Santa Cruz
Polyclonal anti-c-myc (A-14) Santa Cruz
Monoclonal anti-HA (F-7) Santa Cruz
Polyclonal anti-HA (Y-11) Santa Cruz
Monoclonal anti-ubiquitin (P4D1) Santa Cruz
Monoclonal anti-Dpm1 Molecular Probes
Monoclonal anti-Pgk1 Molecular Probes
Polyclonal anti-Kar2 M. Rose (Princeton University)
Secondary antibodies:
HRP-coupled anti-rabbit IgG Dianova
HRP-coupled anti-mouse IgG Dianova
Alexa Fluor 546 anti-mouse IgG Molecular Probes
4.1.3. E. coli strains
XL1-Blue: hsdR17 recA1 endA1 gyrA46 thi-1 supE44 relA1 lac [F’ proAB
lacI
q
ZΔM15 Tn10 (Tet
r
)] (Stratagene)
TG1: supE thi-1 Δ(lac-proAB) Δ(mcrB-hsdSM)5 (rk- mk-) [F’ traD36 proAB lacIq
ZΔM15] (Stratagene)
4.1.4. E. coli media
LB-medium/plates: 1% (w/v) tryptone (Difco)
0.5% (w/v) yeast extract (Difco)
1% (w/v) NaCl
1.5% (w/v) agar (plates)
sterilized by autoclaving
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4.1.5. S. cerevisiae strains
Most yeast strains used in this study are isogenic to DF5. In experiments with the
cim3-1 proteasomal mutant the CMY826 strain was used as WT control. For Yeast-
Two-Hybrid assays the strain PJ69-4a was used.
Table 4-2. Yeast strains
S. cerevisiae strains derived from DF5 WT background
Name Genotype Source
DF5 (WT) his3Δ200, leu2-3,2-112, lys2-801, trp1-1(am), ura3-52 (Finley et al., 1987)
pre1-1 pre1::TRP1, pTX49pre1-1 (Mayer et al., 1998)
Δspt23 Δmga2 spt23::hisG, mga2::LEU2 (Hoppe et al., 2000)
Δspt23 spt23::kanMX this study
Δmga2 mga2::kanMX this study
ufd1-2 ufd1-2 (Hoppe et al., 2000)
Δrsp5 rsp5::HIS3 (Hoppe et al., 2000)
Other S. cerevisiae strains
Name Genotype Source
CMY826 ura3-52, leu2Δ1, his3Δ-200, trp1Δ63, lys2-801, ade2-101,
bar1::HIS3
(Mayer et al., 1998)
cim3-1 cim3-1, ura3-52, leu2Δ1 (Mayer et al., 1998)
cim3-1 Δhrd1 ura3-52, leu2Δ1, his3Δ-200, trp1Δ63, lys2-801, ade2-101,
bar1::HIS3, hrd1::kanMX
this study
Δhrd1 cim3-1, ura3-52, leu2Δ1, hrd1::kanMX this study
rsp5-1 his4-912 ΔR5, lys2-128Δ, ura3-52, rsp5-1 (Huibregtse et al., 1997)
PJ69-4a trp901-, leu2-3,112, ura3-53, his3-200, gal4, gal80,
GAL1::HIS3, GAL2-ADE2, met2::GAL7-lacZ
(James et al., 1996)
4.1.6. S. cerevisiae vectors
CEN plasmids: pYCplac33 (URA3), pYCplac22 (TRP1), pYCplac111 (LEU2)
2µ plasmids: pYEplac195 (URA3), pYEplac112 (TRP1), pYEplac181 (LEU2)
integrative plasmids: pYIplac211 (URA3),pYIplac204 (TRP1), pYIplac128 (LEU2)
(Gietz and Sugino, 1988)
pUG36 (URA3, CEN, MET25 promoter) (Niedenthal et al., 1996)
pSE362 (HIS3, CEN) (Elledge and Davis, 1988)
Yeast-Two-Hybrid vectors: pGAD-C1, pGBD-C1 (James et al., 1996)
4.1.7. S. cerevisiae plasmids
Mga2 constructs are derivatives of previously described mycMga2 version containing
triple myc epitopes introduced directly after the start codon (Hoppe et al., 2000).
mycMga2HA was created by introducing an 3HA tag to the C-terminus of the protein.
HAMga2 protein contained triple HA epitopes inserted at the N-terminus. For the
expression under the control of MET25 promoter, Mga2 constructs were cloned into
the low copy vector pUG36 from which the GFP-encoding fragment was removed
(pUG36ΔGFP). mycMga2ΔTM encodes a truncated protein encompassing amino acids
1-1037. The entire sequence of Mus musculus DHFR (tagged C-terminally with a
3HA cassette) was fused to the C-terminus of mycMga2 (mycMga2-DHFRHA) or
mycMga2ΔTM (mycMga2ΔTM-DHFRHA). DHFR was PCR-amplified from construct XVI,
described previously (Bachmair and Varshavsky, 1989). Plasmids for expression of
Mga2 constructs under the control of GAL1-10 promoter were cloned into an
integrative vector YIplac211. mycMga2(TEV)HA protein is an Mga2 variant with amino
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acids 671-678 replaced with the ENLYFQG sequence (the TEV protease cleavage
site). Truncated Mga2 variants containing ankyrin repeats shown in Figure 2-12 were
tagged with triple HA epitopes at their N-termini and expressed under the control of
the ADH1 promoter from YCplac22 vector. To express Mga2 constructs under the
control of endogenous promoter the 5.1kb HindIII genomic DNA fragment containing
MGA2 locus was subcloned from YEplac181-mycMga2 (Hoppe et al., 2000) into the
integrative YIplac211 or centromeric YCplac22 and YCplac111 vectors. Mutations:
ΔANK (amino acids 719-781 of Mga2), ANK* (mutation of residues 757-761 LHLA to
AAFP) and ΔIPT (amino acids 529-625 of Mga2) were introduced into Mga2
constructs by a PCR-based strategy (see 4.5.3). Mga2 constructs for Yeast-Two-
Hybrid assays (Figure 2-11) were amplified by PCR and cloned into pGAD-C1 or
pGBD-C1 vectors to obtain in frame N-terminal fusions with the activating or binding
domain of Gal4, respectively. In all of the created YTH-constructs, the transactivation
domain, the TM span and the ER lumen domain of Mga2 were omitted.
mycSpt23HA under the control of its own promoter (Hoppe et al., 2000) was
subcloned into the centromeric vector YCplac111. Spt23ΔIPT and ΔANK constructs
lack amino acids 507-598 (encoding the IPT domain) and 709-771 (the ankyrin
repeat domain), respectively. Spt23 deletions shown in Figure 2-5 were created by a
PCR-based strategy. DHFRHA encoding sequence was fused to the C-terminus of the
TM span lacking form of mycSpt23 (residues 1-1005 of Spt23) by a PCR-based
strategy. This construct (mycSpt23ΔTM-DHFRHA) was expressed under the control of
MET25 promoter from pUG36ΔGFP.
6mycHmg2 was subcloned from pRH244 (provided by R.Y. Hampton, University
of California, San Diego; (Hampton et al., 1996) into pUG36ΔGFP and expressed
under the control of the MET25 promoter. Insertion of a 3HA cassette at the C-
terminus resulted in 6mycHmg2HA.
The reporter construct used in Figure 2-13 was subcloned from plasmid D1557
(provided by M. Kalocay, Max Planck Institute of Biochemistry). The XbaI-NsiI
fragment containing the LacZ gene under the control of the OLE1 promoter was
subcloned to XbaI and PstI-partially digested pSE362 vector.
To rescue the Δspt23 Δmga2 strain the plasmid for heterologous expression of
OLE1 was created. The OLE1 ORF was amplified by PCR from yeast genomic DNA
and placed under the control of the ADH1 promoter in YCplac33 or YCplac111.
4.1.8. S. cerevisiae media and solutions
YPD/YPGal: 1% (10 g/l) yeast extract (Difco)
2% (20 g/l) bacto-peptone (Difco)
2% (20 g/l) D-(+)-glucose or galactose
2% (20 g/l) agar (for plates)
sterilized by autoclaving
SC-media/plates: 0.67% (6,7 g/l) yeast nitrogen base (Difco)
0.2% (2 g/l) drop out amino acid mix
2% (20 g/l) glucose, raffinose, or galactose
2% (20 g/l) agar (for plates)
sterilized by autoclaving
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drop out amino acid mix: 20 mg Ade, Ura, Trp, His
30 mg Arg, Tyr, Leu, Lys
50 mg Phe
100 mg Glu, Asp
150 mg Val
200 mg Thr
400 mg Ser
UFAs-containing media were supplemented with oleic, linoleic or palmitoleic acids
(Sigma) resuspended in equal volumes of Nonidet P40 (final concentration of 0.2%
(v/v) each).
Growth media used for experiments with MTX (Sigma) were supplemented with
5mg/ml sulfanilamide (Sigma). MTX was added to a final concentration of 10 µM from
a 55 mM stock solution in 0.1 M NaOH.
Sporulation medium: 1% (w/v) potassium acetate
0.05% (w/v) raffinose
SORB: 100 mM CH3COOLi
10 mM Tris-HCl, pH 8.0
1 mM EDTA, pH 8.0
1 M sorbitol
sterilized by filtration
PEG: 100 mM CH3COOLi
10 mM Tris-HCl, pH 8.0
1 mM EDTA, pH 8.0
40% (w/v) PEG-3350
sterilized by filtration
Zymolase 20T solution: 0.9 M sorbitol
0.1 M Tris-HCl, pH 8.0
0.1 M EDTA, pH 8.0
50 mM DTT (added freshly)
0.5 mg/ml zymolase 20T (ICN Biochemicals)
4.2. Computer-based analyses
For database searches (sequence search and comparison) electronic services were
used provided by the Saccharomyces Genome Database (http://www.yeastgenome.org/)
and the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/).
Most of the protein sequence analyses were done with software programs from
ExPASy Proteomics Server (http://www.expasy.org/). For assessment of protein
domain composition and protein folding, the programs SMART (http://www.smart.embl-
heidelberg.de) and FoldIndex (http://bip.weizmann.ac.il/fldbin/findex) were used,
respectively. DNA sequence analyses (DNA restriction enzyme maps, DNA
sequencing analyses, DNA primer design) were done with DNA-Star (DNA Star Inc.).
Chemiluminescence signals of immunoblots were detected by a CCD camera
(LAS 3000, Fujifilm), quantified with the software program Image Gauge V4.1
(Fujifilm) and processed with Adobe Photoshop (Adobe Systems Inc.). Digitalized
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immunoblot films were processed with Adobe Photoshop (Adobe Systems Inc.). For
the presentation of text, tables, graphs and figures, software programs of the
Microsoft Office package (Microsoft Corp.) were used.
4.3. E. coli techniques
4.3.1. Cultivation and storage of E. coli
Liquid cultures were grown in LB media shaking at 200 rpm at 37 °C. Cultures on
agar plates were incubated at 37 °C. For the selection of transformed bacteria,
ampicillin (50µg/ml) was used. The culture density was determined by measuring the
absorbance at a wavelength of 600 nm (OD600). Cultures on solid media were
stored at 4 °C up to 7 days. For long-term storages, stationary cultures were frozen in
15% (v/v) glycerol solutions at –80 °C.
4.3.2. Preparation of competent E. coli cells
DNA plasmids were transformed into E. coli competent cells by calcium chloride or
by electroporation methods. For the preparation of competent cells, 1 l liquid LB
medium was inoculated with 10 ml of an overnight culture derived from a single E.
coli colony and grown to OD600 of 0.6-0.8 at 37 °C. After chilling the culture flask on
ice for 0.5 h, cells were harvested by centrifugation (10 min, 5000 g, 4 °C). All
following steps were performed with pre-chilled sterile materials and solutions at 4
°C. For the preparation of chemically competent cells, the pellets were carefully
resuspended in 200 ml MgCl2 solution (100 mM). The resuspended cells were
sedimented by centrifugation, resuspended in 400 ml CaCl2 solution (100 mM) and
after incubation on ice for 20 min centrifuged again. Finally, the competent cells were
resuspended in 20 ml CaCl2 solution (100 mM) containing 10% (v/v) glycerol and
stored in 100 µl aliquots at –80 °C. For the preparation of electrocompetent bacteria,
the pellets were washed once with 1 l ice-cold water and once with 0.5 l ice-cold 10%
(v/v) glycerol. Then the cells were resuspended in 3 ml 10% (v/v) glycerol and stored
in 100 µl aliquots at –80 °C.
4.3.3. Transformation of plasmid DNA into E. coli cells
Competent cells were thawed on ice. For the chemical transformation, 50 µl
competent cells were mixed with 10 ng plasmid DNA and incubated on ice for 30
min. Subsequently cells were incubated at 42 °C for 90 s. After the heat shock the
cell suspension was resuspended in 1 ml LB medium without antibiotics and
incubated on a shaker at 37 °C for 1 h. Transformed cells were selected by streaking
out the cell suspension on LB agar plates containing ampicillin and incubated over
night at 37 °C.
For the electroporation, 40 µl competent cells were mixed with 2 µl ligation
sample. The suspension was electroporated in a pre-chilled Gene pulser cuvette, 0.1
cm (Biorad) with a pulse of 1.8 kV and 25 µF at the resistance of 200 Ω. After adding
1 ml LB medium without antibiotics, the suspension was incubated for 1 h on a
shaker at 37 °C. Selection of transformants was carried out on ampicillin-containing
LB agar plates over night at 37 °C.
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4.4. S. cerevisiae techniques
4.4.1. Cultivation and storage of S. cerevisiae
Cultivation of yeast cells was performed according to standard protocols (Ausubel et
al., 1987; Sambrook et al., 1989). Liquid pre-cultures were inoculated with a single
colony-derived yeast from a plate and grew with shaking over night at 30 °C or 23 °C
(thermosensitive mutants). The culture density was determined by measuring the
absorbance at the wavelength of 600 nm (OD600), where OD600 equal 1
corresponds to 1.5x10
7 
cells/ml. The main culture was inoculated with the pre-culture
to OD600 0.1-0.2 and incubated at appropriate temperature with shaking at 150-200
rpm until the culture had reached the mid-log phase of growth (1–5x10
7 
cells/ml).
When UFAs containing growth media were used, cells were washed three times with
water before OD600 measurement. Cultures on solid media were stored at 4 °C up to
1-2 months. For long-term storages, stationary cultures were frozen in 15% (v/v)
glycerol solutions at –80 °C.
4.4.2. Preparation of competent yeast cells
50 ml-culture of yeast cells was inoculated from a fresh pre-culture and grown to a
density of 0.5–0.7 OD600. The cells were pelleted by centrifugation (500 g, 5 min),
washed once with 25 ml sterile water, then with 10 ml volume SORB solution and
resuspended in 360 µl SORB solution. After adding of 40 µl carrier DNA (salmon
sperm DNA, 10 mg/ml, Invitrogen), competent cells were stored in 50 µl aliquots at
–80 °C.
4.4.3. Transformation of yeast cells
For transformation of yeast ~ 0.2 µg of circular or ~ 2 µg linearized plasmid DNA (or
PCR products) was mixed with 10 µl or 50 µl competent cells, respectively. After
addition of 6 volumes of PEG solution, the cell suspension was incubated at RT for
30 min. Subsequently, DMSO was added to a final concentration of 10% and a heat
shock was performed at 42 °C for 15 min. Cells were sedimented by centrifugation
(400 g for 3 min), resuspended in 100 µl sterile water and plated on the respective
SC medium plates. After 2-3 days of incubation at RT (in case of temperature
sensitive strains) or 30 °C transformants colonies were used for further analysis.
When the antibiotic G418 was used for selection, transformed cells were incubated
with shaking in YPD medium for 3 h before they were streaked out onto plates
containing G418. If necessary, transformants were replica-plated on G418-containing
plates to remove false-positive clones.
Genomic integration by homologous recombination
For the stable integration of DNA into yeast genome vectors of the YIplac series
(Gietz and Sugino, 1988) were used. Since they do not contain autonomous
replication elements, only stably integrated vectors are propagated in yeast. Before
transformation, these vectors are linearized by a single cut within the auxotrophy
marker gene. The free DNA ends of the marker gene on the linearized plasmid
recombine with the homologous DNA sequences at the endogenous locus of the
marker gene and enable the vector to integrate.
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A similar strategy was applied for creating yeast strains harbouring
chromosomal gene deletions. This method employs a PCR-based strategy (Knop et
al., 1999; Longtine et al., 1998). PCR product used to transform competent yeast
cells contained a selection marker gene flanked by sequences homologous to the
target gene, allowing homologous recombination within the endogenous locus. The
primers required to target the PCR product to the gene locus were designed to
amplify the selection marker cassette and in addition possessed 50 bp extensions at
their 5’ ends that are complementary to the promoter and terminator sequences of
the target gene. After amplification, the PCR product was precipitated with ethanol,
transformed into competent yeast cells and plated on the selection medium. The
correct recombination was confirmed by PCR analysis.
4.4.4. Analysis of yeast mutants
Mating type analysis of haploid strains
The tester strains RC634a and RC75-7α were used for identification of yeast mating
types. These strains are hypersensitive to the pheromone secreted by yeast of the
opposite mating type. 50 µl of the tester strain culture was mixed with 10 ml of molten
1% (w/v) agar resuspended in YPD (cooled down to 45 °C) and poured over the YPD
plate. Analyzed strains were replica plated on the a- and α-tester agar plates and
incubated for 1-2 days. The tester strains cannot grow in proximity of colonies of the
replica-plated strain displaying the opposite mating type, therefore a halo of clear
agar appears around them, allowing the identification of their mating type. Diploid
cells do not secrete any mating type pheromones and give no halo on both mating
type tester strains plates.
Mating of haploid S. cerevisiae strains
Haploid strains of opposite mating types (MATa, MATα) grown to mid-log growth
phase were mixed and incubated in YPD at 30 °C for 3-4 h. Zygotes were streaked
after mating onto the respective selection plates to select diploid cells.
Sporulation and tetrad analysis of diploid S. cerevisiae strains
Diploid yeast cells were grown to the stationary phase and 500 µl of the culture was
harvested by centrifugation (500 g, 3 min). Cells were washed 3 times with sterile
water and resuspended in 5 ml sporulation medium. After incubation on a shaker at
RT for 3 days, 10 µl of the culture was mixed with 10 µl zymolase-20T solution and
incubated at RT for 10 min. The spores were dissected in tetrads with a
micromanipulator (Singer MSM Systems) and grown on YPD plates for 2-3 days.
Subsequently, tetrads were replica plated and analyzed genotypically on selection
plates for specific markers or by their phenotypes.
4.4.5. Analysis of protein-protein interactions with the yeast two-hybrid
system
Selected truncated variants of Mga2 were fused to the C-terminus of the DNA-
binding (“baits”) or activation domain (“preys”) of the Gal4 protein by cloning them
into pGBD-C1 or pGAD-C1 vectors, respectively. Bait constructs were co-
transformed with empty pGAD-C1 vector to investigate their auto-activation. The
construct encompassing amino acids 514-796 did not activate reporter genes in this
test, whereas constructs 529-1037ΔANK and 514-640 exhibited auto-activation,
which could be blocked on SC –Leu –Trp plates supplemented with 10 mM 3-AT or
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on SC –Ade plates. Various combinations of baits and preys plasmids were
transformed into PJ69-4a cells (James et al., 1996) and plated on SC –Leu –Trp
plates. Equal amounts of transformants were spotted on SC –Leu –Trp –His without
and with 3-AT supplement or SC –Leu –Trp –Ade plates. Physical interaction
between bait and prey proteins leads to reconstitution of the Gal4 transcription factor,
which induces expression of HIS3 and ADE2 reporter genes and allows yeast cells to
grow on the respective selection media.
4.4.6. Phenotype analysis by growth tests
Analysis of the yeast growth phenotype is based on the comparison of growth rates
upon various conditions (e.g. different temperature or presence/absence of 18:1) of
different yeast strains cells spotted in equal amounts on a solid medium. Yeast
cultures grown to mid-log growth phase or collected from fresh plates were diluted
with sterile water to an OD600 of 0.2. In the 96-well microtiter plate 4-5 ten-fold serial
dilutions were prepared. 5µl of each cells suspension were spotted on respective
plates with a 96-pin-stamp and the plates were incubated at different temperatures
for several days.
4.4.7. Expression shut-off experiments
The stability of proteins was determined by cycloheximide chase experiments.
Cycloheximide is an inhibitor of cellular translation and after addition to the growth
medium blocks de novo production of proteins, allowing monitoring over time protein
levels in yeast cells. In case of proteins expressed under the control of the GAL1-10
promoter this approach was combined with selective repression of the promoter in
the presence of glucose in the growth medium (GAL promoter shut-off experiment).
WT and cim3-1 cells expressing 6mycHmg2HA (Figure 2-8) were grown in YPD
medium at permissive temperature to exponential phase and then shifted to 37°C for
90 min prior to addition of cycloheximide. cim3-1 cells expressing mycSpt23HA or
mycSpt23ΔIPTHA (Figure 2-4b and Figure 2-7e) were grown on SC medium
supplemented with 0.2% palmitoleic acid at RT for 3h and then shifted to 37°C for 90
min. Cells were centrifuged, washed, and resuspended in palmitoleic acid-free
medium prior to addition of cycloheximide. Translation was inhibited by
cycloheximide (final concentration 0.5 mg/ml). For each time point, samples
corresponding to OD600 of 1 were withdrawn, and protein extracts were prepared
(see 4.4.8).
Yeast expressing proteins under the control of the GAL1-10 promoter were
grown on plates containing raffinose and galactose (both 2% w/v) for 2-3 days. Cells
were transferred to a liquid medium containing galactose (2% w/v galactose) and
grown to saturated pre-culture. For preparation of the main culture, usually 25 ml
YPGal or SC-Gal medium was inoculated with the pre-culture to OD600 of 0.05-0.1
and grown several hours to reach log-phase of growth. When the protein turnover
was investigated in temperature sensitive mutants ufd1-2 and rsp5-1, these cells
(and the WT cells control) were shifted to the non-permissive temperature (37 °C) for
3 h prior to the start of the promoter shut-off experiment. Cells were harvested by
centrifugation (500 g, 5 min) and resuspended in YPD containing 0.5 mg/ml
cycloheximide. The incubation was continued at respective temperatures and equal
amounts of cells were withdrawn after indicated times for extracts preparation.
Materials and methods
83
4.4.8. Preparation of cell extracts and microsomal fractions
Preparation of denatured yeast extracts
For analysis of cellular levels of proteins and examination of post-translational
modifications of proteins, denatured protein extracts were prepared in order to avoid
proteolysis and de-conjugation during the lysis procedure. Usually, 1 ml of mid-log
phase yeast cells corresponding to an OD600 of 1 were harvested by centrifugation
and resuspended in 1 ml ice-cold water. Subsequently, 150 µl of lysis buffer (1.85 M
NaOH, 7.5% β-mercaptoethanol) was added and placed on ice for 15 min. Next, 150
µl 55% (w/v) trichloroacetic acid (TCA) was added and the mixture was incubated for
10 min on ice. The precipitated material was pelleted by centrifugation (20000 g at 4°
for 10 min) and the supernatant was carefully removed. The pellet was washed once
with acetone, air-dried and resuspended in 50 µl HU sample buffer.
Preparation of native yeast extracts and microsomal fractions
Native proteins extracts were prepared to obtain microsomal fractions and to study
interaction of proteins by immunoprecipitation under native conditions. Yeast cells of
mid-log phase culture were harvested by centrifugation, washed once with ice-cold
water and resuspended in 200-400 µl lysis buffer (Tris-HCl, pH 7.4, 150 mM NaCl)
containing protease inhibitors (complete inhibitors set from Roche, 2 mM PMSF, 5
mM benzamidine, 20 mM NEM). After addition of glass beads (ø 425-600 µm,
Sigma) the cells were lysed by vortexing 4-5 times for 30 s at 4 °C or using a bead
beater (Retsch). The sample tube was perforated with a 23-gauge needle and the
cell lysate was separated from beads by centrifugation. The cell debris was removed
by centrifugation (700 g, 5 min, 4 °C). The whole cell extract contains the soluble
fraction (cytosolic and nuclear proteins) as well as microsomes (ER, nuclear
envelope and other organelles). The cytosolic fraction is partially contaminated with
proteins from the lumen of organelles, which upon the lysis with glass bead are
partially disrupted. For separation of microsomes from the soluble phase, whole cell
extracts were fractionated by high spin centrifugation (20000 g, 1 h, 4 °C).
Determination of protein concentration
Protein concentrations were determined by using the Bradford method (BioRad
protein assay; BioRad) and compared to a BSA standard dilution series by
measuring the OD595.
4.4.9. Investigation of protein localization in cells
Immunofluorescence microscopy
Intracellular localization of proteins was studied by indirect deconvolution
immunofluorescence microscopy. Yeast cells were cultured in sterile-filtered (not
autoclaved) SC medium to OD600 of 1. To fix proteins 1/9 volume of 1M potassium
phosphate buffer, pH 6.5 and 1/9 volume 37% formaldehyde (Sigma) was added to
the culture, and the suspension was incubated on a falcon roller at RT for 1 h. Cells
were harvested by centrifugation (1500 g, 5 min, 4 °C) and the pellet was carefully
washed 3 times in 1ml SP-buffer (0.1 M potassium phosphate buffer, pH 6.5, 1.2 M
sorbitol). Subsequently, cells were resuspended in 900 µl SPβ-buffer (10 ml SP-
buffer, 14 µl β-mercaptoethanol), 100 µl Zymolase 100T solution (2.5 mg/ml in SPβ-
buffer) was added and the digestion reaction was performed at 30 °C for 30 min.
After a 3-step washing with SP-buffer (1500 g, 5 min, 4 °C) cells were resuspended
in 100 µl PBSB-buffer (1 mg/ml BSA in PBS) and the suspension was placed on a
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polylysine-coated slide. After addition of the primary antibody (anti-myc monoclonal,
9E10) the slide was incubated in the dark, in a moist chamber at 4 °C for 12 h. Next,
cells were carefully washed 5 times with PBSB buffer and the fluorophore-coupled
secondary antibody (Alexa Fluor 546 anti-mouse IgG) was added for 2 h at RT (in the
dark). Subsequently, the slide was washed once with PBST (1% (v/v) Triton X-100 in
PBS), 6 times with PBSB-buffer and finally 5 µl DAPI (2.5 µg/ml DAPI in 50% (v/v)
glycerol) was added. The slide was covered with a cover slip, sealed with nail polish
and examined under the microscope.
Membrane fractionation
To investigate membrane localization of proteins membrane fractions were prepared
(see 4.4.8). To analyze whether proteins are peripherally associated with ER,
membrane fractions were divided in equal parts and incubated with a lysis buffer
containing 1 M Na2CO3, pH 11.3, 500 mM NaCl or 0.1% (w/v) SDS for 30 min on ice
with occasional vortexing. Subsequently, samples were subjected to centrifugation
(20000g, 30 min, 4 °C) to separate soluble and membrane-associated fractions, and
further analyzed by immunoblotting.
Proteinase K protection assay
To confirm localization of proteins to the ER lumen, the Proteinase K protection
assay was performed. Cells were lysed as described above (see 4.4.8), except that
the lysis buffer did not contain protease inhibitors. Total lysates were incubated with
Proteinase K (0.2 mg/ml) or Proteinase K and 1% Triton X-100 for 30 min on ice. The
reaction was stopped with PMSF (2 mM final concentration), and proteins were TCA-
precipitated (see 4.4.8) and subjected to Western blot analysis.
4.4.10. Analysis of protein-protein interactions by immunoprecipitation
Immunoprecipitation under native conditions
To examine protein-protein interactions whole cell extracts were subjected to
immunoprecipitation under native conditions. Triton X-100 was added to the lysates
(to a final concentration of 0.1-0.4%) to avoid unspecific binding. To extract integral
membrane proteins (Mga2 p120) 0.2% dodecyl maltoside (Sigma) was added to the
lysates. Immunoprecipitation was carried out with 20 µl slurry anti-HA IgG (3F10;
Roche) or anti-myc IgG (9E10; Santa Cruz) coupled to agarose beads, rotating on a
falcon roller for 2 h at 4 °C. Unspecifically bound material was removed by 4 washing
steps with the lysis buffer containing 0.1% Triton X-100, followed by one washing
step with lysis buffer without detergent. The specifically bound material was eluted
from the beads by incubation with 20 µl HU sample buffer at 65 °C for 15 min.
Cleavage of proteins with the TEV protease
Beads containing immunoprecipitated Mga2(TEV) were washed and resuspended in
600 µl TEV cleavage buffer (Invitrogen). The suspension was divided in two equal
parts and to one of them 20 U of recombinant TEV protease (Invitrogen) was added,
while the second part served as a control sample without enzyme. Both samples
were incubated at 4 °C for 12 h with constant rotating. TEV protease is a site-specific
enzyme, which cleaves between Gln and Gly residues in a seven-amino acid
recognition sequence: Glu-Asn-Leu-Tyr-Phe-Gln-Gly. After the digestion reaction, the
beads were sedimented by centrifugation (1000 g, 2 min, 4 °C). The unbound
material from supernatants was TCA-precipitated (see 4.4.8) and denatured in 20 µl
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HU sample buffer for 10 min at 65 °C. The beads were washed 3 times with a buffer
containing 0.1% Triton X-100, once with PBS and then the bound material was eluted
from beads by incubation in 20 µl HU sample buffer at 65 °C for 15 min. Soluble and
bound proteins were analyzed by immunoblotting.
Microsomes containing Mga2(TEV) were resuspended in 1 ml TEV cleavage
buffer and divided in two equal parts. One part was control sample without TEV
protease and to the other part 30 U of recombinant TEV protease (Invitrogen) was
added. Digestion was performed with constant rolling at 4 °C for 12 h. Membrane
bound material was pelleted by centrifugation (20000g, 45 min, 4 °C), resuspended
in 50 µl HU sample buffer and proteins were denatured at 65 °C for 15 min.
4.4.11. Analysis of protein modification by ubiquitylation
Immunoprecipitation under denaturing conditions
For examination of post-translational modifications of proteins, whole cell extracts
were subjected to immunoprecipitation under denaturing conditions. Cell amounts
corresponding to OD600 of 10 were harvested by centrifugation and lysed in 300 µl 2
M NaOH/7.5% β-mercaptoethanol for 15 min on ice. Proteins were precipitated by
addition of 300 µl 55% TCA and pelleted by centrifugation (20000 g, 15 min, 4 °C).
The protein pellet was resolved in 100 µl boiling buffer (100 mM Tris, pH 11, 3%
SDS) and incubated at 98 °C with shaking for 5 min. After removal of the unsolved
material by centrifugation (16000 g, 5 min), the protein solution was diluted by
addition of 700 µl IP-buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton X-100). For
the immunoprecipitation 0.4 µg polyclonal anti-myc antibody (A-14; Santa Cruz) was
added and the mixture was rotated on a falcon roller for 2 h at 4 °C. After clearing the
sample from occasionally precipitated material by centrifugation (20000 g, 20 min, 4
°C), 20 µl Protein A agarose beads (Amersham Biosciences) was added to bind
antibodies with immunoprecipitated proteins. Unspecifically bound material was
removed by 2 washing steps with washing-buffer (50 mM Tris, pH 7.5, 300 mM NaCl,
1% Triton X-100), one with IP-buffer and one with PBS. The specifically bound
material was eluted from the column by adding 20 µl HU sample buffer and analyzed
by Western blotting.
4.4.12. X-Gal agarose overlay assay
To semi-quantitatively measure lacZ reporter activity, X-Gal agarose overlay assays
were performed. In the presence of β-galactosidase, which is the product of the
LacZ gene, X-Gal is hydrolyzed and yields a blue byproduct. Equal amounts of
yeast were spotted on solid medium and grown for 36 h at 30 °C. On the top of the
plate 10 ml overlay solution was poured (40-45 °C). After the agarose layer became
stiffed, the plate was incubated at 30 °C for 90 min. Yeast clones of high activity of
the reporter promoter turn blue, while less active become light blue or stay colourless.
Overlay solution: 50 mM sodium phosphate buffer, pH 7.0
1% (w/v) SDS
10 mM KCl
1 mM MgCl2
0.4% (w/v) low melting agarose
0.2% (v/v) β-mercaptoethanol
10 mM X-Gal
1% (v/v) DMF
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4.5. Molecular biology methods
4.5.1. Isolation of DNA
Isolation of plasmid DNA from E. coli
LB medium (5 ml) containing the appropriate antibiotic was inoculated with a single
E. coli colony harbouring the DNA plasmid of interest and incubated with shaking for
8-14 h at 37 °C. Plasmids were isolated using kits from the companies Qiagen
(plasmid mini kit) or Macherey-Nagel (nucleospin plasmid quick pure).
Isolation of plasmid DNA from S. cerevisiae
Rapid isolation protocol for plasmid DNA isolation from yeast and direct propagation
in E. coli was used. Saturated yeast culture (1.5 ml) was harvested by centrifugation
(16000 g, 30 s) and sedimented cells were resuspended in 200 µl breaking buffer.
Glass beads (0.3 g; ø 425-600 µm; Sigma) and 200 µl phenol/chloroform/isoamyl
alcohol (24:24:1 v/v/v; Roth) were added and cells were lysed by vortexing for 2 min.
After centrifugation (16000 g, 5 min), 0.5 µl of the aqueous phase containing DNA
was used for transformation of E. coli for plasmid propagation.
Breaking buffer 2% (v/v) Triton X-100
1% (w/v) SDS
100 mM NaCl
10 mM Tris-HCl, pH 8.0
1 mM EDTA, pH 8.0
Isolation of chromosomal DNA from S. cerevisiae
Chromosomal yeast DNA was isolated to serve as a template for the amplification of
yeast genes via PCR. Cells from a saturated yeast culture (10 ml) were sedimented
by centrifugation (1500 g, 5 min, 23 °C), washed once in 0.5 ml water and
resuspended in 200 µl breaking buffer. After addition of 0.3 g glass beads (ø 425-600
µm; Sigma) and 200 µl phenol/chloroform/isoamyl alcohol (24:24:1 v/v/v; Roth) cells
were lysed by vortexing for 3 min. The lysate was mixed with 200 µl TE buffer,
centrifuged for 5 min and then the aqueous layer transferred to a microcentrifuge
tube. DNA was precipitated by adding 1 ml ethanol (100%) and centrifugation (16000
g, 3 min). The pellet was resuspended in 0.4 ml TE buffer. To remove RNA
contamination 30 µl of DNase-free RNase A (1 mg/ml) (Sigma) was added and the
samples were incubated for 5 min at 37 °C. DNA was precipitated with 1 ml ethanol
(100%) and 10 µl of ammonium acetate (4 M), briefly centrifuged and the pellet
resuspended in 100 µl TE buffer. The yield of the isolated DNA was estimated
photometrically (see below).
TE buffer 10 mM Tris-HCl, pH 8.0
1 mM EDTA
sterilized by autoclaving
Precipitation of DNA
For ethanol precipitation 1/10 volume sodium acetate (3 M, pH 4.8) and 2.5 volume
ethanol were added to the DNA solution and incubated at –20 °C for 30 min. The
mixture was centrifuged at 16000 g at 4 °C for 20 min and the pellet was washed
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once with 0.5 ml 70% ethanol. The DNA pellet was air-dried and resuspended in TE
buffer or sterile water.
Determination of DNA concentration in solution
The DNA concentration was photometrically determined by measuring the
absorbance at a wavelength of 260 nm (OD260). An OD260 of 1 equals a
concentration of 50 µg/ml double-stranded DNA.
4.5.2. Molecular cloning methods
Digestion of DNA with restriction enzymes
The sequence-specific cleavage of DNA with restriction enzymes was performed
according to standard protocols (Sambrook et al., 1989) and the instructions of the
manufacturer (New England Biolabs). Usually, 5-10 units of the restriction enzyme
was used for the digestion of 1 µg DNA. Reaction samples were incubated in the
appropriate buffer at the recommended temperature for 1-2 h. Linearized vectors
were incubated at 37 °C for 1 h with the calf alkaline phosphatase (New England
Biolabs) to avoid the re-circularization of DNA in the ligation reaction.
Separation of DNA by gel electrophoresis
DNA samples were mixed with 6x DNA loading buffer and subjected to
electrophoresis in 0.8-2% agarose gels containing ethidium bromide (final
concentration 0.5 µg/ml) at 100 V in TBE buffer. Separated DNA fragments were
visualized by using an UV transilluminator (324 nm). The size of the fragments was
estimated by standard size markers (1 kb DNA ladder from Gibco and 100 bp DNA
ladder from New England Biolabs).
TBE buffer 5x 90 mM Tris
90 mM boric acid
2.5 mM EDTA, pH 8.0
sterilized by autoclaving
DNA loading buffer 10x 0.5% (w/v) SDS
0.25% (w/v) bromophenol blue or orange G
0.25% (v/v) glycerol
25 mM EDTA, pH 8.0
Isolation of DNA fragments from agarose gels
DNA fragments separated by gel electrophoresis were excised from the agarose gel
using a razor blade. The DNA was extracted from the agarose block using kits from
Qiagen (QIAExII, QIAquick gel extraction kit) or Macherey-Nagel (Nucleospin Extract
II) and eluted with an appropriate volume of sterile water.
Ligation of DNA fragment
The amounts of isolated insert DNA fragments and linearized vectors were estimated
by electrophoresis in an agarose gel containing ethidium bromide. For the ligation
reaction a vector to insert ratio of 1:3 – 1:10 was used. The reaction sample (10 µl)
contained ~ 100 ng of vector DNA and 10 units of T4 DNA ligase (New England
Biolabs). The ligation reaction was performed at 23 °C for 1 h or at 6 °C for 6-12 h.
Before transformation of electrocompetent E. coli cells, the ligation sample was
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dialyzed against de-ionized water for 15 min using a nitrocellulose filter (pore size:
0.05 µm, Millipore).
DNA sequencing
Sequencing of DNA was performed by the Microchemistry Core Facility of the Max
Planck Institute of Biochemistry on an ABI 3730 sequencer. The sample usually
contained 0.5 µg of plasmid DNA and 5 pmol primer. Sample preparation and
sequencing reactions were performed with the DYEnamic ET terminator cycle
sequencing kit (Amersham-Pharmacia).
4.5.3. Polymerase chain reaction (PCR)
PCR is an easy and quick method to specifically amplify DNA fragments from small
amounts of DNA template. This technique was applied for cloning, amplification of
cassettes for chromosomal gene disruptions, and analysis of recombination events
after chromosomal integration into yeast strains or of cloned inserts. All PCR
reactions were prepared in 0.2 ml tubes (Biozym) on ice, in a volume of 15 µl or 50 µl
for preparative PCR. A typical reaction was set up as follows:
50 ng plasmid DNA or 0.2 µg genomic DNA
10x PCR buffer 1.5 µl
50 mM MgCl2 (optional) 0.6 µl
10 mM dNTPs mix 0.6 µl
10 µM forward primer 0.75 µl
10 µM reverse primer 0.75 µl
Taq DNA polymerase 0.6 µl
sterile de-ionized water to 15 µl
For amplification of fragments used for cloning, Vent or Phusion DNA
polymerases (New England Biolabs) were used, as they are characterized by lower
error rates than the Taq polymerase. The reaction samples amplified with the
Phusion polymerase were prepared according to the manufacturers’ instructions.
To pre-select E. coli transformants containing desired plasmids, a colony form a
plate was transferred directly into a reaction sample with a pipette tip. During an
initial denaturation step, bacterial cells are lysed and their released DNA serves as a
template for the amplification via PCR.
For the verification of chromosomal gene disruptions, the yeast colony-PCR
method was applied. Cells from a single yeast colony were resuspended in 40 µl 20
mM NaOH, to which a small amount of glass beads (ø 425-600 nm, Sigma) was
added and shaken in a thermomixer at 100 °C at maximum speed for 5 min. After
brief centrifugation 4 µl of the supernatant was used as a template DNA for the PCR
reaction carried out in a 50 µl volume. For amplification PCRs a Mastercycler
(Eppendorf) was used.
The reaction profile (e.g. annealing temperature or elongation time) was
adjusted according to the quantity and quality of the template DNA, the length and
G/C content of the oligonucleotides and the length of the amplified sequence. In
general, the following program was used:
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initial denaturation 94 °C 3 min
94 °C 45 s
30 amplification cycles 50 °C 45 s
72 °C 2 min
72 °C 10 min
cooling 4 °C
Site-directed mutagenesis
To introduce point mutations or deletions in DNA sequences, a PCR-based strategy
was developed according to the Quikchange method (Stratagene). This method uses
two complementary oligonucleotide primers with the codon to be mutated in the
middle flanked by at least 15 additional base pairs, each corresponding to the target
sequence. The reaction was performed in a volume of 50 µl and prepared as follows:
50 ng plasmid DNA
10x Pfu Buffer (Stratagene) 5 µl
10 mM dNTPs mix 1.25 µl
10 µM forward primer 1.25 µl
10 µM reverse primer 1.25 µl
Pfu Turbo DNA polymerase (Stratagene) 1 µl
sterile de-ionized water to 50 µl
Cycling parameters:
initial denaturation 95 °C 30 s
95 °C 30 s
18 amplification cycles 55 °C 60 s
68 °C 2 min / kb of plasmid
cooling 4 °C
In the PCR, both strands of the plasmid with the desired mutation are fully
amplified. To eliminate the template DNA, the reaction was digested with DpnI at 37
°C for 1.5 h. This restriction enzyme cleaves specifically methylated template DNA.
After dialysis, the PCR product can be directly used for transformation. The
mutagenesis was verified by DNA sequencing.
Fusion of DNA fragments by PCR
For direct fusion of DNA fragments, a two-step PCR method was used. The first step
involves two conventional PCR reactions, in which oligonucleotide primers are
partially complementary at their 5’ ends to the adjacent fragments that are fused to
create the chimeric product. The second PCR step leads to the fusion of the PCR
fragments generated in the first step and their amplification using the complementary
sites and flanking primers. The final PCR product is a direct fusion of two fragments
of DNA without introducing any additional sequences (e.g. restriction enzymes sites).
For these reactions the highly accurate and processive Phusion DNA polymerase
(New England Biolabs) was used.
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4.5.4. Protein analysis
SDS polyacrylamide gel electrophoresis (SDS-PAGE)
For separation of proteins, SDS-PAGE was preformed in Mighty Small or Tall
electrophoresis chambers (Hoefer) using 4-12% gradient Bis-Tris polyacrylamide
gels (Invitrogen or self-poured; see below). These gels allow good resolution of
proteins over a large range of different molecular weights (10-200 kDa) and do not
require stacking gels. Electrophoresis was carried out at a constant voltage of 100 V
in the MOPS running buffer. Protein samples were prepared in Laemmli or HU
sample buffer by boiling for 10 min at 95 °C or 65 °C, respectively. For denaturation
of the 6mycHmg2HA protein (in Figure 2-8) which possess a large TM domain,
denaturation of samples was performed by incubation at 37 °C for 15 min, to avoid
formation of high molecular weight aggregates. Finally, gels were removed from the
electrophoresis chamber and the separated proteins were transferred to PVDF
membranes (see below). Alternatively, gels were incubated for 30 min in the Coomassie
brilliant blue solution, which stains non-specifically virtually all proteins. To remove the
non-bound day, gels were destained for 12 h in destaining solution and photographed.
Solutions for pouring 4-12% Bis-Tris SDS-PAGE gradient gels:
4% solution 12% solution
30% acrylamide/0.8% bis-acrylamide
(ProtoGel; National diagnostics) 5.9 ml 17.8 ml
2.5 M Bis-Tris-HCl pH 7.5 6.5 ml 6.5 ml
65% (w/v) sucrose - 3.4 ml
10% (w/v) SDS 225 µl 225 µl
10% (w/v) ammonium peroxidisulphate 225 µl 225 µl
TEMED (Sigma) 45 µl 22.5 µl
H2O 32.1 ml 17 ml
HU sample buffer: 200 mM Tris, pH 6.8
8 M urea
5% (w/v) SDS
1 mM EDTA
1.5% (w/v) DTT
0.1% (w/v) bromophenol blue
Laemmli sample buffer: 2% (w/v) SDS
20% (v/v) glycerol
100 mM Tris base
60 mM EDTA
0.1% (w/v) bromophenol blue
MOPS running buffer: 50 mM MOPS
50 mM Tris base
3.5 mM SDS
1 mM EDTA
Coomassie brilliant blue solution: 20% (v/v) methanol
10% (v/v) acetic acid
0.1% (w/v) Coomassie Brilliant Blue R-250
Materials and methods
91
Destaining solution 20% (v/v) methanol
10% (v/v) acetic acid
Immunoblotting
Western blotting enables for specific detection of proteins separated according to
their sizes by the SDS-PAGE technique (see above). Proteins were transferred by
electrophoresis form the polyacrylamide gel to a PVDF membrane (Immobilon-P,
Millipore) in Mini Transfer Tank (Hoefer) in the blotting buffer at a constant voltage of
80 V for 1.5 h at 4 °C. The PVDF membrane was blocked with 5% (w/v) skim milk
powder (Fluka) solution in TBST for 1 h. After addition of the primary antibody, blots
were incubated for 1 h at RT or overnight at 4 °C. Subsequently, the membrane was
washed 3 times for 5 min in TBST and incubated for 1 h with the solution of
secondary antibody coupled to horseradish peroxidase (Dianova) dissolved in 1:5000
ratio in 5% milk in TBST. The blot was washed 5 times in TBST and detection was
carried out with the chemiluminescence kit (ECL or ECL plus, Amersham) followed
by exposure to ECL hyperfilm (Amersham) or to a CCD (charged-coupled device)
camera (LAS 3000, Fujifilm). Digitalized images acquired by a CCD camera were
quantified with the software program Image Gauge V4.1 (Fujifilm).
Blotting buffer: 250 mM Tris base
1.92 M glycine
0.1% (w/v) SDS
20% (v/v) methanol
TBST: 25 mM Tris-HCl, pH 7.5
137 mM NaCl
2.6 mM KCl
0.1% (v/v) Tween 20
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Abbreviations
µ micro (x10-6)
2µ multi-copy vectors
3-AT 3-aminotriazole
AAA ATPases associated with various cellular activities
AD Gal4 activation domain
ANK ankyrin repeat domain
APC/C anaphase promoting complex/cyclosome
ARS autonomous replicating sequence
ATP adenosine 5-triphosphate
BD Gal4 DNA binding domain
bp base pairs
BSA bovine serum albumin
CCD camera charged-coupled device camera
cDNA complimentary DNA
CEN centromeric (low copy vectors)
CHX cycloheximide
C-terminal carboxyl-terminal
C-terminus carboxyl terminus
CUE coupling of ubiquitin conjugation to endoplasmic reticulum
degradation
DAPI 4',6-diamidino-2-phenylindole
DMF N,N-dimethylformamide
DMSO dimethylsulfoxide
DNA deoxyribonucleic acid
dNTP deoxy nucleoside triphosphate
DTT dithiothreitol
DUB deubiquitylating
E1 ubiquitin activation enzyme
E2 ubiquitin conjugation enzyme
E3 ubiquitin ligase
E4 polyubiquitylation factor
EDTA ethylenediaminetetraacidic acid
ER endoplasmic reticulum
ERAD ER-associated degradation
F farad
g gram
g gravitational constant (6.6742x10-11 N m2 kg-2)
Gal galactosidase
GRR glycine-rich region
h hours
HECT homologous to E6AP C-terminus
Ig immunoglobulin
IP immunoprecipitation
IPT immunoglobulin-like/plexins/transcription factors
k kilo (x103)
kan kanamycine
kb kilo base pairs
Abbreviations
102
kDa kilo dalton
LB Luria-Bertani
M molar
m milli (x10-3)
MAT mating type
MHC major histocompatibility complex
min minutes
MOPS 3-N-Morpholinopropane sulfonic acid
mRNA messenger RNA
MTX methotrexate
MW molecular weight
n nano (x10-9)
NEM N-ethylmaleimide ADP adenosine 5-diphosphate
N-terminal amino-terminal
N-terminus amino terminus
OD optical density
ORF open reading frame
PAGE polyacrylamide gel electrophoresis
PBS phosphate-buffered saline
PCNA proliferating cell nuclear antigen
PCR polymerase chain reaction
PEG polyethylene glycol
PMSF phenylmethylsulphonyl fluoride
PVDF polyvinylidene fluoride
RING really interesting new gene
RIP regulated intramembrane proteolysis
RNA ribonucleic acid
rpm rounds per minute
RT room temperature
RUP ubiquitin/proteasome-dependent processing
s seconds
S sedimentation coefficient (Svedberg)
SC synthetic complete medium
SCF Skp1-Cul1-F-box complex
SDS sodium dodecylsulfate
TAD transactivation domain
TBE Tris/borate/EDTA buffer
TBS Tris-buffered saline
TCA trichloro acidic acid
TEMED N,N,N’,N’-tetramethylethylenediamin
TM transmembrane
Tris Tris(hydroxymethyl)aminomethane
U unit
Ub ubiquitin
UBA ubiquitin associated
UBC ubiquitin conjugating enzyme
UFA unsaturated fatty acid
UFD ubiquitin fusion degradation
UIM ubiquitin interacting motif
UPS ubiquitin/proteasome system
Abbreviations
103
UV ultraviolet light
V volt
v/v volume per volume
w/v weight per volume
WT wild type
YPD yeast bactopeptone dextrose medium
Ω ohm
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